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The present thesis is written in a cumulative manner. It includes the following four 
manuscripts: 
Chapter 4.1: Wunderlich et al.: “Retinal functional alterations in mice lacking the 
intermediate filament proteins glial fibrillary acidic protein (GFAP) and vimentin” 
(manuscript);  
Chapter 4.2: Wunderlich et al.: “The inability to produce glial fibrillary acidic protein 
(GFAP) and vimentin does not protect photoreceptors in a genetic model of 
degeneration” (manuscript);  
Chapter 4.3: Wunderlich et al., 2010: “Altered expression of metallothionein-I and -II 
and their receptor megalin in inherited photoreceptor degeneration”;  
Chapter 4.4: Sancho-Pelluz et al., 2008: “Sialoadhesin expression in intact 
degenerating retinas and following transplantation”. 
Chapters 4.3 and 4.4 have already been published in the ARVO journal Investigative 
Ophthalmology & Visual Science. Chapters 4.1 and 4.2 are included as manuscripts. 
The results of the four studies are summarized in chapter 4 before each manuscript. 
Major parts of the experimental work were performed at the University of Lund, in the 
Institute of Clinical Sciences, Division of Ophthalmology, in Lund, Sweden, under the 
supervision of Dr. Maria Thereza Perez. The ERG experiments were carried out in 
collaboration with project partners at the Center for Ophthalmology, Institute for 
Ophthalmic Research of the University of Tübingen, Germany, within the EARN-RET 
agreement between the Medical Faculty of the University of Tübingen and the 
Medical Faculty at the University of Lund. The microarray analysis was carried out by 
partners at the Institute de la Vision in Paris, France, within the EU EVI-GenoRet 
program. 
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1. Introduction 
Our senses determine how we perceive the world, and accordingly, how we can act and live 
in it. For us humans, sight is the dominant sense, and the ability to see has a great impact on 
the quality of life. Blindness is a substantial obstacle to leading an economically and socially 
independent life. Inherited degenerations of the retina are an important cause of blindness. 
So far, there is no known cure, and most of the diverse underlying disease mechanisms are 
not well understood yet. Many studies suggest a role for secondary reactive changes 
mediated by the retinal glial cells (macroglia and microglia) in the progression of retinal cell 
dysfunction and loss. With this thesis, I want to provide new insights into the role of glial cells 
during retinal function, disease and therapy. Specifically, I focused:  
 
i. on the glial intermediate filament proteins glial fibrillary acidic protein (GFAP) and 
vimentin and their potential impact on retinal function (chapter 4.1) and on the 
progression of retinal degeneration (chapter 4.2);  
ii. on the putative neuroprotective proteins metallothionein-I and -II, which are 
expressed by activated retinal glial cells  (chapter 4.3); 
iii. and on the cell adhesion protein sialoadhesin, which is expressed by a subset of 
retinal microglia after intraocular transplantation of neonatal retinal cells in wild-type 
mice and in a mouse model for retinal degeneration (chapter 4.4). 
 
In the following chapters, I will first give an introduction to the human sensory system, 
particularly the eye with the retina and common forms of neurodegeneration with the 
emphasis on retinal degenerations, before I present the methodologies with which I have 
approached my projects. Since the model animals of choice were rats and mice, I will point 
out major differences between man and rodent, where appropriate. The outcome of my 
studies is described in the four papers/manuscripts that are included in this thesis (chapter 
4). 
1.1 Sensory systems 
Parts of the nervous system are specialized to detect physical or chemical input from the 
environment. These sensory systems consist of receptors that transform a stimulus into a 
neuronal signal (stimulus transduction) and neuronal pathways that conduct the information 
to the perceptive region of the brain. Further processing may lead to conscious awareness 
(sensation). 
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Sensory receptors are either specialized endings of neurons that initiate action potentials 
upon stimulation (e.g. the chemosensory receptors of the olfactory receptor neurons), or 
separate cells that synapse with afferent neurons (e.g., the hair cells of the inner ear and the 
photoreceptor cells in the retina). Each receptor is specific to a certain type and intensity 
range of stimulus but might react in its typical manner even by nonspecific stimuli with high 
intensity; we see stars after strong pressure on the eye for example. The magnitude of a 
stimulus is represented by a graded receptor potential that results in different action potential 
frequencies, depending on stimulus strength, summation of several receptor responses, and 
receptor sensitivity. Adaptation to a constant stimulus might decrease the receptor sensitivity 
(Smith, 2008).  
The five classical senses in humans were already mentioned by Aristotle: smell, taste, touch, 
hearing and vision. In the following, the latter will be explained in more detail. 
1.2 General anatomy of the eye 
The eye functions as an optical system, collecting light from the surrounding and focusing it 
onto the light-sensitive retina in the back of the eyeball. A pigmented circular muscle, the iris, 
controls the diameter of its central aperture called pupil, and thereby the amount of incident 
light. The iris and the anterior chamber in front of it are covered by the transparent cornea. In 
terrestrial animals, the curved cornea is the strongest refractive element. To ensure 
transparency, the cornea is avascular. Instead it is provided with oxygen through the tear film 
on the outside. At the inner surface, the cornea is nourished by diffusion from the aqueous 
humor in the anterior chamber, the main purpose of which is to keep a steady pressure for a 
rounded surface. The cornea borders on a tough fibrous continuation of the dura mater, 
namely the sclera, which supports the shape of the eyeball and prevents light passage from 
the side. In the posterior chamber, behind the iris, lies the biconvex crystalline lens 
(Wormstone and Wride, 2011). The lens has only about half the refractive power of the 
cornea. But, as opposed to the fixed curvature of the cornea, the shape of the human lens 
can be changed by the action of the ciliary muscles in order to focus the incoming light from 
various distances to the photoreceptors in the retina (accommodation). The lenses of rodents 
become proportionally much bigger than human lenses and are less flexible. UV-light can 
pass through the lenses of mice and rats (Henriksson et al., 2010), while human lenses filter 
all wavelengths except light of the visible range (Bova et al., 1999; reviewed in Gouras and 
Ekesten, 2004). This may have to be considered when extrapolating functional studies on 
mice to humans. The space between the lens and the back of the eye is filled with vitreous 
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humor that holds the actual light-sensitive tissue in place: the retina 
(http://webvision.med.utah.edu/). See figure 1 for a schematic overview of the eye: 
 
 
 
Figure 1: A schematic section through a human eye. (Reproduced from 
www.webvision.med.utah.edu). Light would hit the eye at the cornea from the left side (yellow arrow), 
pass through the pupil and the lens and eventually reach the retina in the back of the eye. 
1.3 The retina 
The thin neural retina is part of the brain, having derived from invaginations of the anterior 
neuroectoderm during embryogenesis. It is specialized to convert light into electrical signals 
that are transmitted via the optic nerve to the brain. The vertebrate retina is distinctly 
structured into three cellular (nuclear) layers that are separated by synaptic (plexiform) 
layers. The light-sensitive photoreceptor cells are situated in the outermost layer of the 
retina; hence incoming light has to pass the inner layers first: 
the inner limiting membrane (ILM) that separates the vitreous body from the retina 
the nerve fiber layer (NFL)  
the ganglion cell layer (GCL) 
the inner nuclear layer (INL)  
the outer plexiform layer (OPL) 
and the outer nuclear layer (ONL)    
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Apically, the photoreceptors interconnect with the retinal pigment epithelium (RPE), a single 
cell layer just behind the neural retina (Kolb et al., 2001; http://webvision.med.utah.edu/). 
 
 
Figure 2: (A) Light micrograph of a rat retinal section stained with hematoxilin and eosin. (B) 
Schematic section through a human retina.  
The inner limiting membrane that separates the vitreous body from the retina is made by astrocytes 
and Müller cell endfeet. Astrocyte cell bodies and processes are mainly located in the nerve fiber 
layer.  Moreover, the nerve fiber layer consists of axons from retinal ganglion cells that converge at the 
optic disc into the optic nerve. The cell bodies of the ganglion cells are located in the ganglion cell 
layer (GCL) together with cell bodies of displaced amacrine cells. In the inner plexiform layer (IPL), 
ganglion cells get input from bipolar cells. Additionally, horizontal interactions with amacrine cells take 
place. Bipolar cells and most amacrine cells have their cell bodies in the inner nuclear layer (INL), as 
well as horizontal cells and interplexiform cells. Also Müller glial cells that vertically span the whole 
retina have their cell bodies in the INL (note the Müller cell in the scheme; it is drawn in gray on the left 
side. Photoreceptors, the vertically oriented bipolar cells, and horizontal cells synapse in the outer 
plexiform layer (OPL). The photoreceptors have their cell bodies with the nucleus in the outer nuclear 
layer (ONL). Most of the cell organelles are located in the inner segments beyond the outer limiting 
membrane (OLM), which is formed by connections between apical Müller cell processes and the 
photoreceptor cells. The thin connecting cilium (CC) connects the inner segment (IS) with the outer 
segment (OS) of the photoreceptor. Apically, the outer segments interconnect with the retinal pigment 
epithelium (RPE), a single cell layer just behind the neural retina. (Scheme reproduced from 
http://webvision.med.utah.edu/) 
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1.4 Retinal neurons 
Photoreceptor cells are specialized to convert light into neuronal signals. Signal integration 
begins already in the post-photoreceptor neurons in the retina, when these signals are 
transmitted via bipolar cells to the output neurons of the retina, the ganglion cells.  A 
certain degree of preliminary processing takes place through modulation by horizontal, 
amacrine, and interplexiform cells. Final processing takes place in the visual cortex, in the 
posterior pole of the occipital lobe (Kolb et al., 2001; Smith, 2008). 
1.4.1 Photoreceptors 
Photoreceptors are highly polarized neurons. Their axons synapse with the next order 
neurons in the outer plexiform layer. Photoreceptor somata are located in the outer nuclear 
layer. The apical end of a photoreceptor beyond the outer limiting membrane, which is 
formed by connections between apical Müller cell processes and the photoreceptor cells, 
consists of an inner and an outer segment. A thin connecting cilium connects the inner 
segment with the outer segment of the photoreceptor. Most of the cell organelles are located 
in the inner segment, most importantly the Golgi apparatus and large numbers of 
mitochondria that are important for the metabolically highly active photoreceptor cell. 
Phototransduction, on the other hand, takes place in the outer segment. The outer segment 
is filled with stacks of invaginated membranes, which carry the photo-active pigment 
molecules and other transduction components.  
Two types of photoreceptors exist in the vertebrate retina: rods and cones. In humans, most 
of the cones are concentrated in the rod-free central fovea within the macula lutea, whereas 
the periphery is particularly rich in rods. In mice, the cones, which comprise approximately 
1% of the photoreceptors, are distributed evenly (Jeon et al., 1998). Rods have thin and long 
segments, and their membrane disc stacks are detached from the outer membrane. They 
contain the visual pigment rhodopsin and are very sensitive and reactive under dim light 
conditions. Rhodopsin is therefore used as a marker protein for rod photoreceptor cells 
(Hicks and Barnstable, 1987: Hicks and Molday, 1986; chapter 4.1 and 4.2 of this thesis). 
The shorter, conically shaped cones respond only to brighter stimuli but are faster to react 
and recover. Cones are responsible for visual acuity. The membrane discs of cones stay 
connected to the outer membrane. They contain different cone opsins that respond to distinct 
wavelengths thereby enabling color vision. Humans are typically trichromatic, which means 
that they have three different kinds of cones: S-cones (Short wavelength) have a response 
maximum in the blue light, M-cones (Medium wavelength) in the green, and L-cones (Long 
wavelength) in the red range. Mice and rats are dichromatic. They have cones that are 
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sensitive for middle-wavelength light and cones that respond to UV light (Jacobs et al., 
1991). 
1.4.2 Bipolar cells 
Bipolar cells transmit the signals from rod and cone photoreceptors to the ganglion cells. One 
rod-driven and 11 cone-driven bipolar cell types have been discovered so far that can be 
divided into two groups: ON-bipolar cells and OFF-bipolar cells. ON-bipolar cells depolarize 
upon a light stimulus, while OFF-bipolar cells hyperpolarize under the same conditions, but 
depolarize recognizing dark areas on a light background. Both, ON- and OFF-bipolar cells 
can express rapidly or slowly inactivating glutamate receptors, so additional distinctions 
between sustained and transient bipolar cells can be made. Further differentiation can be 
made according to their diverse connectivity to photoreceptors and postsynaptic targets. 
Cone bipolar cells synapse directly with ganglion cells, whereas rod bipolar cells transmit 
their signals first to amacrine cells that connect to cone bipolar cells or form a feedback-loop 
back to the rods. An antibody against the protein kinase C (PKC), which has been shown to 
be expressed by rod bipolar cells, was employed to identify the latter in chapter 4.1 (Ruether 
et al., 2010; Wässle and Boycott, 1991). Stainings with an antibody against recoverin were 
performed to mark a subset of cone bipolar cells (and photoreceptors)(Dizhoor et al., 1991;  
Milam et al., 1993). Most bipolar cells contact several cones, being described as diffuse 
bipolar cells, but in the primate macula, the special midget bipolar cells receive input from 
only one cone, each contributing to the high visual resolution of this area. (reviewed in:  Kolb 
et al., 2001; Masland, 2012: http://webvision.med.utah.edu/). 
1.4.3 Ganglion cells 
The final output neurons of the retina are the ganglion cells. Their axons converge to form 
the optic nerve that transmits the signals from the intermediate neurons via action potentials 
to the brain. Numerous distinct ganglion cell types have been discovered that differ from 
each other e.g., by molecular and electrophysiological properties or morphology like dendritic 
arborization. Some ganglion cells have very wide receptive fields, while others, like the 
midget ganglion cell, might receive signals from as little as one single midget bipolar cell 
allowing a high resolution one-to-one signal transmission. Again, ON-center and OFF-center 
cells constitute two basic types of ganglion cells, being excited by brighter (ON) or darker 
(OFF) stimuli than the mean background. Ganglion cells integrate the opposing signals of 
center and surrounding allowing the perception of forms, color, contrast, and directional 
movement (Kolb et al., 2001; Masland, 2012; http://webvision.med.utah.edu/; Jacobs et al., 
2004; Lyubarsky et al., 1999). A subpopulation of ganglion cells is also photosensitive. They 
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contain the pigment melanopsin and are involved in the pupillary light reflex and daily 
adjustment of the circadian rhythm but do not participate in image formation (Hattar et al., 
2002; Provencio et al., 2000). 
1.4.4 Horizontal cells 
A lot of signal processing takes place in the different layers of the retina. The first lateral 
processing of the visual signals is carried out by horizontal cells. The cell bodies of horizontal 
cells are situated in the inner nuclear layer, next to the outer plexiform layer, where they 
interconnect the photoreceptor terminals in both, a feedback and a feed-forward manner. 
Two types of horizontal cells exist, though a third type is discussed for some species. One 
type is connecting both, rods via the axons and cones via the dendrites, whereas the second 
type synapses with cones only. Horizontal cells receive input from many photoreceptors, 
covering a large receptive field. The receptive field becomes even larger through gap 
junction connections between different horizontal cells. One of the main functions of this 
modulation is to shape adaptational responses to light intensity changes (Kolb et al., 2001; 
Masland, 2012; http://webvision.med.utah.edu/). 
1.4.5 Amacrine cells 
The third type of interneurons in the INL are amacrine cells that have their cell bodies at the 
inner border of the INL or in the ganglion cell layer (displaced amacrine cells). Approximately 
30 different amacrine cell types can be distinguished, mainly by their size and stratification 
pattern, and so far, many of their functions are not understood yet (Masland, 2012). The 
different amacrine cells are often divided into three major groups: the wide-field, medium-
field, and narrow-field amacrine cells. The probably best known type, the narrow-field AII 
amacrine cell, transmits the signals of many rod bipolar cells to cone bipolar cells, which then 
pass it on to the ganglion cells. This classical rod pathway increases the light sensitivity to a 
degree that enables the detection of the absorption of a single photon (Wässle, 2004). AII 
cells express the calcium-binding proteins parvalbumin and calbindin, which were therefore 
used as marker proteins in chapter 4.1 and 4.2 (Haverkamp and Wässle, 2000; Wässle et 
al., 1995). The wide-field A17 cell collects even input from thousands of rod-driven bipolar 
cells and forms feedback loops back to the rod bipolar terminals. Amacrine cells mostly 
release inhibitory neurotransmitters such as GABA (e.g. A17) and glycine (e.g. AII) but also 
other neuroactive substances, which may diffuse longer distances across the retina 
(Masland, 2012). Most amacrine cells are axonless, lack obvious polarity, and often 
interconnect via gap junctions. It is suggested that the strength of the electrical coupling is 
dependent on the level of background light (Hartveit and Veruki, 2012). Amacrine cells seem 
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to be involved in center-surround interactions, reciprocal inhibitions between the ON- and 
OFF-pathways, periphery effects and direction-selective light responses (Wässle, 2004). 
1.4.6 Interplexiform cells 
Most vertebrate retinas have a fourth type of interneuron: the interplexiform cell. 
Interplexiform cells link the two plexiform layers; they receive input from amacrine cells in the 
inner plexiform layer and have synaptic output upon the neurons of the outer plexiform layer. 
So far, not much is known about their exact function (Kolb et al., 2001; 
http://webvision.med.utah.edu/). 
1.5 Phototransduction 
The visual pigment, integrated in the membranes of the photoreceptor outer segments, is 
composed of the transmembrane protein opsin and retinal, a derivative of vitamin A. When a 
photon hits the chromophore, it converts from the isoform 11-cis-retinal to an all-trans form 
inducing conformational changes in the opsin (bleaching). The activated opsin promotes the 
dissociation of the GTP-binding alpha-subunit of transducin, which in turn activates the 
cGMP-phosphodiesterase that catalyzes the conversion of cGMP to 5´-GMP. Thus, dark-
adapted photoreceptors have very high levels of cGMP that keep membrane-bound cGMP-
gated cation channels open. This leads to an influx of mainly Na+, but also Ca2+. Accordingly, 
photoreceptors are constantly depolarized in the dark and release the neurotransmitter 
glutamate. Since one single photon can stimulate several hundreds of cGMP-
phosphodiesterases with this cascade, cGMP levels decrease significantly upon light 
stimulation, and the cation channels close, causing hyperpolarization of the photoreceptor 
cells, and diminishing levels of released glutamate (http://webvision.med.utah.edu/). 
Mutations in components of the phototransduction chain often lead to retinal degenerations. 
A deletion in the beta-subunit of the cGMP-phosphodiesterase, for example, is causative for 
the photoreceptor degeneration retinitis pigmentosa in patients (McLaughlin et al., 1995) and 
mice (Bowes et al., 1990; Chang et al., 2002). The retinal degeneration (rd) 1 mouse, 
carrying a nonsense-mutation in the relevant gene, is therefore often used as a model 
organism to study causes, consequences and possible therapies for this devastating group 
of diseases. Likewise, in chapter 4.2, 4.3, and 4.4 included in this thesis, rd1 mice were 
employed as one model of choice. 
The regeneration of the visual pigment after photoexcitation occurs partly in the 
photoreceptor cells but involves the adjacent tissue as well: the all-trans-retinal separates 
from the opsin protein and is reduced to all-trans-retinol within the outer segment before 
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being released from the cell. With the help of the carrier molecule interphotoreceptor retinoid-
binding protein (IRBP), all-trans-retinol is transferred through the extracellular compartment 
to the retinal pigment epithelium, where the 11-cis-retinal isoform is restored involving 
different proteins, including e.g. the cellular retinal-binding protein (CRALBP), which was 
used as a marker for retinal pigment epithelium and Müller glia cells in chapter 4.1 and 4.3 in 
this thesis. Blood-derived all-trans-retinol can also be fed into the visual cycle. The recycled 
11-cis-retinal moves back to the photoreceptor, again chaperoned by IRBP, and is re-
conjugated to opsin to newly form a light sensitive visual pigment. Rod photoreceptors rely 
completely on this retinal pigment epithelium-dependent rod visual cycle, whereas cone 
photoreceptors can additionally use 11-cis-retinol provided from Müller cells, which is, 
however, still much less characterized (Saari, 2012). 
1.6 Non-neuronal cells 
1.6.1 Retinal pigment epithelium 
The retinal pigment epithelium is a single cell layer of flattened, hexagonal, melanin-
pigmented epithelium between the neural retina and the choroid. The melanin granules in the 
retinal pigment epithelium absorb abundant photons preventing blurred images by reflecting 
light strays. With tight junctions between its cells, the epithelium is part of the blood-retina-
barrier, controlling the entry of nutrients, e.g., glucose and retinol, from the choroidal 
vasculature behind it. In the reverse direction, the epithelium transports water, ions and 
metabolic end products from the subretinal space to the blood (reviewed in (Strauss, 2005)). 
Furthermore, the retinal pigment epithelium interacts structurally and functionally with 
photoreceptors and is important for the maintenance of visual function (see above). With 
their apical processes, one retinal pigment epithelial cell envelopes the photoreceptor outer 
segments of approximately 20 to 30 photoreceptor cells in the human retina (Gao and 
Hollyfield, 1992). New membrane discs are constantly added at the base of the 
photoreceptor outer segments, pushing the older discs towards the distal end where they are 
shed from the tip. The retinal pigment epithelial cells phagocytose those photoreceptor outer 
segment discs and digest them by lysis. Shedding of rod discs mostly happens at light onset, 
whereas cone outer segment pieces are mainly shed at light offset (Strauss, 2005). A 
mutation in the Mertk gene that leads to the failure of disc uptake and consequently of 
phagocytosis is the basis for retinal degeneration in a group of patients (Gal et al., 2000) and 
in the RCS (Royal College of Surgeons) rat (D'Cruz et al., 2000), one of the examined animal 
models in chapter 4.3 of this thesis. Many growth factors that are important during 
development and maintenance of the retina and the choroidal vasculature are secreted by 
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the retinal pigment epithelium (Strauss, 2005). It expresses the metal-binding proteins 
metallothionein-I and -II (Oliver et al., 1992; chapter 4.3). Last but not least, the retinal 
pigment epithelium contributes to the immune defense of the retina by innate and adaptive 
immunity mechanisms, expressing Toll-like receptors, complement components, major 
histocompatibility complex (MHC) class I and II molecules, and a variety of cytokines, just as 
macrophages and dendritic retinal pigment epithelial do (Detrick and Hooks, 2010). During 
the cause of several diseases, activated cells may also proliferate and migrate (Li et al., 
2007; reviewed in (Schraermeyer and Heimann, 1999). 
1.6.2 Retinal glia 
Approximately ten times more glial cells than neurons exist in the central nervous system. 
Glial cells support neurons structurally and metabolically, but also interact actively with 
neurons and vasculature, the retinal pigment epithelium, and each other. There are three 
different types of glia in the vascularized retina: microglia, radial Müller cells, and astrocytes 
(reviewed in Bringmann et al., 2006; Newman, 2009). 
 
 
Figure 3: Retinal glia cells. (A) Two ramified microglia cells (asterisks) in the inner plexiform layer of 
a PN42 RCS (Royal College of Surgeons) rat stained with isolectin B4 (IB4), which also labels vessels 
(arrowhead). (B) Section of a PN28 mouse retina stained for the Müller cell marker cellular retinal-
binding protein (CRALBP). Müller cell somata are located in the middle of the inner nuclear layer 
(INL). Müller cell processes span from the inner limiting membrane at the inner surface of the retina to 
the outer limiting membrane, which is located apically of the outer nuclear layer (ONL). Note how the 
Müller cell end feet coat a vessel (arrowhead) in the ganglion cell layer (GCL). (C) Astrocytes in the 
nerve fiber layer of a flat-mounted PN35 mouse retina stained with a fluorophore-conjugated antibody 
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against the glial fibrillary acidic protein (GFAP). Astrocytes grow in close association with vessels. 
Scalebar: 50 µm. 
1.6.3 Microglia 
An important part in the local host defense is carried out by retinal microglia. Microglia are of 
hematopoietic origin and invade the retina during development. In the healthy rodent retina, 
the ramified microglia reside in the inner retinal layers, mainly in the inner plexiform layer. 
Human retinal microglia are distributed in all retinal layers (reviewed in (Chen et al., 2002). 
Resting microglia are structurally very dynamic, constantly monitoring the surrounding area 
with their long, highly mobile protrusions (reviewed in Karlstetter et al., 2010; Langmann, 
2007). Invading microorganisms, injury, and degeneration rapidly activate microglial cells. 
They change to a more amoeboid shape with only few branched processes, divide and 
migrate to the place of insult, where they phagocytose debris and release a range of 
cytokines and chemokines, initiating both inflammatory processes and tissue repair 
(reviewed in Chen et al., 2002; Karlstetter et al., 2010). Neurons that die by apoptosis during 
normal retinal development are also phagocytosed by microglia (Newman 2009). The 
expression of metallothionein-I and -II (see chapter 1.11.2) in retinal microglia was examined 
in chapter 4.3. In chapter 4.4, the expression pattern of sialoadhesin (see chapter 1.11.3) 
was assessed in healthy and degenerating retinas as well as after intraocular transplantation 
of neonatal retinal cells. Several surface proteins are commonly used as marker proteins for 
microglia, as for instances CD11b (in chapter 4.3 and 4.4), the isolectin IB4 (chapter 4.3), 
and tomato lectin (chapter 4.3) (reviewed in (Langmann, 2007)). 
1.6.4 Radial glia: Müller cells 
The principal macroglial cells of the retina are the Müller cells, discovered and first described 
by the anatomist Heinrich Müller in 1851 (Müller, 1851). Their cell bodies are located in the 
middle region of the inner nuclear layer, and their distal and proximal processes span almost 
the entire thickness of the retina, thereby providing structural support and limiting the width of 
the retina. The apical villi restrict the retina at the outer limiting membrane, and the so-called 
endfeet, enlarged structures at the vitreous side, form the inner limiting membrane together 
with astrocytes (Newman, 2009). The geometry of Müller cells, with conical endfeet and 
elongated cell shape, oriented in the direction of the passing light, facilitates image transfer 
through the retina with minimal loss and distortion. Thereby, Müller cells act as optical fibers 
(Franze et al., 2007). Like astrocyte endfeet, Müller cell endfeet coat the retinal vessels in the 
nerve fiber layer and, additionally, also within the retina, mediating neurovascular coupling, a 
signaling process to adjust the blood flow to the activity-dependent oxygen needs of the 
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retina (Newman, 2009). Furthermore, glial endfeet support the blood-retina barrier that 
isolates the retina and restricts uncontrolled passage of water and solutes (reviewed in 
(Bringmann et al., 2006)). Fine secondary processes of the Müller cells contact every retinal 
cell and fill out all space that is left by neurons and vessels. This allows for the close 
interactions between Müller cells and neurons. 
Müller cells most probably participate in the recycling of photopigments from the 
photoreceptors (reviewed in Wang and Kefalov, 2009; Wang and Kefalov, 2011)). They  
metabolize glucose and provide the resulting lactate/pyruvate to the photoreceptors 
(Bringmann et al., 2006; Poitry et al., 2000; Poitry-Yamate et al., 1995). Rapid uptake of 
glutamate through high affinity glutamate-aspartate transporters (GLAST) ensures a low 
glutamate concentration in the extracellular space. Thus, neuronal signals are terminated 
quickly, and any glutamate excitotoxicity is prevented. Other neurotransmitters, like GABA 
and glycine, are also removed by Müller cells. Glutamate is processed in several different 
ways. The glutamine synthetase (GS) uses ammonia to recycle glutamine, and this 
neurotransmitter precursor is provided back to the neurons (Bringmann et al., 2009; Matsui 
et al., 1999). Both, GLAST and GS are commonly used as Müller cell markers (see also 
chapter 4.1, 4.2, and 4.3 of this thesis. The glutathione synthetase converts glutamate, 
cysteine, and glycine to glutathione. Glutathione is an antioxidant that protects the retina 
against oxidative damage. Müller cells influence neuronal signaling not only by rapid 
neurotransmitter uptake, recycling and provision of neurotransmitter precursors, but also by 
releasing glutamate and other substances, which modulate excitability (Bringmann et al., 
2006; Newman and Zahs, 1998). 
Müller cells contain bundles of intermediate filaments made of vimentin and glial fibrillary 
acidic protein (GFAP) (see chapter 1.11.1), though the latter is expressed only at very low 
levels unless the glial cells get activated. GFAP and vimentin are therefore often used as 
markers for activated glia/gliosis, as e.g., in chapter 4.3. The effect of intermediate filament-
deficiency on normal retinal function as well as on the progression of retinal degeneration 
was examined in chapter 4.1 and chapter 4.2, respectively. 
Müller cells produce numerous neurotrophic factors and cytokines that act on neurons: such 
as basic fibroblast growth factor (bFGF), brain-derived neurotrophic factor (BDNF), nerve 
growth factor (NGF), neurotrophin-3, neurotrophin-4, and glial cell line-derived neurotrophic 
factor (GDNF) (Bringmann et al., 2006; Newman, 2009; Wahlin et al., 2000). The putatively 
neuroprotective protein metallothionein is also expressed by Müller cells (Gerhardinger et al., 
2005; Wunderlich et al., 2010), see also chapter 4.3. 
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Important for neuronal function and excitability are parameters like pH, water and ion 
concentration in the extracellular space. Müller cells are important players in maintaining 
homeostasis through several acid/base transport systems, water channels (e.g., aquaporins, 
AQP) and ion channels (e.g., inwardly rectifying potassium channels, Kir) (reviewed in  
(Bringmann et al., 2006; Newman, 2009)). The expression of the two latter was examined in 
healthy and degenerating retinas of mice lacking the intermediate filaments GFAP and 
vimentin (chapter 4.1 and 4.2). 
1.6.5 Astrocytes 
The typical macroglial cells of the nervous system are astrocytes. Astrocytes have a flat, 
almost two-dimensional, star-like shape. They contain much of the intermediate filament glial 
fibrillary acidic protein (GFAP), which is therefore often used as a marker for astrocytes. 
During retinal development, the astrocytes migrate through the optic nerve head into the 
retina, forming a framework for the retinal vasculature that develops shortly after. They stay 
mostly restricted to the nerve fiber layer and in close contact to the blood vessels. Species 
with no retinal circulation, e.g., guinea pigs, do not have retinal astrocytes (Newman, 2009). 
1.7 Blood supply 
The retina is metabolically highly active and has the highest oxygen consumption per unit 
weight of any tissue. Thus, a sufficient blood supply is very important, and a minimal 
interference with the passing light has to be ensured. The outer retina is therefore indirectly 
nourished by the choroid behind the retinal pigment epithelium, while the retinal vasculature 
supplies the inner two thirds. Except for the central fovea, which is avascular to facilitate high 
acuity vision, and a small avascular rim at the very periphery of the retina, the human as well 
as murine and rat retinas are completely vascularized (holangiotic), whereas the retinas of 
some animals, like the rabbit, are only partly vascularized and rely more on nutritive support 
from the choroid. During development, a third vessel network, the transient hyaloid 
vasculature, supplies the lens and the retina. All ocular vessels originate from a branch of the 
internal carotid artery, namely the ophthalmic artery (reviewed in Kur et al., 2012). 
1.7.1 The choroid 
The choroid consists of three vascular layers delimited by the Bruch’s membrane towards the 
retinal pigment epithelium and the suprachoroidea on the outer surface attached to the 
sclera. The choroidal capillaries are fenestrated with especially large pores enabling a high 
permeability. Aside from supplying the outer retina, the choroid is also involved in 
thermoregulation, modulation of intraocular pressure, and adjustment of the position of the 
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retina by changes in choroidal thickness (reviewed in Nickla and Wallman, 2010). In contrast 
to the retinal vessels, the smooth muscles of the choroidal circulation are innervated by 
sympathetic and parasympathetic nerves (reviewed in Kur et al., 2012; Nickla and Wallman, 
2010; Saint-Geniez and D'Amore, 2004). 
1.7.2 The retinal vasculature 
The retinal blood vessels branch off the central retinal artery, which enters the retina through 
the optic nerve, and are organized in two interconnecting planar networks. During retinal 
development, astrocytes spread from the optic nerve head towards the peripheral retina, 
guiding the outgrowth of a superficial plexus located in the nerve fiber layer and ganglion cell 
layer. Subsequently, a deeper plexus between the inner nuclear layer and outer plexiform 
layer develops, sprouting from the primary plexus. The venous system is similarly arranged, 
with the central retinal vein leaving the retina along the optic nerve again. Astrocyte-derived 
vascular endothelial growth factor (VEGF) is thought to play a key role in the vascular 
development; however, recent studies have demonstrated that retinal vessels can form 
independently of VEGF (Weidemann et al., 2010). Still, the temporal and spatial distributions 
point to a relationship during development. Astrocytes and Müller glia stay in close contact 
with the retinal vessels, controlling their distribution and, as mentioned above, contributing to 
the tight blood-retina-barrier (reviewed in Kur et al., 2012; Riva et al., 2011; Saint-Geniez and 
D'Amore, 2004). 
1.7.3 The hyaloid vasculature 
The retinal vascular network is fully mature only after birth. During retinal development, prior 
to the formation of the retinal vessel net, the lens and the developing inner retina are 
supported by the hyaloidal vasculature. The hyaloid artery enters the eye cup through the 
embryonic fissures, branches into the vitreous humor as the vasa hyaloidea propria, and 
ensheaths the lens. The main vessels branch over the lens surface, forming a dense 
capillary network, the so-called tunica vasculosa lentis  At the anterior margin of the optic 
cup, the capillary network merges into the annular vessel, a loop of the hyaloid artery, and 
connects to the choroidal system, which accomplishes the venous drain, since the hyaloidal 
system consists only of arteries. From the annular vessel, the tunica vasculosa lentis 
spreads over the anterior sector of the lens forming the pupillary membrane. Since the fully 
developed lens has a very low metabolism, it can be nourished by diffusion from the aqueous 
and the vitreous humor alone. The hyaloidal vessels therefore regress before birth in humans 
and within the first three postnatal weeks in mice (Ito and Yoshioka, 1999). Defective hyaloid 
retraction may lead to different eye pathologies (Saint-Geniez and D'Amore, 2004). 
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1.8 Neurodegeneration 
The progressive loss of neuronal function and integrity of a specific subpopulation of neurons 
is called neurodegeneration (Przedborski et al., 2003). The different diseases of this large 
and very heterogeneous group are usually categorized based on the affected localization 
and/or the dominant clinical symptoms. Within the central nervous system, many 
neurodegenerative diseases affect also the retina. Recent studies suggest that the retina is 
affected in mouse models of Alzheimer’s disease as well as in human patients, affecting 
especially the ganglion cells, the optic nerve, and the vasculature. This fact could become 
important as there is so far no possibility for an early and accurate diagnosis of Alzheimer’s 
disease in living patients (reviewed in Chiu et al., 2012; Guo et al., 2010). In Parkinson's 
disease, there is evidence for visual disturbances regarding visual acuity, contrast sensitivity, 
color vision, and motion perception, as well as visual hallucinations (Archibald et al., 2009). 
Disrupted retinal structure and function, especially of the dopaminergic neurons, is probably 
responsible for such problems, additionally to malfunctioning cortical processing (Archibald et 
al., 2009). Visual impairments, specifically on the level of the retina, are being discussed for 
Huntington’s disease as well (Helmlinger et al., 2002; O'Donnell et al., 2008; Paulus et al., 
1993; Petrasch-Parwez et al., 2005). Much better explored are the visual deficits during the 
course of spinocerebellar ataxias 7 (SCA 7). The retinal degeneration starts with cone 
photoreceptor loss in the central fovea, but spreads over the whole retina as the disease 
progresses and eventually also affects rod photoreceptors and the inner retina leading to 
complete blindness (Aleman et al., 2002; Michalik et al., 2004; Hugosson et al., 2009).  
Many neuronal degenerations affect the retina specifically: 
1.9 Retinal degeneration 
1.9.1 Predominance 
According to the World Health Organization (WHO), about 39 million people were estimated 
to be blind in 2010 (http://www.who.int/blindness/en/). While infectious diseases and 
operable cataracts are major causes of vision loss in economically less developed areas of 
the world, retinal degenerations take the lead in the most industrialized countries. However, 
the specific prevalence may vary greatly, e.g., by ethnicity. One major risk factor for retinal 
degenerations is aging; about 82% of the blind are over 50 years old 
(http://www.who.int/blindness/en/). 
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1.9.2 Glaucoma 
Second to cataract, glaucoma is the leading cause of blindness worldwide (Resnikoff et al., 
2004). Glaucoma is the term that describes disorders with a distinct type of optic nerve 
damage that leads to irreversible defects of the visual field. It is characterized by the 
progressive loss of retinal ganglion cells and their axons, leading to changes in the optic disc 
that are visible on fundus examinations. A major risk factor for glaucoma is elevated 
intraocular pressure (IOP) (Caprioli and Varma, 2011). Normally, the IOP stays steady as a 
result of a balanced rate of aqueous humor formation and fluid removal. In many glaucoma 
patients, this homeostasis is disturbed. But glaucoma may also occur despite normal IOP. 
Recent studies suggest an involvement of hypoxia, oxidative stress, excitotoxicity, and 
autoimmune processes in the pathogenesis (reviewed in (Rieck, 2013)). Glaucoma may lead 
to blindness, and so far there is no cure known. However, lowering the IOP may stop or slow 
the progression in some cases (reviewed in (Caprioli and Varma, 2011)). 
1.9.3 Age related macular degeneration 
Age-related macular degeneration (AMD) is another leading cause of blindness, especially in 
the elderly of European descent. The prevalence among people over the age of 75 is 1:4 
(Klein et al., 2004; van Leeuwen et al., 2003). The immune system seems to be involved in 
the disposition for the disease, as specific haplotypes for certain components of the 
complement system have an increased or decreased risk for developing AMD (Hageman et 
al., 2005; Haines et al., 2005). A hallmark of AMD is the formation of drusen - subretinal, 
extracellular deposits that are composed of glycoproteins and lipids - in the Bruch’s 
membrane of the macula. A limited number of small drusen in the peripheral retina is normal 
in the aged eye, but greater number, size, and confluency are common risk factors for AMD 
(Klein et al., 2004; reviewed in Katta et al., 2009 and Coleman et al., 2008). Other features of 
the disease are structural changes of the Bruch's membrane, lipofuscin accumulation in the 
retinal pigment epithelium, and geographic atrophy in the macular region (Coleman et al., 
2008). The retinal pigment epithelium is affected most, but big parts of the outer nuclear layer 
degenerate progressively as well, which leads to the irreversible loss of central vision. In the 
late stage of the disease, AMD is commonly divided into the 'dry' and the 'wet' form. 
Approximately 10-20% of the patients develop wet AMD. Wet AMD is the more severe form 
due to choroidal neovascularization that enters the subretinal space, where leaking, scarring, 
and possible retinal detachment cause the majority of the cases of legal blindness in AMD. 
The neovascularization in the wet form is treated with thermal photocoagulation, 
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photodynamic therapy, and anti-angiogenic (anti-VEGF) therapy (reviewed in Coleman et al., 
2008 and Joussen and Bornfeld, 2009). So far, there is no cure for dry AMD. 
1.9.4 Diabetic retinopathy 
In industrialized countries, the most common cause of visual impairment in people of 
working-age is diabetic retinopathy (reviewed in Heng et al., 2013). Approximately 40% of 
diabetic people show signs of diabetic retinopathy; one third of them suffer from vision-
threatening conditions (Cheung et al., 2010; Heng et al., 2013). Primarily, diabetic 
retinopathy is defined as a vascular complication: impaired retinal vessel walls and changed 
blood properties during diabetes may cause capillary occlusions and pathologically higher 
permeability that lead to ischemia and blood leakage in the retina (Jackson and Barber, 
2010; Kollias and Ulbig, 2010). The local hypoxia leads to elevated levels of vascular 
endothelial growth factor (VEGF) and other growth factors, which in turn stimulate 
neovascularization in the proliferative form of diabetic retinopathy (Kollias and Ulbig, 2010). 
Similarly to wet AMD, diabetic retinopathy is thus mostly treated by photocoagulation and 
anti-angiogenic (anti-VEGF) and anti-inflammatory therapy (Heng et al., 2013; Heng et al., 
2013). Nevertheless, diabetic retinopathy is not a mere micro-vascular disease but also leads 
to retinal neurodegeneration and dysfunction, as well as glial activation, in parallel, if not 
before the onset of vascular changes (Antonetti et al., 2012; Johnson et al., 2013). It is thus 
currently debated which is the initial cause and what is consequence (Heng et al., 2013). 
Numerous interconnected biochemical mechanisms seem to be involved in the 
pathogenesis, including oxidative stress, protein kinase C (PKC) activation, differentially 
regulated cellular metabolism, signaling and release of growth factors (Cheung et al., 2010; 
Heng et al., 2013). However, the exact molecular connection between altered blood sugar 
levels and the appearance of neurovascular changes remains elusive (Heng et al., 2013).  
1.9.5 Pigmentary retinopathies (retinitis pigmentosa) 
The term retinitis pigmentosa refers to a heterogeneous group of inherited retinal 
degenerations that is characterized by a progressive and irreversible loss of rod 
photoreceptor cells, followed by cone cell death. Later in the disease, other cell types may 
degenerate as well, and vessel abnormalities may occur. Disease onset and progression can 
vary substantially. In some cases, retinitis pigmentosa is first noticed during childhood and 
advances over several decades. Usually, the first symptom is night blindness, followed by 
progressive vision loss from the periphery towards the center in daylight as well, reduced 
visual acuity, and loss of cones, eventually leading to complete blindness. Fundus 
examinations show retinal pigment deposits, starting in the periphery.  
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Electroretinogram (ERG) measurements can reveal altered photoreceptor responses 
regarding amplitudes and latencies even in childhood, before the first symptoms are noticed 
(Hamel, 2006)(Hartong et al., 2006). To date, more than 60 genes have been identified at 
which mutations cause retinitis pigmentosa (RETNET database, 
http://www.sph.uth.tmc.edu/retnet/sum-dis.htm#B-diseases; information retrieved in 
November 2013). Mutations that lead to retinitis pigmentosa are primarily mutations in rod-
specific genes, many of them in the rhodopsin gene (Athanasiou et al., 2013) or other 
proteins involved in phototransduction (reviewed in (Delyfer et al., 2004)). Further disease-
causing genes encode for structural proteins, transcription factors, proteins involved in 
intracellular transport, signaling, photoreceptor differentiation, and many more. But also 
genes specific to other cell types, e.g., RPE cells, and even ubiquitously expressed genes 
may cause retinitis pigmentosa. The prevalence of non syndromic retinitis pigmentosa is 
about 1:4,000 (Hamel, 2006). 
Around one quarter of the retinitis pigmentosa cases are not restricted to the eye but are part 
of a syndrome. Overall, there are over 30 different syndromes in which retinitis pigmentosa is 
part of the disease. The most frequent one is the human Usher syndrome, in which retinitis 
pigmentosa occurs along with hearing impairment, and sometimes balance difficulties 
(Wolfrum, 2011). Around 5% of retinitis pigmentosa patients suffer from the Bardet-Biedl 
syndrome, where retinitis pigmentosa is often associated with obesity, cognitive impairment, 
polydactyly, hypogenitalism, and renal disease (Hamel, 2006; Hartong et al., 2006).  
1.9.6 Pigmentary retinopathies (cone rod dystrophy) 
With a prevalence of 1:40,000, the cone rod dystrophy is much rarer than retinitis 
pigmentosa, but the disease progression is more rapid and severe, leading much faster to 
legal blindness (Hamel, 2007). Retinal pigment deposits are primarily found in the macular 
region. The primary cone photoreceptor cell degeneration is followed by the loss of rods. 
Thus, the first symptoms are a decrease in the visual acuity, central scotomas, color vision 
deficiency, and photophobia. Night blindness, loss of peripheral vision, and vessel 
attenuations occur later. Early during the disease, the electroretinogram (ERG) displays 
delayed photopic responses, in later stages the response amplitudes decrease dramatically. 
Most cone rod dystrophies are non-syndromic, but they may also be associated with some 
syndromes, such as the Bardet-Biedl syndrome or SCA7 (Hamel, 2007). 
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1.9.7 Leber congenital amaurosis (LCA) 
Approximately 5% of all hereditary retinopathy cases are based on Leber congenical 
amaurosis (LCA), the most severe infantile onset retinal dystrophy (Chung and Traboulsi, 
2009). Caused by a variety of recessive single-gene defects, LCA is characterized by very 
low visual acuity, severely reduced ERG signals of either rods, cones, or both, nystagmus, 
absent pupillary responses and photophobia (Chung and Traboulsi, 2009)(Estrada-Cuzcano 
et al., 2012)(Hamel, 2007). The relatively mild form of LCA, caused by gene defects in the 
retinal pigment epithelium-specific protein 65 kDa (RPE65), was the first retina degeneration 
that was approached with gene-based therapy in humans (Chung and Traboulsi, 2009). 
1.10  Cell death mechanisms 
Numerous mutations in a variety of genes encoding for very different protein families may 
cause neurodegeneration, including retinal degenerations (RETNET database, 
http://www.sph.uth.tmc.edu/retnet/). Although the disease-causing mutations are often 
known, the downstream events leading to cell death remain most often obscure. Yet, many 
disease processes converge on common cell death mechanisms. Some well-described cell 
death concepts are programmed cell death mechanisms, such as apoptosis and autophagy, 
which are regulated by intracellular, energy-consuming (signaling) cascades, or necrosis, a 
more passive event resulting in autolysis and inflammatory responses, most often also 
affecting the surrounding tissue.  
1.10.1 Apoptosis 
Apoptosis, the best-described cell-death mechanism, is morphologically characterized by 
condensation of the nucleus, membrane blebbing, reduction of cellular volume, rounding-up 
and budding of the cell, and finally engulfment by phagocytic cells before leakage of any cell 
contents (Martin and Henry, 2013; Murakami et al., 2011; Murakami et al., 2013; Sancho-
Pelluz et al., 2008). Any damage of neighboring tissue and inflammation is avoided during 
this well-regulated cell removal - be it during development or due to cellular damage. 
Classically, the biochemical changes are mediated by activated caspases, a family of 
cysteine proteases, and for a long time, caspase-driven apoptosis has been thought to be 
the relevant mechanism of cell death in retinal dystrophies (Leist and Jäättelä, 2001; Lohr et 
al., 2006). However, apoptosis during retinal degeneration may also occur independently of 
caspase activation (Doonan et al., 2003).  
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1.10.2 Autophagy 
There is evidence that autophagy contributes to a second form of programmed cell death 
that is distinct from apoptosis. Autophagy is defined by the lack of cellular condensation and 
fragmentation but the formation of double- or multimembrane vacuoles (autophagosomes) 
that fuse with lysosomes forming autolysosomes. This is where the content, cytoplasmic 
material and organelles, is degraded (Murakami et al., 2013). Yet, autophagy also seems to 
be important for cell survival as it regulates the cellular homeostasis by removing 
dysfunctional organelles and proteins and thereby providing recycled energy (Murakami et 
al., 2013). While it is clear that autophagy takes place during retinal degeneration, especially 
when apoptosis is prevented, its role in either promoting or protecting against cell death 
remains elusive (Murakami et al., 2013). 
1.10.3 Necrosis 
Several studies have shown that both autophagy and apoptosis are linked to necrosis 
(Murakami et al., 2013; Sancho-Pelluz et al., 2008). Features of necrosis are swelling of 
cytoplasm and organelles, thus an increasing cellular volume, along with plasma membrane 
rupture, which leads to the release of cellular content, often causing inflammation (Murakami 
et al., 2011). Usually, necrosis is a reaction to external factors. Although earlier thought to be 
purely passive, necrosis has now been shown to involve regulated signal transduction 
pathways as well (Murakami et al., 2011). This programmed necrosis is called necroptosis 
(Murakami et al., 2011).  
The predominant cell death patterns might change during different stages of the disease. In 
fact, the various mechanisms are not necessarily separated events but may have 
overlapping features or occur in combination in the degenerating retina (Sancho-Pelluz et al., 
2008; Trifunović et al., β01β; Wright et al., 2010). 
1.10.4 Cellular stress factors 
With its unique structure and highly specialized physiology, the retina has to be finely tuned 
to integrate function and survival. Many stress factors are able to disturb this balance 
towards photoreceptor cell death, especially when mutations make the cells even more 
vulnerable, no matter whether the mutations affect photoreceptor specific genes or disturb 
more general functions (Wright et al., 2010). The above mentioned cell death mechanisms 
are tightly controlled by signaling pathways, either promoting or preventing cell death. 
Factors triggering pro-apoptotic cascades include excitotoxicity, mitochondrial dysfunction, 
endoplasmatic reticulum (ER) stress, and oxidative stress (Jing et al., 2012). 
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1.10.5 Misfolded proteins 
Major stressors are misfolded proteins. Protein synthesis is a complex process during which 
approximately one third of the synthesized proteins is not folded correctly even under normal 
circumstances (Schubert et al., 2000). The continuous shedding and replacement of 
photoreceptor discs requires a very high protein turnover. Mutations that lead to misfolded 
proteins (e.g., many rhodopsin mutations) challenge the cell’s quality control mechanisms 
even more (Athanasiou et al., 2013). Many mechanisms have evolved to avoid or remove 
misfolded proteins that could affect normal function. Accumulation of misfolded proteins in 
the endoplasmatic reticulum triggers the unfolded protein response (UPR), which leads to 
inhibition of protein synthesis and increased protein folding capacity and degradation, 
respectively (Athanasiou et al., 2013). The endoplasmatic reticulum associated degradation 
acts in three steps: recognition of the misfolded proteins, retrotranslocation into the cytosol, 
and degradation through the ubiquitin proteasome system. However, the UPR has been 
shown to occur even independently of protein misfolding in retinal degenerations and is thus 
discussed to be a common process, activated as a response to degenerative events 
(Athanasiou et al., 2013). If the endoplasmatic reticulum stress remains despite 
counteractive efforts, cell death may be induced actively. Prolonged UPR can generate 
reactive oxygen species, which in turn affects the functionality of the ER (Haynes et al., 
2004).  
1.10.6 Oxidative stress 
Oxidative stress occurs when the generation of reactive oxygen species (ROS), such as 
singlet oxygen, superoxide and hydrogen peroxide, as well as reactive nitrogen species, 
exceeds the capacity of the cell’s counter mechanisms, ultimately harming the cell, because 
high concentrations of ROS mediate damage to lipids and membranes, proteins, and nucleic 
acids (reviewed in (Valko et al., 2007)). ROS are normal byproducts of the mitochondrial 
respiratory chain (Valko et al., 2007). The retina, one of the tissues in the body with the 
highest metabolic activity, a large oxygen gradient between the different layers, and very 
high membrane content in the photoreceptor outer segments, is particularly vulnerable to 
oxidative damage. Excessive ROS in photoreceptors may also originate from the exposure to 
light in the presence of abundant photosensitizing molecules like retinoids (Sun and Nathans, 
2001; reviewed in Athanasiou et al., 2013 and Wright et al., 2010) and decline of energy 
utilization and resulting hyperoxia during retinal degeneration (Wright et al., 2010). Indeed, it 
could be shown that oxidative damage occurs during the course of retinal degeneration 
(Sanz et al., 2007; chapter 4.3), in parallel with a downregulation of defense systems (Ahuja 
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et al., 2005; Ahuja-Jensen et al., 2007). Under normal conditions, the effects of harmful ROS 
are counterbalanced by repair mechanisms, antioxidant enzymes such as glutathione-S-
transferase and glutathione peroxidase, and non-enzymatic antioxidants. Among the latter 
are metallothioneins (Ruttkay-Nedecky et al., 2013), which were the focus of chapter 4.3 of 
the present thesis. 
1.11 Secondary reactive changes 
Normal development and survival of retinal cells rely on an equilibrium of pro- and anti-
survival factors. In the case of retinal degenerations, this balance tips over towards cell 
death. Most frequently, photoreceptors and ganglion cells are the primary targets. Although 
the disease-causing mutations might affect only one single type of cells, the neighboring cells 
are likely to be affected by the new situation. This is the reason why retinitis pigmentosa, for 
example, is leading to legal blindness: the cones die secondarily, possibly due to lack of 
structural (Hewitt et al., 1990) or trophic support (Faktorovich et al., 1990; Léveillard et al., 
2004) by the rods or to hyperoxia associated with oxidative stress (Komeima et al., 2006; 
Shen et al., 2005). Furthermore, remodeling and degeneration of third order neurons 
occasionally takes place (Gargini et al., 2007; Strettoi et al., 2002). At the same time, 
secondary reactions occur, in the vulnerable cells themselves, but also in the non-neuronal 
elements of the retina: vasculature, retinal pigment epithelial cells, macroglia, and microglia.  
Some of the vessel alterations, i.e. vascular occlusions and neovascularization, are 
already mentioned above (chapter diabetic retinopathy, chapter AMD). As a result of several 
retinal diseases, e.g. proliferative diabetic retinopathy and AMD, as well as breakdown of the 
blood-retina-barrier, retinal pigment epithelium cells can get activated. Activated retinal 
pigment epithelium cells can reenter the cell cycle, proliferate and migrate (Hiscott et al., 
1999; Miller et al., 1986). They react to changes of certain cytokine levels, such as TNF-α, IL-
1ȕ, and IFNȖ by altered secretion of a variety of chemokines, cytokines, and extracellular 
matrix proteins (Shi et al., 2008). The levels of some cytokines, as for example TGF-ȕ, 
regulate the expression of antigen-presenting molecules and thus the inflammatory 
reactivity of microglia (D'Orazio and Niederkorn, 1998; Paglinawan et al., 2003; reviewed 
in Langmann, 2007). Activated microglia change shape, divide and migrate. Several studies 
have shown that activation of microglia and recruitment of macrophages from the circulation 
are associated with retinal degeneration (Roque et al., 1996; Zeiss and Johnson, 2004; see 
also chapter 4.4). In vivo studies, in which neurons were cultured in microglia-conditioned 
medium, supported the hypothesis that microglia activation may induce neuronal cell death 
(Roque et al., 1999).  
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There is a constant reciprocal signaling also between microglia and macroglia in the retina. 
Typical reactive changes of the two macroglial cell types in the retina, astrocytes and Müller 
cells, include increase in the expression of the intermediate filament proteins glial fibrillary 
acidic protein and vimentin (Ekström et al., 1988; reviewed in Bringmann et al., 2006 and 
Bringmann et al., 2009), but also alterations in Müller-cell specific proteins, such as 
glutamine synthetase, inwardly rectifying potassium channels and aquaporins (reviewed in 
Bringmann et al., 2006). These features may lead to dysregulation of the homeostases in the 
extracellular space, possibly adding to the cell stress of the dying neurons and their primarily 
unaffected neighbors. Many of the gliotic features also correspond to immature Müller cells. 
And indeed are activated Müller cells thought to de-differentiate before proliferation and 
migration (reviewed in Bringmann et al., 2006).  
Many of the above changes may be detrimental and contribute to the disease progression, 
others may promote survival and repair, e.g., by production of anti-oxidants, trophic factors, 
various cytokines, metallothionein, etc. In any case, they are likely to influence putative 
treatments. 
1.11.1 Intermediate filament proteins 
Intermediate filaments are intermediate in size (≈10 nm on a cross-section) between actin 
filaments (6-7 nm) and microtubules (23-25 nm). The expression of the intermediate filament 
proteins glial fibrillary acidic protein (GFAP) and vimentin is activation stage- and age-
dependent (Pekny and Lane, 2007; Szeverenyi et al., 2008). Both these structural elements 
of the glial cytoskeleton are very conserved between species (Lewis et al., 1984; Wood et al., 
1989), and were thus expected to play very important roles during development and the 
function of adult glial cells.  
Surprisingly, the in different laboratories independently developed mice deficient for either 
GFAP (Gomi et al., 1995; Liedtke et al., 1996; McCall et al., 1996; Pekny et al., 1995), 
vimentin (Colucci-Guyon et al., 1994) or even both (Giménez Y Ribotta et al., 2000; Pekny et 
al., 1999) not only survived, but did not show any obvious alteration in development, 
anatomy, histology, glial cell number and distribution, viability, behavior, or any other 
abnormal phenotype other than not having any normal amounts of intermediate filaments in 
their glia (Galou et al., 1997; Wilhelmsson et al., 2004). Although in aged GFAP-/- mice, 
dysmyelination and locally higher permeability of the blood brain barrier becomes apparent, 
and the prevalence of mice that develop a hydrocephalus rises (Liedtke et al., 1996). 
Moreover, mice deficient for vimentin display abnormal Bergmann glia and Purkinje cells, as 
well as an impaired motor coordination (Colucci-Guyon et al., 1999). No other possible 
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compensatory filament like e.g., nestin seems to be induced (Liedtke et al., 1996; McCall et 
al., 1996).  
Mutations in the gene encoding GFAP lead to the fatal Alexander disease that is 
characterized by diffuse demyelination and protein aggregations in astrocytes (Mignot et al., 
2004; Quinlan et al., 2007). Similar cellular inclusions are seen in mice that transgenically 
overexpress GFAP (Eng et al., 1998; Messing et al., 1998). Very strong GFAP 
overexpression will even lead to the death of the animals within the first weeks after birth 
(Messing et al., 1998).  
Overexpression of vimentin disturbs normal lens development in mice (Capetanaki et al., 
1989), and a connection between vimentin mutations and dominant cataract formation has 
been postulated in humans as well (Müller et al., 2009). 
Many studies have been carried out to examine the role of intermediate filament proteins 
during glial cell reactivity, a process that is usually accompanied by characteristic up-
regulation of GFAP and vimentin. So, it has, for instance, been shown that astrocytes in 
GFAP-/- Vim-/- mice are less reactive in response to injury than those of wildtype mice in the 
sense that they become less hypertrophic and do not upregulate endothelin B receptors 
(Wilhelmsson et al., 2004). The degeneration early after the injury is more severe, but the 
recovery later is far better (Wilhelmsson et al., 2004). 
Similarly, there is a less gliotic response to retinal detachment in the eye, which includes less 
glial scar formation and better recovery (Nakazawa et al., 2007; Verardo et al., 2008). 
Rather little is known, however, about the functions of intermediate filament proteins in the 
unchallenged, healthy state. 
1.11.2 Metallothionein 
Neuroinflammation, injury, oxidative stress, and several other insults have been shown to 
induce upregulation of the cysteine-rich, metal-binding proteins metallothioneins in brain 
tissue. Metallothioneins exists in four major isoforms: Metallothionein-I, -II, -III, and -IV. Most 
tissues ubiquitously express Metallothionein-I and -II, including the central nervous system, 
while metallothionein-III and -IV are restricted to a few specific tissues (reviewed in West et 
al., 2008). Altered levels of metallothionein have been observed during the course of several 
neurological diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and 
multiple sclerosis (West et al., 2008). Metallothionein-I and -II are structurally and functionally 
almost indistinguishable and are thus often referred to as a single entity (metallothionein-I+II; 
chapter 4.3). The low-molecular-mass (6-7 kDa) proteins bind and release both essential and 
                              
 Introduction 
25 
 
toxic metals and seem to play important roles in protection against metal toxicity, zinc 
absorption and homeostasis, and to exhibit redox capacity (reviewed in (Coyle et al., 2002; 
Haq et al., 2003; Ruttkay-Nedecky et al., 2013; West et al., 2008). Increased levels of 
metallothionein-II mRNA and protein have been shown in different experimental models of 
retinal degeneration induced by intense light (Chen et al., 2004; Chen et al., 2004) or 
intravitreal injection of excitotoxic N-Methyl-D-Aspartate (NMDA) (Suemori et al., 2006), as 
well as after hypoxic preconditioning (Thiersch et al., 2008), and mechanical damage 
(Vázquez-Chona et al., 2004). Lower zinc levels and metallothionein synthesis, on the other 
hand, have been reported in cynomolgus monkeys and human patients with age-related 
macular degeneration (AMD) (Nicolas et al., 1996; Sato et al., 2000). Thus, one focus of 
chapter 4.3 was to evaluate the expression pattern of metallothionein-I+II in the retinas of 
different rodent models of retinal degeneration.  
Metallothioneins potentially have neuroprotective functions since cell loss after NMDA 
application is increased in metallothionein-deficient mice (Suemori et al., 2006), and direct 
and indirect up-regulation of metallothionein in the retinal pigment epithelium has been 
shown to contribute to protect the cells against oxidative damage (Lu et al., 2002; reviewed 
in West et al., 2008). Further studies have shown that metallothionein seem to regulate also 
neuronal survival in a paracrine manner, being released by astrocytes and taken up by 
retinal ganglion cells in vitro (Chung et al., 2008; Fitzgerald et al., 2007). The release of 
metallothionein seems to take place in a non-classical, still selective manner (reviewed in 
Lynes et al., 2006), whilst uptake might be mediated through interaction with megalin, a 
member of the low-density lipoprotein receptor (LDLR) family (Ambjörn et al., 2008; Leung et 
al., 2012).  
In chapter 4.3, a potential interaction between metallothionein-I+II and megalin was 
examined with the in situ proximity ligation assay. 
1.11.3 Sialoadhesin 
Sialoadhesin (alternative names: CD169 or Siglec-1, formerly Ser-4), a member of the sialic 
acid-binding Ig-like lectin (Siglec) family, is a macrophage-restricted cell-adhesion molecule 
(reviewed in Martinez-Pomares and Gordon, 2012). Under normal conditions, high levels of 
sialoadhesin are found on subsets of macrophages in secondary lymphoid tissues, such as 
the marginal zone of the spleen and the perifollicular zones of lymphoid tissues (Crocker and 
Gordon, 1986). Sialoadhesin can also be expressed by inflammatory macrophages and has 
been shown to mediate adhesion of macrophages to e.g., T cells, neutrophils, or other 
activated macrophages (Crocker et al., 1995). In mice, microglia/macrophages need to have 
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been in contact with serum in order to express sialoadhesin (Crocker et al., 1988). 
Accordingly, sialoadhesin expressing microglia in the central nervous system imply an 
impaired blood-brain barrier (Perry et al., 1992). Sialoadhesin has been shown to support 
immunoregulating functions influencing T-cell behavior in a pro-inflammatory manner (Wu et 
al., 2009). Recent publications have shown that sialoadhesin positive macrophages play an 
important role in enforced viral replication, thereby activating adaptive immunity (Honke et 
al., 2012). Sialoadhesin seems to participate in the recognition and discrimination of 
pathogens versus ‘self’ (reviewed in Klaas and Crocker, 2012).  
In the eye, sialoadhesin has been shown to be expressed by macrophages following 
experimental autoimmune uveoretinitis, contributing to the inflammatory response triggered 
in this model (Jiang et al., 1999; Jiang et al., 2006). Sialoadhesin was reported to be present 
in retinal microglia/macrophages also in a model of photoreceptor degeneration, which has 
been suggested to indicate a breakdown of the blood-retina barrier (Hughes et al., 2003).  
In chapter 4.4, the expression of sialoadhesin in healthy and degenerating mouse retinas 
was assessed, as well as after intraocular transplantation of neonatal retinal cells.  
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2. Aim of the thesis 
More than 200 identified genes have so far been found to be associated with inherited retinal 
degenerations (RETNET database, http://www.sph.uth.tmc.edu/retnet/sum-dis.htm#B-
diseases; information retrieved in November 2013). Despite the progress in elucidating the 
genetic background, little is known about the exact mechanisms of photoreceptor 
degeneration, and no effective treatments are yet available. Recent studies suggest a role for 
secondary reactive changes mediated by glial cells in the progression of retinal cell loss 
(Caicedo et al., 2005; Joussen et al., 2004; Nakazawa et al., 2006).  
The aim of this thesis was to examine some of the dynamics of reactive changes and how 
these affect the progression of photoreceptor cell degeneration in several models of human 
retinal degeneration. The analysis of reactive changes focused primarily on those mediated 
by the retinal glial cells (macroglia and microglia). An understanding of the nature of these 
changes and how they may be controlled is critical for the improvement of clinical treatments 
aimed at preserving photoreceptor cell function and vision. 
The key goals of this thesis were 
a) to first characterize the role of the type III intermediate filament proteins GFAP and 
vimentin, typically highly upregulated during reactive gliosis, in normal physiology in 
healthy mouse retinas (chapter 4.1); 
b) to investigate the potential impact of GFAP and vimentin on the progression of retinal 
degeneration in a mouse model for retinitis pigmentosa (chapter 4.2); 
c) to evaluate the temporal and spatial expression pattern of the putative 
neuroprotective metallothionein-I+II and their potential interaction with the low-density 
lipoprotein receptor megalin in retinal glia of three different rodent models of retinal 
degeneration (chapter 4.3); 
d) to examine the expression of the macrophage-restricted cell-adhesion molecule 
sialoadhesin in healthy and degenerating mouse retinas, as well as after intraocular 
transplantation of neonatal retinal cells (chapter 4.4). 
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3. Methods 
The following chapter presents the methods that I have employed in the studies described in 
this thesis. These methods were mainly aiming at the analysis of the retinal morphology in 
different rodent models of photoreceptor degeneration and at the quantification as well as 
spatial/temporal expression patterns of RNA and proteins, respectively. The exact details can 
be found in each individual chapter and in previous publications. Methods performed by the 
co-authors, as for example full-field electroretinography (chapter 4.1 and 4.2), microarray 
analysis (chapter 4.3), and transplantation of neonatal retinal tissue (chapter 4.4), are 
described in the according studies (see Authors’ contributions). 
3.1 Ethics/Animals 
To date, there is no cure for retinal degenerative diseases such as retinitis pigmentosa. 
Profound knowledge of the biological mechanisms behind disease development, progression 
and treatment impact is crucial, and animal models are still indispensable for many 
investigations. Rodents are often the animals of choice, and a number of models with 
spontaneous or genetically engineered mutations exist that are representative for human 
forms of the disease. Some retinal degenerations (rd) have been found in natural populations 
of mice numbered from rd1 to rd16, based on the order of their discovery (Fletcher et al., 
2011). Because of the heterogeneous nature of retinitis pigmentosa, several different rodent 
models were used in this thesis. In chapter 4.2, 4.3, and 4.4, rd1 mice were included.  
In the rd1 mouse, a mutation in the ȕ-subunit of the rod cGMP-phosphodiesterase gene 
(Pde6b) causes a rapid degeneration of rods within less than two weeks after opening their 
eyes (Bowes et al., 1990). This fast degeneration allows an easy evaluation of cell death at 
different time points. A major drawback is, however, that the course of the disease overlaps 
with the normal developmental cell death and the photoreceptors never fully mature before 
dying (Fletcher et al., 2011; Sancho-Pelluz et al., 2008).  
Mice homozygous for a null mutation in the Prph2 gene (Prph2Rd2) encoding peripherin, the 
so-called retinal degeneration slow (rds) mice, were evaluated in chapter 4.3 and 4.4. Due to 
the lack of this structural protein, the photoreceptors of these mice do not develop outer 
segments and die over a period of several months (Sanyal and Jansen, 1981). Therefore, 
rather few photoreceptors are lost at a time, making assessments of cell death events at 
different stages difficult.  
In the Royal College of Surgeons (RCS) rat, photoreceptors degenerate during the first 3 
months after birth although the primary defect is not in a photoreceptor-specific gene. The 
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underlying mutation in the Mertk gene prevents the retinal pigment epithelium from taking up 
shed photoreceptor outer segment discs, which leads to the accumulation of debris in the 
subretinal space (D'Cruz et al., 2000). 
The possibility to knockout specific genes in mice enables investigations on the functional 
role of the encoded proteins. In chapter 4.1 and 4.2, mice lacking GFAP (GFAP-/-), vimentin 
(Vim-/-), or both (GFAP-/-Vim-/-) were used to examine the role of these glial intermediate 
filaments on retinal function, and the progression of retinal degeneration in rd1 mice. 
Sialoadhesin-deficient mice were examined in chapter 4.3.  
The animals were bred on homozygous backgrounds and kept on a 12-hour light-dark cycle 
with no limitation of food or water. All experiments were performed with the approval of the 
local committee for animal experimentation and ethics. Animals were killed with carbon 
dioxide and their eyes were quickly enucleated for further processing. Handling of animals 
was in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and 
Vision Research.  
3.2 Genotyping 
The DNA for genotyping was extracted as follows: pieces of tail or ear were broken up and 
lipids and proteins partly digested by addition of a lysis buffer containing detergents and 
proteinase (100 µg/ml proteinase K in 100 mM Tris pH 8.5, 5 mM EDTA, 0,2% SDS, 200mM 
NaCl) at 55°C overnight. Chelation of divalent ions, such as Mg2+ and Ca2+, by EDTA 
prevented DNase activity. The solution was vortexed, and the supernatant with the released 
DNA was transferred to an equal amount of isopropanol. The DNA precipitated and formed a 
pellet that was washed with 70% ethanol before being resuspended in 80 µl water and stored 
at -20°C. 
Polymerase chain reaction (PCR) was used to genotype the animals. The purpose of a PCR 
is the selective amplification of a specific DNA region through repetitive cycles of DNA-
melting by heating up to approximately 94–98°C, annealing of specific primers 
complementary to the DNA target region on each strand at lower temperatures (50-65°C), 
and elongation catalyzed by polymerase close to its optimal activity temperature (70-75°C). 
Temperature settings and buffer compositions were optimized for each primer set. The PCR 
products can be separated by size with agarose gel electrophoresis. The ethidium bromide in 
the gel intercalates into nucleic acids and makes them visible under UV-light. 
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3.3 Quantitative Real-Time PCR 
Quantitative real-time PCR (q-RT-PCR) is a technique used to quantify the amount of DNA in 
a sample. It is based on the same principle as a conventional PCR, but the fluorescent signal 
derived from a dye such as SYBR green that binds to double stranded DNA is measured 
after each cycle. The signal strength is proportional to the amount of product. Since the 
number of target DNA-copies ideally doubles in each cycle, comparison to standard curves 
and/or other samples allows conclusions about the initial absolute or relative amount of DNA 
template. This method is often used to make predictions about gene expression. To do so, 
the mRNA is first converted to its complementary DNA (cDNA) by the enzyme reverse 
transcriptase and can then be amplified as described above. The retinas for q-RT-PCR 
examination in chapter 4.3 were removed through a slit in the cornea immediately after the 
animals were killed, snap frozen separately in liquid nitrogen, and stored at -80°C until further 
processing. The RNA was isolated following the manual of the utilized RNeasy MiniKit 
(Qiagen, Hilden, Germany), including a DNase treatment step to remove any contamination 
of genomic DNA. 
3.4 Western blot analysis 
Evaluation of gene expression permits only predictions about the actual levels of resulting 
protein as translation and degradation efficiency have to be considered. A Western blot (WB) 
analysis allows quantitative evaluation of protein expression itself. Proteins are denatured 
when heated in homogenizing buffer containing detergents like sodium dodecyl sulfate (SDS) 
and further reduced to their primary structures by strong reducing agents as dithiothreitol 
(DTT) in the buffer, in which they are loaded onto a polyacrylamide gel. SDS denatures 
proteins and covers them with a negative charge, so once an electrical current is applied 
they move through the pores of the gel and are separated according to their size. A current 
perpendicular to the gel transfers the proteins to a polyvinylidene fluoride transfer (PVDF) 
membrane. After a blocking step, the membrane (blot) is incubated with a primary antibody 
that is later detected by a secondary antibody conjugated to horseradish peroxidase. This 
enzyme cleaves a chemiluminescent substrate producing a signal that can be detected on a 
photographic film. The relative amount of protein can be analyzed by comparison of the light 
intensities/the sizes and densities of the bands on the film. In chapter 4.1 and 4.2, expression 
levels of several glial and neuronal proteins from wildtype retinas (control) and retinas from 
GFAP/vimentin knockout mice were compared. 
 
  Methods 
31 
 
3.5 Immunohistochemistry 
Immunohistochemistry allows for qualitative assessments about the localization of a protein 
within a tissue. For the immunohistochemical studies in this thesis, enucleated eyes were 
fixed in 4% paraformaldehyde in Sörensen’s buffer at 4°C for β hours. After several rinses 
with the same buffer and ensuing cryo-protection with increasing concentrations of sucrose 
in the buffer, the eyes were embedded in an albumin-gelatin medium and frozen. Cryostat 
sections of 12 µm thickness were collected on gelatin/chrome alum-coated glass slides and 
stored at -20°C until further processing. Thawed and air-dried sections were preincubated in 
blocking solution [Tris-buffered saline (TBS) or Phosphate-buffered saline (PBS) containing 
bovine serum albumin (BSA) and normal serum corresponding to the species in which the 
secondary antibody was made] for 60-90 minutes at room temperature to prevent unspecific 
binding of the antibodies. Incubation with primary antiserum was performed overnight at 4°C. 
In case the primary antibody was not directly conjugated to a fluorescent label, a fluorophore-
conjugated secondary antibody was utilized after several washing steps and applied for 60-
90 minutes at room temperature or a biotinylated secondary antibody was used, followed by 
washing steps and labeling with CY3-conjugated streptavidin. Since more than one 
secondary antibody carrying the fluorophore binds to the primary antibody, a weak signal can 
be enhanced. Moreover, the biotinylated secondary antibodies provide even more docking 
sites for dye-labeled streptavidin, which results in further signal enhancement. Washed 
sections were mounted with an antifading medium (Vectashield, Vector Laboratories, 
Burlingame, CA, USA), examined with a fluorescence microscope (Axiophot, Carl Zeiss 
Meditec, Inc., Oberkochen, Germany), and documented with an Axiocam camera with the 
associated software (Axiovision 4.2, Carl Zeiss Meditec). Incubation times were prolonged 
when whole flat mounted retinas were stained.  
Specificity controls were performed by either omitting the primary antibody, by preincubating 
it with the according peptide, by staining tissue from animals that do not express the 
particular protein, or by western blot analyses. In papers 4 and 5, a number of co-stainings 
with the antibodies of interest and known cellular markers were performed to establish which 
cell type expresses the proteins of interest (e.g., metallothionein-I and –II; sialoadhesin). 
3.6 Proximity ligation assay 
In order to make predictions about possible protein-protein interactions, it is necessary to 
show that the relevant proteins are located in close proximity. The proximity ligation assay 
(PLA) visualizes molecules that are at least as close as 40 nm from each other. The applied 
primary antibodies, which are raised in different species, are recognized by the according 
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secondary antibodies tagged with complementary oligonucleotides (PLA probes). Following 
hybridization, ligation, and a rolling circle DNA amplification step, the product is labeled with 
a complementary DNA linker conjugated to a fluorophore. This method was applied 
according to the manufacturer's instructions to visualize the co-localization of 
metallothionein-I+II and megalin in the mouse retina in situ and described in more detail in 
chapter 4.3. 
3.7 Lectin staining 
Lectins are proteins that bind to specific sugar moieties. A number of lectins have been found 
to have strong affinities to specific tissues or cell structures and are therefore often used as 
markers for those. Many lectins require calcium for binding. So, incubation with lectins was 
performed in a buffer containing CaCl2 (300 mM NaCl, 100 μM CaCl2, and 10 mM HEPES, 
pH 7.5). 
Microglia and vessels were stained with isolection B4 (IB4) and tomato-lectin in chapter 4.3. 
The lectin peanut agglutinin (PNA) was used as a cone photoreceptor marker in chapter 4.1 
and 4.2.  
3.8 Oxidative stress-/damage-assay 
Above a certain threshold, free radicals cannot be handled by the cells and may cause 
damage to proteins, lipids and DNA (see Oxidative stress). Oxidized nucleotides are 
products of oxidative DNA damage. Avidin has been found to bind to 8-oxodeoxyguanosine 
(and 8-oxoguanine) with high specificity. In chapter 4.3, avidin was used as a marker for 
oxidatively damaged DNA on retinal sections. Sections were incubated for one hour at room 
temperature with Texas Red- or Alexa Fluor 488-conjugated avidin (10 μg/ml in PBS-T-BSA, 
Molecular Probes Inc., OR, USA). 
3.9 TUNEL-assay 
Programmed cell death, such as apoptosis, is associated with DNA fragmentation in its last 
phase. Endogenous endonucleases break up the DNA into short fragments of regular size. In 
the TUNEL-assay (Terminal deoxynucleotidyl transferase dUTP Nick End Labeling = 
TUNEL), the enzyme “terminal deoxynucleotidyl transferase” catalizes the addition of labeled 
dUTPs (deoxyuridine triphosphate) to free nick ends of the DNA fragments. TUNEL-staining 
was used for detection of dying cells in chapter 4.1 and 4.3. The enzyme solutions of the In 
Situ Cell Death Detection Kit (TMR red, Roche Diagnostics, Mannheim, Germany) were 
diluted as described in detail in the according chapter (4.1 and 4.3) and applied to the 
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sections for 45 minutes at 37°C. The reaction was stopped by several washes with cold PBS 
before mounting with antifading solution. However, the results have to be interpreted with 
caution: although traditionally used to identify apoptotic cell death, the TUNEL assay fails to 
discriminate between different types of (programmed) cell death (Grasl-Kraupp et al., 1995).  
3.10 Hematoxylin and eosin staining 
Some eyes in chapter 4.1 and 4.3 were fixed in Bouin's solution (Sigma, Saint Louis, USA) at 
4°C overnight, dehydrated in ethanol of increasing concentrations and xylene, embedded in 
paraffin and cut into 4-5 µm sections. Prior to morphological examination under the light 
microscope, the sections were stained with hematoxylin and eosin to stain nuclei and 
surrounding structures, respectively. 
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4.1 Retinal functional alterations in mice lacking the intermediate filament 
proteins glial fibrillary acidic protein (GFAP) and vimentin 
Manuscript 
Summary 
Gliotic astrocytes and Müller cells undergo characteristic morphological and biochemical 
changes, such as increased expression of the intermediate filament proteins glial fibrillary 
acidic protein (GFAP) and vimentin ((Ekström et al., 1988); reviewed in (Bringmann et al., 
2006; Bringmann et al., 2009). The inability of astrocytes to produce GFAP and vimentin was 
shown to have a positive effect on neurite outgrowth and cell survival in co-cultured neurons 
(Menet et al., 2001). GFAP and vimentin deficient mice have been studied extensively to 
gain more knowledge about the function of astrocytic intermediate filaments in response to 
different insults (Eliasson et al., 1999). However, little is known about the role of those 
intermediate filaments in normal retinal physiology. 
In chapter 4.1, retinal function of knockout mice for GFAP, vimentin or both was assessed by 
electroretinography (ERG; performed by Naoyuki Tanimoto, Tübingen), and the expression 
patterns of different neuronal and glial proteins were analyzed by means of 
immunohistochemistry and western blot. 
The ERG analyses revealed distinct alterations in the scotopic responses of GFAP-vimentin 
double knockout, but not the single-knockout mice, compared to wildtype controls. While the 
comparison of all four mouse lines did not indicate any measurable differences in the 
photoreceptoral responses (a-waves), the scotopic b-wave amplitudes were significantly 
increased and returned much more slowly to baseline in double-knockout animals than in 
wildtype or single-knockout mice. These alterations seem to mainly involve the rod pathways, 
since no differences could be observed under photopic conditions. However, when 
measuring the responses to a series of flashes (flicker), the situation reversed: at frequencies 
above 5 Hz, which are usually attributed to the cone system, flicker responses in GFAP-/-Vim-
/- mice were smaller than those in wildtype mice. It is possible that very minor defects in the 
cone system could only be observed after continuous repetitive stimuli. 
The main source of the b-wave is the depolarization of bipolar cells (Lei and Perlman, 1999). 
Since the a-wave was not altered, the higher b-waves were most likely not a response to 
higher input from photoreceptors but rather emerged on the post-photoreceptor level.  
No obvious morphological differences could explain the ERG results. All retinal layers 
displayed the same overall thickness in all genotypes, and no abnormal cell death could be 
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detected. Likewise, the evaluation of the retinal expression of different established neuronal 
marker proteins did not result in any detectable differences between the four groups. The 
number and distribution of rod and cone photoreceptors, bipolar, ganglion, horizontal and 
amacrine cells tested was comparable in all four mouse lines. 
Since GFAP and vimentin are glial intermediate filaments, it appeared likely that the 
expression of other glial proteins is altered. Indeed, although the number of Müller cells 
seemed comparable in GFAP-/-Vim-/- and wildtype mice, indicated by similar expression 
levels of the Müller cell markers SOX-9 and cellular retinaldehyde binding protein (CRALBP), 
some proteins involved in fundamental glial functions were differentially expressed in the 
different genotypes. Of the two proteins involved in glutamate homeostasis that were 
examined, the glutamate aspartate transporter (GLAST) appeared slightly higher expressed 
in  GFAP-/-Vim-/- compared to wildtype mice, whereas glutamine synthetase (GS) levels were 
clearly reduced. Both proteins were found to be expressed in all retinal layers in association 
with Müller cell processes. The protein levels of the water channel aquaporin 4 (AQP4) 
increased with age in both, double-knockout and wildtype mouse retinas, but no major 
difference could be observed between the two in terms of protein expression level or 
distribution along the Müller cells. The levels of the inwardly rectifying potassium (Kir) 
channels Kir2.1 and Kir4.1, on the other hand, were considerably lower in mice lacking 
GFAP and vimentin or vimentin only. GFAP single knockout mice resembled the wildtype 
phenotype. An overall reduction of the Müller cell staining of Kir2.1 could be observed on 
retinal sections of GFAP-/-Vim-/- and Vim-/- mice, while the reduction in Kir4.1 expression was 
particularly reduced in the proximal Müller cell processes. Kir channels are important for the 
potassium homeostasis of the extracellular space to ensure proper neuronal functionality. 
Müller cells are responsible for the so-called potassium siphoning, the uptake of extracellular 
potassium and its release into vessels, subretinal space and vitreous (Kofuji et al., 
2002)(Newman, 1993). The resulting ion current is supposedly responsible for the slow and 
small negative-going PIII component of the ERG, by which Müller cells are thought to 
modulate the b-wave (Frishman, 2006). Inactivation of Kir4.1 channels has indeed been 
shown to diminish the PIII response and to increase the intraretinal b-wave in eyecup 
preparations (Kofuji et al., 2000)(Wu et al., 2004). The disturbed Kir channel expression and 
localization could thus possibly underlie in parts the functional abnormalities observed in 
GFAP-/-Vim-/- mice. However, vimentin single knockout mice displayed similar disturbances in 
Kir channel expression, although their ERG responses did not significantly deviate from the 
controls. It remains to be evaluated, which role the lack of GFAP plays to produce the 
functional phenotype in the double-knockout animals. 
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ABSTRACT 
Activation of retinal glial cells following damage is attenuated in mice lacking intermediate 
filament (IF) proteins glial fibrillary acidic protein (GFAP) and vimentin. However, it is not 
known what impact the absence of GFAP and vimentin has on the function of the normal 
retina. In the present study, we performed full-field electroretinograms (ERG) and, by using 
western blot and immunohistochemical analyses, assessed the expression of several 
neuronal and glial retinal markers in mice deficient for GFAP (GFAP–/–), vimentin (Vim–/–) or 
both GFAP and vimetin (GFAP–/–Vim–/–). We show that the levels of glutamine synthetase 
and of inwardly rectifying potassium (K+) channels, 2.1 (Kir2.1) and 4.1 (Kir4.1), between 
postnatal days (PN) 14 and 60, were lower in GFAP–/–Vim–/– mice compared to wild-type. 
ERG analysis at PN60 showed comparable photoreceptoral responses (a-wave) for all 
genotypes under dark- and light-adapted conditions. The latency and ascending edge of the 
b-wave were also unaffected. However, the amplitude of the b-wave was increased under 
mesopic conditions in GFAP–/–Vim–/– mice and its return to baseline was significantly 
delayed. These results suggest that the rod system is affected, as no alterations were noted 
in the cone system under photopic conditions. The decreased levels of K+ channels may 
explain, at least in part, the ERG abnormalities observed. This study provides evidence that 
GFAP and vimentin deficiency affects normal retinal physiology.  
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INTRODUCTION   
Intermediate filament (IF) proteins, known also as nanofilaments, constitute a diverse family 
of proteins encoded by at least 70 genes in the human genome (Szeverenyi et al., 2008). 
They are intermediate in size (≈10 nm on a cross-section) between actin filaments (6-7 nm) 
and microtubules (23-25 nm). Expression of IF proteins is tissue- and cell-specific and for 
some of them also activation stage- and age-dependent (Pekny and Lane, 2007; Szeverenyi 
et al., 2008). 
 In the retina, glial fibrillary acidic protein (GFAP) and vimentin (Vim) are expressed by 
the two macroglial cell types: astrocytes and Müller cells. Astrocytes are found in 
vascularized retinas and are restricted to the innermost retinal layers where they assume a 
characteristic star-shaped or bipolar morphology. Müller cells have their cell bodies in the 
middle of the retina and radial processes that span almost the entire thickness of the retina, 
reaching from the inner limiting membrane on the vitreal side of the retina, where their 
proximal processes terminate in funnel-shaped endfeet, to the outer limiting membrane, 
where their apical processes contact photoreceptors and each other (reviewed in Newman, 
2009).  
 The levels of GFAP and vimentin expression in retinal glia vary, depending on the 
species and developmental stage (reviewed in Lewis and Fisher, 2003; Fischer et al., 2010). 
In the adult healthy mouse retina, astrocytes express detectable levels of GFAP, whereas 
vimentin is observed predominately in the inner portion of the Müller cells (Lewis and Fisher, 
2003). Glial cells are activated under all pathological conditions affecting the retina, such as 
retinal detachment (Lewis et al., 2010), photo-toxic insult (Iandiev et al., 2008), uveitis 
(Eberhardt et al., 2011), diabetic retinopathy (Kumar and Zhuo 2010), inherited retinal 
degeneration (Wunderlich et al., 2010), stick injury, retinal ischemia (Hirrlinger et al., 2010; 
Lu et al., 2011; Rehak et al., 2009), etc. During activation, these cells can proliferate, 
migrate, change shape, and up-regulate the synthesis of a large number of molecules, such 
as cytokines and trophic factors (reviewed in Lewis and Fisher, 2003; Bringmann et al., 
2006). In this process, the expression of GFAP and vimentin is increased, and these IF 
proteins are therefore commonly used as early cellular markers for retinal reactive gliosis. 
 Insight into which functions GFAP and vimentin have in the retina under pathological 
conditions has been gained from studies of mice devoid of GFAP and vimentin (GFAP–/–Vim–
/–). The absence of these IF proteins in Müller cells was shown to lead to an abnormal 
response of the retinal vasculature to ischemia, namely decreased ability of newly formed 
blood vessels to traverse the inner limiting membrane (Lundkvist et al., 2004). In contrast to 
wild-type mice, the retinas of GFAP–/–Vim–/– mice showed also attenuated reactive gliosis 
after neural grafting, retinal ischemia and retinal detachment (Kinouchi et al., 2003; 
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Nakazawa et al., 2007; Verardo et al., 2008; Lu et al., 2011), supported robust neural 
integration from retinal transplants (Kinouchi et al., 2003), and showed less prominent 
monocyte infiltration and photoreceptor degeneration induced by retinal detachment 
(Nakazawa et al., 2007). Unchallenged retinas of GFAP–/–Vim–/– mice, on the other hand, did 
not exhibit differences in the distribution or morphology of astrocytes and Müller cells 
(Kinouchi et al., 2003; Lundkvist et al., 2004) or any other abnormality, except when 
subjected to mechanical stress, revealing that these IF proteins were important for 
maintaining the mechanical integrity of Müller-cell endfeet and of the innermost retinal layers 
(Lundkvist et al., 2004). 
 The present study was performed with the objective of examining whether and how the 
lack of GFAP and vimentin might affect the function of the normal, unchallenged retina. For 
this purpose, an analysis of retinal responses to light stimuli was performed along with a 
screening of retinal cell-type specific markers. 
 
MATERIALS AND METHODS 
Animals 
Mice on a mixed C57BL/129 genetic background with null mutations in the GFAP and/or Vim 
loci (Colucci-Guyon et al., 1994; Pekny et al., 1995; Eliasson et al., 1999; Pekny et al., 1999) 
and age-matched controls were examined: (i) wildtype mice (GFAP+/+Vim+/+, WT); (ii) single-
knockout mice: GFAP+/+Vim–/– (Vim–/–) and GFAP–/–Vim+/+ (GFAP–/–); and (iii) double-knockout 
mice (GFAP–/–Vim–/–, dKO). Mice of various postnatal (PN) ages (ranging from PN0 to 
PN278) were included in the study. The animals were kept on a 12-hour light-dark cycle, with 
free access to food and water. They were handled according to the guidelines set by the 
ARVO statement for the use of animals in Ophthalmic and Vision Research, and all 
experiments were approved by the local animal experimentation ethics committee. 
Electroretinographic Analysis  
To test whether the lack of GFAP and/or vimentin affects in vivo retinal function, 
electroretinograms (ERGs) were recorded binocularly from wildtype, Vim-/-, GFAP-/- and 
GFAP-/-Vim-/- mice at the age of 8 weeks, as described previously (Tanimoto et al., 2009; 
Tanimoto et al., 2013). Mice were dark-adapted overnight and anesthetized using ketamine 
(66.7 mg/kg body weight) and xylazine (11.7 mg/kg body weight). The pupils were dilated 
and single-flash ERG responses were obtained under dark-adapted and light-adapted (with a 
background illumination of 30 cd/m2 starting 10 min before recording) conditions. Single 
white-flash stimuli ranged from –4 to 1.5 log cd s/m2 under dark-adapted and from –2 to 1.5 
log cd s/m2 under light-adapted conditions, divided into ten and eight steps, respectively. Ten 
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responses were averaged with inter-stimulus intervals of 5 s (for –4 to –0.5 log cd s/m2) or 17 
s (for 0 to 1.5 log cd s/m2). Responses to trains of flashes (flicker) for a fixed intensity (0.5 log 
cd s/m2; the International Society for Clinical Electrophysiology of Vision standard flash 
intensity (Marmor et al., 2004) with varying frequency (0.5, 1, 2, 3, 5, 7, 10, 12, 15, 18, 20 
and 30 Hz) were obtained under dark-adapted conditions. Flicker responses were averaged 
either 20 times (for 0.5 to 3 Hz) or 30 times (for 5 Hz and above). Bandpass filter cutoff 
frequencies were 0.3 and 300 Hz for all ERG recordings. The ERG equipment consisted of a 
Ganzfeld bowl, a direct current amplifier, and a PC-based control and recording unit 
(Multiliner Vision; VIASYS Healthcare GmbH, Hoechberg, Germany). 
 
Western blotting 
Wildtype, single- and double-knockout mice (PN7 to PN60) were killed with carbon dioxide 
and the eyes quickly enucleated. Retinas were quickly isolated through a corneal incision 
and were homogenized. Retinal proteins (10 µg or 20 µg) were separated on 10-15% SDS-
polyacrylamide gels and semi-dry-blotted onto Immobilon polyvinylidene fluoride transfer 
membranes (Millipore, Billerica, MA, USA). Membranes were blocked with 5% non-fat dry 
milk and subsequently incubated with primary antibodies (see Tables 1 and 2 for list of 
antibodies used, dilutions, and suppliers), rinsed, incubated with peroxidase-conjugated 
secondary antibodies, and washed. The reaction was visualized by enhanced 
chemiluminescence (ECL) using an ECL Western Blotting detection kit (Amersham 
Biosciences, Sweden). Protein levels were compared between wildtype and single- or 
double-knockout mice of the same age. The level of tubulin or of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) in each sample was used as an internal loading control. 
Additionally, a western blot for Kir4.1 was performed to compare the levels of expression in 
the cerebellum of PN60 wildtype and GFAP–/–Vim–/– mice (2.5 µg protein).   
Morphological analysis 
Mice were killed with carbon dioxide and the eyes quickly enucleated and immersed for 24 
hours in Bouin’s solution (Sigma, Saint Louis, USA) or 4% paraformaldehyde (PFA) in 0.1M 
Sörensen’s buffer (β8 mM NaH2PO4 and 72 mM NaHPO4; pH 7.2). After rinsing and 
dehydrating, the eyes were embedded in paraffin and sectioned (4-5µm). Sections were 
collected on glass slides and counterstained with hematoxylin and eosin. 
 
Immunohistochemistry 
Eyes from PN0-60 and PNβ78 mice were fixed in 4% paraformaldehyde in Sörensen’s buffer 
(0.1 M; pH 7.2) for two hours at 4°C, rinsed, cryoprotected, embedded, and frozen, as 
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described in detail in (Wunderlich et al., 2010). Sections (12 µm) were obtained on a 
cryostat, air-dried, and stored at -20°C until further processing. For immunohistochemical 
analysis, retinal sections were blocked with PBS containing Triton-X (0.25%) and BSA (1%) 
(PBS-TB), and the corresponding normal serum (5%) at room temperature for one hour. This 
was followed by overnight incubation at 4°C with the primary antiserum, diluted in PBS-TB 
containing 2% normal serum. The primary antibodies and lectin used, dilutions, and suppliers 
are listed in Table 1. Following washes with PBS, sections were incubated with secondary 
antibodies (Table 2). Stained sections were mounted with an anti-fading medium 
(VECTASHIELD®, Vector Laboratories, CA, USA) and examined with a fluorescence 
microscope (Axiophot, Carl Zeiss Meditec, Inc., Germany). Images were taken with a digital 
camera and accompanying software (Axiovision 4.2, Carl Zeiss Meditec) using the same 
illumination and acquisition settings for all sections processed with the same antibody. 
Negative controls were included in which the primary antibody was omitted. 
 
TUNEL assay 
The occurrence of dying retinal cells was analyzed with a terminal deoxynucleotidyl 
transferase dUTP nick end-labeling (TUNEL) assay, employing the In Situ Cell Death 
Detection Kit, TMR red (Roche Diagnostics, Mannheim, Germany). The enzyme solution and 
the labeling solution were diluted 1:9 and 1:4, respectively. The two were mixed 1:4.44 
immediately before application to the cryostat sections, which were incubated for 45 minutes 
at 37°C. The reaction was thereafter stopped by three washes with cold PBS before 
mounting with VECTASHIELD®. The sections were examined with a fluorescence 
microscope, as described above.  
 
 
RESULTS 
Electroretinographic (ERG) Analysis 
To investigate retinal function in wildtype, Vim-/-, GFAP-/-, and GFAP-/-Vim-/- mice, we 
performed ERG recordings in vivo. Full-field ERG is a mass response of transient electrical 
activity of the entire retina to light stimulation, but importantly, functionality of certain retinal 
cells types can be assessed by varying stimulus intensity, stimulus frequency, and brightness 
of static background light.  
 Figure 1 shows representative single flash ERG traces from each genotype recorded 
under dark-adapted conditions. The negative deflection that appears directly after light 
stimulation onset (time 0) at intensities brighter than -2 log cd s/m2 corresponds to the a-
wave, which is initiated by the activity of rod photoreceptor cells. The whole activation phase 
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of the rod outer segments is visible, when it saturates at high stimulus intensities, such as 1.0 
and 1.5 log cd s/m2, as the response reaches its peak before the onset of the following 
positive deflection (b-wave). A comparison of all four mouse lines showed no difference in 
the dark-adapted single flash a-wave up to the highest intensity of the protocol (Fig. 1A), 
indicating that the lack of GFAP and/or vimentin had no measurable effect on the 
photoreceptoral responses. 
The single-flash ERG b-wave is evoked by both the rod and the cone systems 
depending on the ERG paradigm, i.e. responses at stimulus intensities up to -2 log cd s/m2 
under dark-adapted conditions are generated exclusively by the rod system (scotopic 
conditions), whereas at stimulus intensities brighter than -2 log cd s/m2 under dark-adapted 
conditions by both systems (mesopic conditions), and at any stimulus intensity under light-
adapted conditions usually by the cone system (photopic conditions). Under all three 
recording conditions, Vim-/- and GFAP-/- mice showed comparable responses to those in 
wildtype mice (Fig. 1A, 1B, 1D), indicating that the output signals from rod and cone 
photoreceptors as well as the responsiveness of both types of depolarising bipolar cells were 
not affected by a lack of vimentin or GFAP. In contrast, GFAP-/-Vim-/- mice showed some b-
wave changes under mesopic conditions of the dark-adapted single flash ERG (Fig. 1A, 1C, 
1D). Whereas the a-wave and the ascending edge of the b-wave were unchanged (Fig. 1C), 
the top of the GFAP-/-Vim-/- b-wave was enhanced [i.e., larger b-wave amplitude (Fig. 1D)], 
which was accompanied by an alteration of the trailing edge of the b-wave. In wildtype, Vim-/-, 
and GFAP-/- mice, the shape of the trailing edge was concave, whereas in GFAP-/-Vim-/- mice 
this concavity became less prominent, particularly at high stimulus intensities (Fig. 1A, 1C). 
As a result, the light-evoked responses of GFAP-/-Vim-/- mice returned to baseline much more 
slowly than those in the other mice.  
 Additionally, we examined the ability of wildtype and Vim-/-GFAP-/- mice to respond to 
train of flashes (flicker) by performing a dark-adapted flicker ERG frequency series at a fixed 
mesopic intensity [0.5 log cd*s/m2; the International Society for Clinical Electrophysiology of 
Vision standard flash intensity (Marmor et al., 2004)], which provides an overview of the 
functionality of both photoreceptor systems without using any background light (Tanimoto et 
al., 2009; Tanimoto et al., 2013). In this protocol, the responses are dominated by the rod 
system up to about 3 Hz and by the cone system at 5 Hz and higher frequencies. The 
phenotype of GFAP-/-Vim-/- mice detected at 0.5 Hz in the flicker ERG was similar to that 
observed in the dark-adapted single-flash ERG, i.e., the negative-going response (a-wave 
analogue) and the onset and the initial part of the positive-going response (b-wave analogue) 
were normal in GFAP-/-Vim-/- mice, whereas the top and the trailing edge of the positive-going 
response were enhanced [Fig. 1E, 1F (top), 1G (blue shading)], and consequently, the 
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responses in GFAP-/-Vim-/- mice returned to baseline slower than those in wildtype mice. With 
increasing stimulus frequency, the response amplitude became smaller in wildtype mice due 
to shorter intervals of flicker stimuli. This amplitude decline was much faster in GFAP-/-Vim-/- 
mice, and therefore, the situation reversed, i.e., flicker responses in GFAP-/-Vim-/- mice were 
smaller than those in wildtype mice at 5 Hz and above [Fig. 1E, 1F (bottom), 1G (red 
shading)], and the GFAP-/-Vim-/- retina could not resolve the flickering stimulus at 30 Hz. 
Here, we found notable amplitude reductions in the frequency range usually attributed to the 
cone system (Tanimoto et al., 2009).  
 
Morphology and TUNEL staining 
No obvious morphological differences were noted between the different genotypes in 
hematoxylin-eosin stained sections (Fig. 2A, 2B). The same overall thickness was observed 
for all the specific retinal layers, except that in GFAP-/-Vim-/- mice, the vitreal margin of the 
retina and, at times, the ganglion cell layer appeared separated from the rest of the retina in 
some places. TUNEL staining was observed sporadically in a very small number of cells in 
the outer nuclear layer in the first postnatal week and in the inner nuclear layer from PN14-21 
in both, wildtype and knockout animals. No aberrant cell death was noted in GFAP-/-Vim-/- 
mouse retinas at any of the time points examined (not shown).  
 
Analysis of retinal proteins 
Although no differences were observed between wildtype and GFAP-/-Vim-/- mice with 
regards to the general morphology, we found, as described above, that the retinal response 
to light stimuli were altered in the latter. To evaluate whether the lack of IFs caused 
alterations in the distribution of a specific retinal cell type, an immunohistochemical analysis 
using several well-established cell markers was performed. For some of the proteins, an 
estimate of the relative levels present in retinal homogenates was, in addition, performed by 
using western blotting. In both cases, retinal samples were obtained from animals of various 
ages, although the images depicting protein localization show PN60 retinas, unless specified 
otherwise. In the latter, the distribution of most markers analyzed agreed with that described 
in previous reports (references are provided in Table 1).  
 
Neuronal markers 
Apart from the occasional disruption of the innermost retina in some GFAP-/-Vim-/- mice, 
ganglion cells appeared labeled with the transcription factor Brn3a (Fig. 2C, 2D) and the 
neuron-specific nuclear protein NeuN (Fig. 2E, 2F) in all specimens analyzed. NeuN labeled 
also a few cells in the inner part of the inner nuclear layer (Fig. 2E, 2F). The calcium-binding 
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proteins parvalbumin and calbindin were detected in cell bodies with the position of amacrine 
cells and, in addition, weakly in a few cells in the ganglion cell layer (Fig. 2G, 2H; 2I, 2J). 
Several horizontal cells were also positive for calbindin in both wildtype and double-knockout 
mice (Fig. 2I, 2J). 
 Upon absorption of light by the rods, these cells hyperpolarize. This leads to a reduction 
in glutamate release by the rods and a consequent deactivation of metabotropic glutamate 
receptors (mGluR6) sitting on the contacting bipolar cells, which then depolarize (rod ON-
bipolar cells) (Ruether et al., 2010). Our functional analysis revealed an increase in the 
amplitude of the b-wave (which originates from depolarizing bipolar cells) under mesopic 
conditions of the dark-adapted single-flash ERG (i.e., with contribution from both, the rod and 
cone systems), but not under photopic conditions. Using an antibody against protein kinase 
C alpha (PKC-α), we examined whether there were differences in the distribution of rod 
bipolar cells or in their morphology. In both genotypes, immunostaining was observed in the 
cell body and in processes extending towards the outer and inner plexiform layers with no 
apparent differences (Fig. 2K, 2L). The western blot analysis of PKC-α expression showed 
also similar levels of the protein in the retinas of wildtype and GFAP-/-Vim-/- mice (Fig. 4). 
 Staining for recoverin, a small Ca2+-binding protein, resulted in labeling of a small 
subpopulation of cells located in the outer half of the inner nuclear layer, which are likely to 
correspond to cone bipolar cells (Fig. 2M, 2N). Immunoreactivity was detected also in the 
inner plexifom layer, next to the inner nuclear layer. In addition, strong labeling of 
photoreceptors including their inner and outer segments, cell bodies, and terminals in the 
outer plexifom layer was observed. Again, no discernable differences were noted between 
the two genotypes. 
 The distribution of other markers associated with photoreceptors showed also the same 
pattern, in both wildtype and GFAP-/-Vim-/- mice. Immunolabeling with an antibody against 
dystrophin resulted in a distinct punctate staining in the outer plexiform layer (Fig. 2O, 2P) 
and is likely to correspond to photoreceptor terminals. In both, wildtype and GFAP-/-Vim-/- 
mouse retinas, the rod outer segments were densely immunopositive for the rod-specific 
visual pigment rhodopsin, while the cell bodies showed a much weaker labeling, as expected 
for healthy, differentiated rod photoreceptors  (Fig. 2Q, 2R). Fluorophore-conjugated peanut 
agglutinin (PNA), a carbohydrate-specific lectin that selectively binds to the surface of cones, 
was detected in the synaptic pedicles at the level of the outer plexiform layer and the inner 
and the outer segments of cones (Fig. 2S, 2T). Small variations were noted in the same 
section, but no consistent differences could be seen between wildtype and GFAP-/-Vim-/- 
mice. 
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Glial markers 
We have screened for several proteins that can be used to identify glial Müller cells and/or 
are involved in some of the main functions of these cells, such as regeneration of visual 
pigment and homeostasis of potassium, water and glutamate. Cellular retinaldehyde binding 
protein (CRALBP), which participates in the processing of visual retinoids, was expressed in 
the retinal pigment epithelium (not shown) and in the Müller cells, from their endfeet at the 
inner limiting membrane to the outer limiting membrane, including their cell bodies in the 
inner nuclear layer (Fig. 3A, 3B). In Fig. 3B, there appears to be a reduced CRALBP 
expression in the proximal processes of the Müller cells; this figure illustrates also the 
disruption of the vitreal surface occasionally seen in the GFAP-/-Vim-/- mice. These 
observations were, however, not consistent, and western blot analysis also did not show any 
differences in the levels of CRALBP between the two genotypes (Fig. 4). Antibodies against 
the HMG-box transcription factor Sox-9 recognized the protein in the nuclei of Müller cells in 
retinas of mice older than PN14 (Fig. 3C, 3D) and in the retinal pigment epithelium (not 
shown). Neither the distribution nor the levels (Fig. 4) of Sox-9 were found to be different in 
GFAP-/-Vim-/- mouse retinas compared to their wildtype controls.  
 Two proteins involved in glutamate homeostasis were analyzed: the glutamate aspartate 
transporter (GLAST) and glutamine synthetase (GS), which participate in glutamate 
metabolism. GLAST immunoreactivity was found in all retinal layers in association with 
Müller cell processes (Fig. 3E, 3F) and a similar distribution was observed with GS (Fig. 3G, 
3H). However, while the expression of GLAST appeared slightly increased in GFAP-/-Vim-/- 
mice, GS levels were found to be reduced (Fig. 4).  
 Moreover, we have examined the distribution and level of expression of the water 
channel aquaporin 4 (AQP4).  The immunolabeling pattern resembled that of GLAST and GS 
with no obvious differences noted between the two genotypes (Fig. 3I, 3J).  In western blots, 
it was seen that AQP4 protein levels increased steadily with age and a second band of ∼60 
kDa, which may represent a dimeric form of AQP4, was found at PN60 (Fig. 4). No 
differences were noted between wildtype and GFAP-/-Vim-/- mice in the levels of AQP4 in 
younger ages. However, at PN60, a slight reduction in the levels of the monomeric form (∼32 
kDa) and an increase in the levels of the putative dimeric form were observed in GFAP-/-Vim-/- 
mice (Fig. 4).  
 Distinct differences were noted in the levels of the inwardly rectifying potassium (Kir) 
channels, Kir2.1 and Kir4.1. Immunostaining corresponding to Kir2.1 was observed mainly in 
the proximal processes of Müller cells and in cell bodies in the inner nuclear layer and 
ganglion cell layer (Fig. 3K-3R), starting at around PN14. Kir4.1 labeling was, in addition, 
found at the level of the outer limiting membrane, in Müller cell distal processes and endfeet 
 - 11 - 
 
and in association with retinal vessels both at PN21 (Fig. 3M, 3N) and at PN60 (Fig. 3O, 3P). 
In retinas of GFAP-/-Vim-/- mice, an overall reduction of Kir2.1 was noted (Fig. 3K, 3L). 
Likewise, a reduction in Kir4.1 was observed, particularly in the proximal Müller cell 
processes, which appeared less intensely labeled (Fig. 3L, 3N, 3P). Kir4.1 immunoreactivity 
was reduced in the same manner in vimentin single-knockout mice (Fig. 3R), but not in 
GFAP single knockouts (Fig. 3Q). Kir4.1-staining remained very strong until at least PN278, 
and the difference between wildtype and GFAP-/-Vim-/- mouse retinas was still observed (data 
not shown). In western blots, the expression of the two potassium channels was seen to 
increase with age in both wildtype and GFAP-/-Vim-/- mice (Fig 5A). This analysis revealed 
also a clearly decreased expression of Kir2.1 and Kir4.1 in retinas of the double-knockout 
mice as compared to the wildtype (Fig. 5A). Kir4.1 expression was also analyzed in lysates 
of cerebellum and we found that levels were similarly reduced in PN60 GFAP-/-Vim-/- mice 
compared with wildtype controls (Fig. 5B).  
 
DISCUSSION 
Mature retinal glial cells respond to structural and metabolic disruptions of normal neuron-glia 
interactions with a massive and relatively fast up-regulation of GFAP and vimentin (Lewis et 
al., 1989), increased synthesis of several other glia-associated proteins (Wunderlich et al., 
2010; Roesch et al., 2012) and increased stiffness of Müller cells (Lu et al., 2011), resulting 
in astroglial activation and reactive gliosis (Pekny and Nilsson, 2005; Pekny and Lane, 2007).  
 Previous studies have shown that the lack of astrocyte IFs attenuates the responses of 
astroglial cells to stress (Pekny et al., 1999, Wilhelmsson et al., 2004; Li et al., 2008), but the 
unchallenged retinas of GFAP-/-Vim-/- mice exhibit a normal morphology (Kinouchi et al., 
2003; Lundkvist et al., 2004; Verardo et al., 2008). This was confirmed in the present study, 
where we noted that the overall structure of the retina was similar in GFAP-/-, Vim-/-, GFAP-/-
Vim-/-, and wildtype mice. There were no signs of degeneration, and TUNEL staining showed 
the same pattern and degree of developmental cell death in all genotypes and a comparable 
number of occasional positive cells in the older ages (data not shown). Nevertheless, we 
observed that the innermost layer of the retina appeared sheared off from the rest of the 
retina in many places, especially in young animals. Earlier studies have also reported on 
such a phenomenon and it was concluded that the retina was most likely intact before 
enucleation and processing of the tissue, and that the shearing was due to mechanical stress 
inflicted during tissue handling (Kinouchi et al., 2003, Lundkvist et al., 2004; Verardo et al., 
2008). Such a lower resistance to mechanical stress is not surprising as different studies 
have shown that mechanical properties of astroglial cells, such as stiffness and elasticity, 
depend on the amount of IFs (Eckes et al., 1998; Lu et al., 2011). 
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 When characterizing control animals for retinal transplantation studies, the retinal 
function of GFAP-/-Vim-/- mice was previously described as being normal as well (Kinouchi et 
al., 2003); nevertheless these experiments were not the primary focus of that study. In our 
more extensive ERG analysis, we found that the lack of GFAP and vimentin does affect the 
electrophysiological responses of the healthy retina to light stimuli. We have shown that the 
amplitude of the mesopic b-wave was increased in GFAP-/-Vim-/- mice while the a-wave was 
unchanged. We argue that this functional phenotype was due only to the rod system (in spite 
of the fact that alterations were noted under mesopic conditions), since there were no similar 
functional alterations of the cone system responses under photopic conditions. We found that 
the ERG responses to flicker stimulations were similarly altered in GFAP-/-Vim-/- mice, where 
the top and the trailing edge of the positive-going response (b-wave analogue) were 
increased and its return to the baseline slowed down. With increasing stimulus frequency, 
however, the responses of GFAP-/-Vim-/- mice became smaller than those of wildtype mice. 
The decline in amplitude occurred in the frequency range usually attributed to the cone 
system (Tanimoto et al., 2009). Since there was no notable alteration in cone system 
responses in the light-adapted single-flash ERG, there are at least two possible 
interpretations for this functional phenotype in GFAP-/-Vim-/- mice: 1) the cone system 
functionality was not strongly affected, therefore, the alteration could be detected only during 
continuous repetitive stimuli but not after a single stimulation; 2) neurons of the cone system 
were normal, but the cone system signaling was disturbed, as the retinal network (including 
cone pathways) became saturated due to the prolonged photoresponses of the rod system 
(for a similar situation, see Seeliger et al., 2011). In this study, we could not discriminate 
between these two possibilities, since it is, to our knowledge, not possible by changing the 
ERG recording parameters.  
 The main source of the b-wave is depolarizing bipolar cells (i.e., rod bipolar cells and ON 
cone bipolar cells) and increases in amplitude could occur if the output from rods and cones 
and/or their responsiveness is increased. We found that the distribution and level of 
expression of some of the proteins involved in the rod and cone pathways were comparable 
in wildtype and GFAP-/-Vim-/- mice.  
 Müller cells also contribute to the b-wave by generating slow and small negative-going 
signals (slow PIII), which are usually masked by the large positive-going signals from 
depolarising bipolar cells (Frishman, 2006). In order to assess whether GFAP and/or 
vimentin deficiency had an effect on the size of the Müller cell population, we analyzed the 
expression of Sox-9 and of CRALBP. Sox-9, a member of the SRY-related HMG-box (Sox) 
gene family of transcription factors, is expressed in the retina in progenitor cells and in Müller 
cells (Muto et al., 2009). This expression is regulated by Notch signaling and promotes 
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differentiation of Müller cells at the expense of rod photoreceptors, such that a reduction in 
Sox-9 levels leads to the specification of a lower number of Müller cells and an increase in 
the number of rods (Muto et al., 2009). Most recently, we demonstrated markedly reduced 
Notch signaling capacity in astrocytes derived from GFAP-/-Vim-/- mice (Wilhelmsson et al., 
2012). In the present study, we found a similar level of Sox-9 expression between PN7 and 
PN60 in the retinas of wildtype and of GFAP-/-Vim-/- mice, suggesting that the lack of these IF 
proteins did not affect the number of Müller cells. Moreover, we did not find that the 
amplitude of the scotopic a-wave (reflecting rod activity) was increased in GFAP-/-Vim-/- 
animals, which could be expected if these animals had an increased number of rods cells.  
 CRALBP is a retinoid-binding cytosolic protein involved in the regeneration of cone 
visual pigment and is expressed in the retinal pigment epithelium (RPE) and in Müller cells 
from their apical microvilli to the endfeet (Bunt-Milam and Saari, 1983; Collery et al., 2008). 
The procedure used to harvest the retinas for western blot analysis could potentially yield 
variable amounts of RPE contamination. Further, as mentioned above, we observed a 
localized reduced resistance of the inner retinal surface of GFAP-/-Vim-/- mice to mechanical 
stress. It is thus possible that a fraction of the proteins normally present in the Müller cell 
endfeet was lost in some places during dissection of the retinas. Yet, our analysis showed no 
differences in the amounts of CRALBP between the different genotypes, further indicating 
that the size of the Müller cell population was not affected by the lack of GFAP and vimentin.
  The functional abnormalities observed in the present study in GFAP-/-Vim-/- mice seem 
therefore likely to reflect changes in synaptic transmission or homeostatic changes, rather 
than alterations in cell numbers. We found in the present study a reduction in the expression 
of the inwardly rectifying potassium (K+) channels Kir2.1 and Kir4.1 in GFAP-/-Vim-/- mouse 
retinas. These channels are found in Müller cells and are important for the regulation of 
extracellular K+ concentrations, allowing entry or exit of K+ depending on their specific 
distribution along the cell membrane and on the K+ levels generated by neuronal activation 
(Newman, 1993; Kofuji et al., 2002). Light absorption by the photoreceptors initiates a series 
of events that result in reduced extracellular K+ concentration in the subretinal space and 
increased concentrations at the level of the outer and inner plexiform layers. These changes 
in extracellular K+ trigger changes in the membrane potential of the Müller cells, which, 
through activation of Kir channels, clear the extracellular K+, redirecting it to the vitreous and 
to the circulation. This is mediated mainly by Kir4.1 channels that are abundant in the 
endfeet and perivascular processes of the Müller cells, in a mechanism of spatial buffering 
denominated K+ siphoning (Newman and Reichenbach, 1996; Kofuji and Newman, 2004). In 
addition, Kir2.1 channels, which are more homogeneously distributed along the Müller cell, 
and Kir4.1/Kir5.1 heterotetrameric channels are believed to mediate K+ influx at the level of 
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the synaptic layers (Kofuji et al., 2002; Ishii et al., 2003). We did not observe Kir5.1 
expression in retinal glia cells (not shown), so the focus of our observations was on Kir2.1 
and Kir4.1. 
 We found, by western blot analysis, a clear reduction in Kir2.1 levels in GFAP-/-Vim-/- 
mice mainly at the later time points examined (PN21 and PN60) whereas the reduction in 
Kir4.1 levels was detectable already at PN14. In tissue sections, a small general decrease in 
Kir2.1 immunostaining was seen while Kir4.1 expression was significantly reduced mainly in 
the inner retina. The latter was noted also in Vim-/- mice, but not in GFAP-/- mice. It seems 
thus that the absence of vimentin is sufficient to affect the number and/or the distribution of 
certain Kir channels in Müller cells. In any case, this could lead to an insufficient clearance of 
extracellular K+ and an insufficient spatial buffering of this ion.  
 Reduced expression and/or mislocation of Kir4.1 are observed in several pathologic 
conditions affecting the retina, such as diabetes (Pannicke et al., 2006), detachment 
(Bringmann et al., 2007), or ischemia (Hirrlinger et al., 2010). However, in these conditions, 
the alterations in Kir4.1 channels occur in association with increased expression of GFAP 
and vimentin and various degrees of neuronal damage, which is not the case with the 
double-knockout mice analyzed here. A total inactivation of Kir4.1 channels in an otherwise 
intact mouse retina has been achieved by a targeted disruption of the Kir4.1 gene (Kofuji et 
al., 2000). In these animals, Müller cells displayed normal morphology and glutamine 
synthetase expression but their resting membrane potential was significantly depolarized and 
K+ conductance markedly reduced. It was also found that the light-induced slow PIII 
response of the ERG was completely absent.  
 Under normal conditions, the light-evoked hyperpolarization of photoreceptors reduces 
the extracellular K+ concentration in the subretinal space. This triggers K+ fluxes through 
Müller cells (the negative-going slow PIII response) and a positive-going response of the 
retinal pigment epithelium, which is counteracted by PIII. Using an eyecup preparation, Kofuji 
et al. (2000) showed that the intraretinal b-wave amplitude was increased in retinas of Kir4.1 
knockout mice, which was attributed to the loss of the slow PIII (Kofuji et al., 2000). The 
same effect was observed following addition of Ba2+ to block the K+ channels on Müller cells 
in preparations of normal mouse retinas, confirming that the PIII component is the result of 
currents produced in these cells (Kofuji et al., 2000). Homozygous Kir4.1 knockout mice die 
during the first postnatal weeks before retinal development is complete, so that the effects 
observed in our study at 8 weeks of age cannot be studied in these animals. Nevertheless, 
similar results were obtained in older animals, heterozygous for the Kir4.1 deletion (Wu et al., 
2004). Kir4.1 channels have been found also in the retinal pigment epithelium (Rehak et al., 
2009). The contribution of these cells to total Kir4.1 levels could not be appreciated in our 
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western blots as the retinas were dissected free of RPE, but no differences were noted in this 
layer by immunocytochemistry in cross sections obtained between wildtype and GFAP-/-Vim-/- 
mice. The b-wave alterations observed in the present study in GFAP-/-Vim-/- mice (increased 
amplitude and prolonged decay) are thus likely to have resulted from a reduction in the 
number (and possibly abnormal distribution) of K+ channels on Müller cells.  
 The most significant protein expression alterations observed in the present study in 
GFAP-/-Vim-/- mice were also noted in Vim-/- mice, but not in GFAP-/- mice, indicating that 
vimentin plays a more crucial role. Further, while GFAP builds abnormal IF bundles in Vim-/- 
astrocytes, vimentin cannot form IFs on its own (Eliasson et al., 1999), with consequences 
predicted to go beyond a mere alteration of the mechanical properties of the cell. Vimentin 
appears to be an organizer of many important proteins associated with cell-cell adhesion, 
migration, and cell signaling (reviewed in Ivaska et al., 2007). It has been suggested to be 
involved in the organization of cell membrane complexes (reviewed in Ivaska et al., 2007) 
and seems to influence the localization and activity of sodium/glucose cotransporter in 
membrane rafts (Runembert et al., 2002). Vimentin binds also to phosphorylated 
extracellular signal-regulated kinases 1 and 2 (ERK1/2), regulating the intracellular 
translocation of these MAP kinases (MAPK; Perlson et al., 2005). It has been shown that 
while bound to vimentin, ERK kinase activity is maintained, as the association of ERK1/2 with 
vimentin prevents their dephosphorylation (Perlson et al., 2006). The inability to produce 
vimentin could thus affect processes that rely on ERK activation. In the retina, ERK-mediated 
signaling takes place in ganglion cells and in Müller cells, mediating e.g., the action of 
several trophic factors and cytokines as well as proliferation and at least some of the 
responses of Müller cells to mechanical stress (Wahlin et al., 2000; Geller et al., 2001; 
Cheng et al., 2002; Azadi et al., 2007; Fischer et al., 2009; Lindqvist et al., 2010). We could 
not find any differences in the distribution or levels of the neuronal markers probed. These 
results suggest that if the levels of phosphorylated ERK1/2 were indeed reduced in the retina 
of GFAP-/-Vim-/- mice, the effect is not sufficient to affect the proliferation/differentiation of the 
Müller cells or the level of trophic support provided by these cells during development.  
 As mentioned above, a reduction in the expression of Kir2.1 and Kir4.1 channels has 
been observed in conditions where IFs are up-regulated. In the present study, we also found 
a reduction, despite the inability of the cells to form IFs. These observations suggest that 
regulation of Kir2.1- and Kir4.1-expression can occur independently of the presence or 
amounts of IFs. However, a direct or indirect role for vimentin in the intracellular translocation 
of Kir2.1 and Kir4.1 may not be ruled out. Dystrophin-associated protein complexes are 
supposed to integrate Kir4.1 into protein complexes at the cell membrane. The water-
channel AQP4 is often connected to these complexes as well; a functional coupling of Kir4.1 
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and AQP was debated but seems to be disproved in most cases (Connors and Kofuji, 2006; 
Ruiz-Ederra et al., 2007; Fort et al., 2008; Zhang and Verkman, 2008; Satz et al., 2009; Sene 
et al., 2009). Our results seem to support that there is at least no functional coupling, as the 
levels of Kir4.1, but not AQP4, were reduced in the GFAP-/-Vim-/- mouse retinas. We could 
not detect glial dystrophin expression, but rather a punctuate staining in the outer plexiform 
layer, localized most likely at the photoreceptor terminals. Further, patients with Duchenne 
and Becker muscular dystrophy, caused by mutations in the gene coding dystrophin have 
attenuated, rather than increased, ERG b-waves (Satz et al., 2009; Cibis et al., 1993; Pillers 
et al., 1999). It appears thus that the alterations observed in GFAP-/-Vim-/- mice cannot be 
explained by abnormal dystrophin expression. 
 Further, vimentin is highly expressed by many cell types during development. The 
morphology and expression of several cell specific markers appeared normal in Vim-/- and 
GFAP-/-Vim-/- mice, suggesting that lack of vimentin had no major impact on the development 
of the retina. However, we cannot exclude the possibility that the maturation of the Müller 
cells was somewhat delayed or impaired in these animals. It has been shown that the 
amplitude of the inward K+ currents in Müller cells is dependent on the degree of 
differentiation of these cells (reviewed in Bringmann et al., 2006). Amplitudes thus increase 
in an age-dependent manner, supported by an increasing number of K+ channels. In the 
present study, we show that the expression of Kir2.1 and Kir4.1 gradually increased along 
with age in both wildtype and in GFAP-/-Vim-/- mice, but that the increase rate was lower in 
the latter, which could suggest that Müller cells were somewhat less mature in these animals. 
 In summary, we have shown that the amplitude of the mesopic b-wave is increased in 
GFAP-/-Vim-/- mice and that the levels of the inwardly rectifying K+ channels, Kir2.1 and Kir4.1 
are decreased, which may explain, at least in part, the electrophysiological findings. 
However, the possibility that other factors, not directly related to the level or distribution of 
Kir4.1 channels, may contribute to the alterations observed can not be excluded. Especially, 
since we observed a clear Kir2.1- and Kir4.1-reduction also in vimentin single knockouts, 
while their b-wave showed only a slight tendency towards higher amplitude. We found also a 
reduced expression of Kir4.1 in association with the retinal vasculature, at least in the earlier 
ages. The functional alterations seen in the retinas of GFAP-/-Vim-/- mice could therefore be 
the result of a combination of different factors. Nevertheless, our observations indicate that 
the expression of intermediate filament proteins (in particular vimentin) is required for normal 
retinal function. Further, we found that Kir4.1 levels were reduced also in the cerebellum of 
GFAP-/-Vim-/- mice, suggesting that the inability to produce IF proteins and IFs may result in 
functional abnormalities also in this part of the CNS. 
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 FIGURE LEGENDS 
Figure 1. Functional characterization of wildtype (GFAP+/+Vim+/+, WT), Vim-/-, GFAP-/-, and 
GFAP-/-Vim-/- mice in vivo by electroretinography (ERG). (A, B) Representative single flash 
ERG recordings from WT (black), Vim-/- (blue), GFAP-/- (green), and GFAP-/-Vim-/- (red) mice 
(age 8 weeks) for increasing stimulus intensity under dark-adapted (A) and light-adapted (B) 
conditions. (C) Overlay of the response traces of WT (black) and GFAP-/-Vim-/- (red) mice 
from (A) (left) and (B) (right). (D) Box-and-whisker plot of dark-adapted (DA) and light-
adapted (LA) single flash b-wave amplitudes in WT (black), Vim-/- (blue), GFAP-/- (green), and 
GFAP-/-Vim-/- (red) mice. The top and the trailing edge of the GFAP-/-Vim-/- b-wave was 
increased at middle and high stimulus intensities under dark-adapted conditions, resulting in 
a delayed return of the light-evoked responses to baseline. (E) Representative flicker ERG 
frequency series from WT (black) and GFAP-/-Vim-/- (red) mice at a flash intensity of 0.5 log 
cd s/m2 under dark-adapted conditions. (F) Overlay of the response traces of WT (black) and 
GFAP-/-Vim-/- (red) mice from (E). (G) Top: Box-and-whisker plot of flicker ERG response 
amplitudes in WT (black) and GFAP-/-Vim-/- (red) mice. Bottom: difference of median 
amplitudes (GFAP-/-Vim-/- median amplitude – WT median amplitude, for each stimulus 
frequency). Whereas the GFAP-/-Vim-/- flicker responses were larger than the WT responses 
at low stimulus frequencies (blue shading), they decrease much faster with increasing 
stimulus frequency and became smaller at 5 Hz and above (red shading). In all quantitative 
plots (D, G), boxes indicate the 25% and 75% quantile range, whiskers indicate the 5% and 
95% quantiles, and the asterisks indicate the median of the data. WT (n=4), Vim-/- (n=6), 
GFAP-/- (n=6), GFAP-/-Vim-/- (n=6). 
Figure 2. Retinal structure and localization of neuronal markers in wildtype mice 
(GFAP+/+Vim+/+, WT) and in GFAP-/-Vim-/- mice (double-knockout mice, dKO). (A, B) Cryostat 
sections of retinas at PN60 stained with hematoxylin and eosin (H&E). The retinas of WT (A) 
and dKO (B) mice both show a clearly stratified structure with all layers of comparable 
thickness. (C-T) Stainings with well-established cell marker proteins did not reveal any 
obvious differences in the distributions of the specific neuronal cell types in retinas of WT and 
dKO: (C, D) Brn3a staining in the nuclei of ganglion cells in GCL. (E, F) NeuN staining in 
ganglion cells, a few amacrine cells in the INL and displaced amacrine cells in the GCL. (G, 
H) Parvalbumin (Parvalb) staining in some amacrine cells. (I, J) Calbindin (Calb) staining in 
horizontal cells in the INL and some amacrine cells. (K, L) Protein kinase C alpha (PKC) 
staining in rod ON-bipolar cells in the INL and their processes in the OPL and IPL. (M, N) 
Recoverin (Recov) staining in photoreceptors and cone bipolar cells. (O, P) Punctate 
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dystrophin labeling in the OPL. (Q, R) Rhodopsin (Rho) staining in the outer segments of rod 
photoreceptor cells. (S, T) Peanut agglutinin (PNA) staining in cone segments. ONL, outer 
nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; 
GCL, ganglion cell layer. Scale bar, µm. 
Figure 3. Localization of glial proteins in the different genotypes. (A, B) Cellular 
retinaldehyde binding protein (CRALBP) staining was observed in Müller glial cell bodies and 
processes extending from the outer to the inner limiting membranes in both wildtype 
(GFAP+/+Vim+/+, WT) and GFAP-/-Vim-/- mice (dKO). (C-D) The SRY-box 9 (SOX9) protein 
was detected in the nuclei of Müller cells in the INL of both genotypes. (E, F) The glutamate 
aspartate transporter (GLAST) was found in Müller cells and in their radial processes as well 
as in the OPL and IPL. No obvious differences between WT and dKO could be observed. (G, 
H) The distribution of glutamine synthetase (GS) appeared similar in WT and dKO mice, 
except that in the latter staining of the Müller cell radial processes was somewhat weaker. (I, 
J) Aquaporin 4 (AQP4) staining was found in Müller cells, with particularly prominent labeling 
associated with vessels. (K, L) Müller cell bodies and processes were positive for the 
inwardly rectifying potassium (Kir) channel Kir2.1. The distribution was comparable in both 
genotypes, the dKO having a slightly weaker overall fluorescence intensity. (M-R) In WT (M 
and O), immunostaining with an antibody against Kir4.1 produced a distinct Müller cell 
labeling within the retina at the level of the outer and inner limiting membranes and in 
association with vessels. In dKO mice (N, P), the staining in the proximal processes of Müller 
cells was clearly reduced. Retinas of GFAP-/--single-knockout mice (Q, GFAP) showed a 
similar distribution pattern as the WT, whereas Kir4.1 staining in Vim-/--single-KO mice (R, 
vim) resembled that of GFAP-/-Vim-/- mice. (M, N) PN21, all other PN60. Note also that the 
inner border of the retina was disrupted in some places in GFAP+/+Vim+/+ (double-knockout, 
dKO) mice (*). ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; 
IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar, µm. 
Figure 4. Expression levels of different proteins in the retinas of wildtype (GFAP+/+Vim+/+, 
WT) and GFAP-/-Vim-/- mice (double-knockout mice, dKO) at different ages. (A) The levels of 
protein kinase alpha (PKC) expressed by retinal bipolar cells, and the glial proteins cellular 
retinaldehyde-binding protein (CRALBP), SRY-box 9 (SOX9), glutamate aspartate 
transporter (GLAST), glutamine synthetase (GS), and aquaporin 4 (AQP4) were compared 
between GFAP+/+Vim+/+ (WT) and GFAP-/-Vim-/- mice (dKO) at different ages: PN (postnatal 
day) 7, PN14, PN21, and PN60. The housekeeping proteins glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and tubulin served as loading controls. From PN14 and onwards, 
PKC showed an equally strong expression in both genotypes. The levels of CRALBP did not 
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change with age or genotype. An equally sized protein band of SOX9 was observed in all 
ages and genotypes. A second, weaker band appeared from PN21 and onwards. The levels 
of GLAST increased with age, being first detectable at PN14. No GS expression could be 
observed by PN7, but from PN14 and onwards, increasing levels were detected. GS 
expression was found to be higher in wildtype (WT) than in GFAP-/-Vim-/- mice. The 
expression of AQP4 (∼32 kDa) increased with age in both genotypes, starting with non-
detectable levels at PN7. A second band of ∼60 kDa was also detected at PN60. At this age, 
the levels of the ∼32 kDa band were reduced and those of the ∼60 kDa band were increased 
in GFAP-/-Vim-/- mice. 10 µg of protein pooled from 3-5 retinas from different animals were 
loaded to each lane, except for PKC and for AQP4 at PN7 and PN14, where 20 µg of protein 
were loaded. 
 
Figure 5. Expression levels of the inwardly rectifying potassium channels Kir2.1 and Kir4.1 in 
retinas and cerebellum of wildtype (WT) and GFAP-/-Vim-/- mice (double-knockout mice, dKO) 
at different ages. (A) The expression levels of Kir2.1 (top) increased with age in both 
GFAP+/+Vim+/+ (WT) and GFAP-/-Vim-/- mice (dKO), but expression was lower in dKO at PN21 
and PN60. Expression of Kir4.1 (bottom) was not detectable at PN7, but increased with age. 
Kir4.1 levels were lower in the dKO than in age-matched WT mice. 10 µg of protein pooled 
from 3-5 retinas from different animals were loaded to each lane. (B) Kir4.1 expression is 
lower also in the cerebellum of dKO animals compared to WT animals. 7.5 µg of protein 
obtained from a mouse cerebellum (PN60) were loaded to each lane. 
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TABLE 1. Primary antibodies and lectin used in the study. 
 
AQP4 = Nagelhus et al., 1999; Brn3a = Quina et al., 2005; Calbindin = Haverkamp and 
Wässle, 2000; CRALBP = Bunt-Milam and Saari, 1983; Dystrophin = Wersinger et al., 2011; 
GFAP = Sarthy and Huang, 1991; GLAST = Derouiche et al., 2005; GS = Derouiche et al., 
2005; GAPDH = ; Kir2.1, Kir4.1 = Kofuji et al., 2002; NeuN = Mullen et al., 1992; Parvalbumin 
= PNA = Blanks and Johnson, 1984; PKC-α = Ruether et al., 2010; Recoverin = Milam et al., 
1993; Rhodopsin = Hicks and Molday, 1986; Sox-9 = Muto et al., 2009; Vimentin = Lewis and 
Fisher, 2003. 
  
Lectin/Antibody Host 
Dilution 
(IHC) 
Dilution 
(WB) 
Company 
AQP4 Rabbit 1:800 
1:3,000 
1:4,500 
Sigma-Aldrich, St Louis, MO, USA 
Brn3a Goat 1:200 - Santa Cruz Biotechnology, USA 
Calbindin Mouse 1:200 - Sigma-Aldrich, St Louis, MO, USA 
Cellular retinaldehyde-binding 
protein (CRALBP) 
Rabbit 1:5,000 1:30,000 
Kind gift from J. C. Saari, 
University of Washington, Seattle, 
USA 
Dystrophin Mouse 1:20 - 
Leica Biosystems (Novocastra) 
Newcastle Upon Tyne, UK 
Glial fibrillary acidic protein (GFAP) Rabbit 1:1500 - DAKO A/S, Glostrup, Denmark 
Glial fibrillary acidic protein (GFAP)  
(cy3-conjugated) 
Mouse 1:100 - Sigma-Aldrich, St Louis, MO, USA 
Glutamate aspartate transporter 
(GLAST) 
    
Glutamine synthetase (GS) Mouse 1:2,000 1:25,000 
BD Biosciences, Franklin Lakes, 
NJ, USA 
Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 
Rabbit - 1:2,000 Abcam, Cambridge, UK 
Kir2.1 (KCNJ2) 
Rabbit 1:500 1:400 Sigma-Aldrich, St Louis, MO, USA 
Rabbit 1:100 1:400 
Alomone Labs Ltd., Jerusalem, 
Israel 
Kir4.1 (KCNJ10) 
Mouse 1:200 1:400 
Sigma-Aldrich, St  Louis, MO, 
USA 
Rabbit 1:1,000 1:500 
Alomone Labs Ltd., Jerusalem, 
Israel 
NeuN Mouse 1:100 - Millipore, Billerica, MA, USA 
Parvalbumin     
Peanut agglutinin (PNA) - lectin - 1:500 - 
Vector Laboratories, Burlingame, 
CA, USA 
Protein kinase C-α  (PKC-α) Mouse 1:200 1:200 Nordic BioSite, Täby, Sweden 
Recoverin Rabbit 1:12,000 - Millipore, Billerica, MA, USA 
Rhodopsin (clone RET-P1) Mouse 1:400 - Millipore, Billerica, MA, USA 
Sox-9 Rabbit 1:500 1:500 Millipore, Billerica, MA, USA 
Tubulin Mouse - 1:20,000 Abcam, Cambridge, UK 
Vimentin     
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TABLE 2. Secondary antibodies used in the study. 
 
  
Antibody Host Dilution  Company 
Anti-guinea pig Goat 1:200 Sigma-Aldrich, St Louis, MO, USA 
Anti-guinea pig 
(peroxidase-conjugated) 
Goat - 
Jackson Immunoresearch, Westgrove, PA, 
USA 
Anti-mouse 
(Alexa Fluor
®
488-conjugated) 
Goat 1:200 Invitrogen Ltd., Paisley, UK 
Anti-mouse 
(DyLight
TM
549-conjugated) 
Donkey 1:400 
Jackson Immunoresearch, Westgrove, PA, 
USA 
Anti-mouse 
(peroxidase-conjugated) 
Goat - 
Jackson Immunoresearch, Westgrove, PA, 
USA 
Anti-mouse 
(Texas Red
®
-conjugated) 
Donkey 1:200 
Jackson Immunoresearch, Westgrove, PA, 
USA 
Anti-rabbit 
(Alexa Fluor
®
488-conjugated) 
Goat 1:200 Invitrogen Ltd., Paisley, UK 
Anti-rabbit 
(Alexa Fluor
®
594-conjugated) 
Goat 1:200 Invitrogen Ltd., Paisley, UK 
Anti-rabbit 
(DyLight
TM
488-conjugated) 
Donkey 1:400 
Jackson Immunoresearch, Westgrove, PA, 
USA 
Anti-rabbit 
(peroxidase-conjugated) 
Goat - Nordic BioSite, Täby, Sweden 
Anti-rabbit 
(Texas Red
®
-conjugated) 
Donkey 1:200 
Jackson Immunoresearch, Westgrove, PA, 
USA 
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4.2 The inability to produce glial fibrillary acidic protein (GFAP) and vimentin 
does not protect photoreceptors in a genetic model of degeneration 
Manuscript 
Summary 
The inability of retinal glia to up-regulate the intermediate filament protein glial fibrillary acidic 
protein (GFAP) and vimentin has been shown to be beneficial for photoreceptor survival in a 
model of retinal detachment (Nakazawa et al., 2007)(Verardo et al., 2008). To investigate the 
role of GFAP and vimentin on the progression of inherited retinal degeneration in the rd1 
mouse, a model for retinitis pigmentosa, the retinal function of rd1 mice lacking these 
intermediate filament proteins (rd1, GFAP-/-Vim-/-) was examined by electroretinography 
(ERG; performed by Naoyuki Tanimoto, Tübingen). Retinal morphology was evaluated with 
DAPI-stained retinal sections and the expression patterns of different photoreceptor and glial 
marker proteins were analyzed by the means of immunohistochemistry and western blot. 
By postnatal day (PN) 21, the retinal responses to light stimuli were already weak, with non-
distinguishable a-waves. Nevertheless, rd1, GFAP-/-Vim-/- mice distinctly exhibited higher b-
waves under dark- and light-adapted conditions, with prolonged implicit times, latencies, and 
delayed return to the baseline than the rd1 control mice. By 5 weeks of age, no light 
responses were recordable, regardless of the genotype. 
These results indicate that the lack of GFAP and vimentin could indeed have a small positive 
effect on photoreceptor survival.  
To investigate whether the higher ERG responses reflect a beneficial effect on neuronal 
degeneration, the morphology of the retina, particularly that of the photoreceptor layer, was 
examined in more detail. The thickness of all retinal layers was comparable in rd1, GFAP-/-
Vim-/- and rd1, GFAP+/+Vim+/+ mice, including the outer nuclear layer, which consisted of  
approximately one to two cell rows at the age of three weeks. Stainings with common cellular 
markers for rods (rhodopsin) and cones (peanut agglutinine, cone arrestin) revealed no 
differences in the number or distribution of photoreceptor cells in the two mouse lines.  
Similar to what was described in chapter 4.1, the expression patterns of some essential glial 
proteins were evaluated. As in chapter 4.1, the number of Müller cells seemed to be similar 
in rd1, GFAP-/-Vim-/- and rd1, GFAP+/+Vim+/+ mice, since the levels of SOX9 expression were 
comparable. GS expression was also reduced in mice lacking GFAP and vimentin, 
particularly at PN14 and PN21. In contrast to chapter 4.1, however, the levels of glutamate 
aspartate transporter (GLAST) were also reduced, as well as the levels of the water channel 
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aquaporin 4. Again, levels of the inwardly rectifying potassium channels Kir2.1 and Kir4.1 
were lower in the animals lacking the intermediate filament proteins than in control mice. 
Kir4.1 expression was visibly lower in the proximal processes of the Müller cells.  
No rescue effect on photoreceptors could be observed in this study. Furthermore, 
considering that chapter 4.1 revealed larger b-waves in GFAP-/-Vim-/- animals even without 
photoreceptor degeneration, the apparently improved retinal function seems rather to be an 
effect of the altered glial physiology. 
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ABSTRACT 
 Purpose: Glial cell activation is characterized by proliferation and up-regulation of several 
molecules, including the intermediate filaments (IFs), glial fibrillary acidic protein (GFAP) and 
vimentin (Vim). Commonly used as markers for reactive gliosis, their function in the process 
has yet to be unraveled. The lack of GFAP and vimentin has been shown to be beneficial for 
photoreceptor survival after retinal detachment. In the present study, we have investigated 
whether the inability to produce these IFs might also affect the progression of inherited 
photoreceptor cell degeneration. 
Methods: Two groups of animals were studied: mice with retinal degeneration (Pde6b 
mutation, rd1) expressing GFAP and Vim (rd1, GFAP+/+Vim+/+) and mice with retinal 
degeneration and lacking the IFs (rd1, GFAP-/-Vim-/-). Electroretinogram (ERG) analysis has 
been performed in animals of 3 and 5 weeks of age. Retinas from postnatal day 7 (PN7) to 
PN60 mice were processed for immunohistochemistry and Western Blot analysis of 
photoreceptor and glial cell markers. 
Results: ERG recordings revealed slightly larger b-waves and longer latencies in rd1 mice 
that do not express GFAP and vimentin compared to rd1 mice expressing these IFs. No 
differences were noted in the distribution of rod and cone cell markers or in the thickness of 
the outer nuclear layer at a PN21 in the two groups of rd1 mice. The number of Müller cells 
was also comparable in both genotypes. The expression of several astrocyte and Müller cell 
proteins, including the inwardly rectifying potassium channels Kir2.1 and Kir4.1, was altered 
in retinas lacking GFAP and vimentin.  
Conclusions: Our findings do not support the idea that the inability to up-regulate GFAP and 
vimentin is beneficial for photoreceptor survival in the rd1 mouse, an inherited model of 
retinal degeneration, or that it slows down the progression of the disease. The higher b-
waves in the animals lacking glial IFs do not seem to be an effect of better preserved cone 
function and/or improved photoreceptor survival, but rather an effect of the altered glial 
physiology. 
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INTRODUCTION 
With a prevalence of 1/3,500 to 1/4,000, retinitis pigmentosa (RP) is the most frequent 
hereditary retinal degeneration, named after the accumulation of subretinal cell debris, which 
is visible as a pigmented fundus. In fact, RP comprises a group of different diseases caused 
by many different mutations in primarily rod-specific genes 
(http://www.sph.uth.tmc.edu/Retnet/, RetNet is provided in the public domain by the 
University of Texas, Houston Health Science Center, Houston, TX, USA) that lead first to 
night blindness and tunnel vision due to rod cell death, but subsequently also to cone cell 
death, causing a total loss of vision (Daiger et al., 2007; Hamel, 2006; Hartong et al., 2006). 
Several transgenic (Flannery, 1999) and naturally occurring (Chang et al., 2002; Fauser et 
al., 2002) animal models for RP are available, such as the retinal degeneration 1 (rd1) 
mouse that has been examined in the present study. In the rd1 mouse, a mutation in the ȕ-
subunit of the rod cGMP-phosphodiesterase gene (Pde6b) causes a rapid degeneration of 
rods within less than two weeks after eye opening (Bowes et al., 1990; Farber and Lolley, 
1976) Although the mutation is rod-specific, cones also degenerate eventually (Carter-
Dawson et al., 1978). The lack of protective survival factors provided by the rods might in 
part explain this secondary (cone) cell death (Sahel, 2005). Additionally, reactive changes, 
such as glial activation, may contribute to the disease progression.  
 There are two types of macroglia in the vascularized retina: astrocytes, which are largely 
restricted to the innermost layer of the vascularized retina, and the more prominent radial 
Müller glia cells, which span almost the entire thickness of the retina with their processes 
(reviewed in (Newman, 2009). Much like astrocytes in other parts of the central nervous 
system, the retinal glial cells are important for maintenance of ion-, water-, and 
neurotransmitter-homeostasis and support the neurons metabolically and structurally 
(Bringmann et al., 2006). Astrocytes in the normal adult mouse retina express detectable 
levels of the intermediate filament (IF) glial fibrillary acidic protein (GFAP), while Müller cells 
are mostly vimentin-positive under normal conditions (reviewed in Lewis and Fisher, 2003). 
Activation of astrocytes and Müller cells under pathologic conditions, including RP, is 
characterized by proliferation, hypertrophy, and increased expression of numerous growth 
factors and cytokines, as well as strong up-regulation of IFs (reviewed in Bringmann et al., 
2006; Bringmann et al., 2009; Ekström et al., 1988; Lewis and Fisher, 2003; Luna et al., 
2010; Sarthy and Egal, 1995). Despite the fact that these IFs are commonly used as early 
markers for reactive gliosis, their exact role in the pathologic processes has yet to be 
unraveled. It has been observed in vitro that neurons co-cultured with astrocytes lacking 
GFAP and vimentin have an improved survival and neurite outgrowth compared to co-
cultures with normal astrocytes (Menet et al., 2001). In vivo, a better integration of neural 
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grafts transplanted next to retinas of GFAP- and vimentin-deficient mice has been observed 
(Kinouchi et al., 2003), possibly due to reduced hypertrophy of cell processes and limited 
scar formation (Pekny et al., 1999; Verardo et al., 2008; Wilhelmsson et al., 2004). Further, it 
has been shown that the lack of GFAP and vimentin results in an attenuation of the overall 
gliotic response (normally observed following detachment of the retina) and in better 
photoreceptor survival (Nakazawa et al., 2007; Verardo et al., 2008). These observations 
point to a role for GFAP and vimentin in the reactive state, and suggest that they may, 
directly or indirectly, contribute also to the degenerative process. 
 We have recently shown that the inability to produce GFAP and vimentin affects not only 
the reactive properties of the glial cells, but also normal retinal function (Wunderlich et al., 
submitted). Furthermore, we found that the expression of certain potassium channels was 
reduced in animals lacking these IFs (Wunderlich et al., submitted). In the present study, we 
have investigated whether the inability to produce GFAP and vimentin affects the rate of 
progression of photoreceptor cell degeneration in a mouse model of RP, the rd1 mouse. A 
functional analysis was performed using electroretinography (ERG) along with tissue 
analysis in which the distribution and levels of expression of several neuronal and glial 
proteins were evaluated. 
 
MATERIALS AND METHODS 
Animals 
Retinas from two groups of C57BL/129 mice were analyzed: mice with retinal degeneration 
(Pde6b mutation, rd1) expressing GFAP and vimentin (rd1, GFAP+/+Vim+/+) and mice lacking 
these IFs (rd1, GFAP-/-Vim-/-) (Eliasson et al., 1999; Pekny et al., 1995) with retinal 
degeneration. Polymerase chain reaction (PCR) genotyping confirmed the presence of the 
rd1 allele (data not shown). Both male and female animals were used for the experiments. All 
experiments were conducted with the approval of the local animal experimentation ethics 
committee. The mice were handled in accordance to the guidelines set by the Government 
Committee on Animal Experimentation at the University of Lund and the ARVO Statement for 
the Use of Animals in Ophthalmic and Vision Research. The mice had free access to food 
and water and were kept on a 12-hour light-dark cycle.  
 
Electroretinogram (ERG) analysis 
Full-field electroretinographic (ERG) analysis was performed in rd1, GFAP+/+Vim+/+ (n=5) and 
rd1, GFAP-/-Vim-/- (n=5) mice at postnatal day (PN) 21, as described previously (Seeliger et 
al., 2001; Tanimoto et al., 2009; Tanimoto et al., 2013). After dark-adaptation overnight, the 
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mice were anesthetized with ketamine (66.7 mg/kg body weight) and xylazine (11.7 mg/kg 
body weight) and the pupils were dilated. Single-flash ERG recordings were obtained under 
both scotopic (dark-adapted) and photopic (light-adapted for 10 min at 30 cd/m2) conditions. 
Single-white-flash-stimulus intensities ranged from -4 to 1.5 log cd*s/m2 under scotopic and 
from -2 to 1.5 log cd*s/m2 under photopic conditions, in ten and eight steps, respectively. The 
ERG equipment consisted of a Ganzfeld bowl, a direct current amplifier, and a PC-based 
control and recording unit (Multiliner Vision; VIASYS Healthcare GmbH, Hoechberg, 
Germany).  
 
Immunohistochemistry 
Rd1, GFAP+/+Vim+/+ and rd1, GFAP-/-Vim-/- mice (PN7 to PN60) were killed with carbon 
dioxide and eyes quickly enucleated. The eyes were fixed in 4% paraformaldehyde in 
Sørensen's buffer (0.1 M; pH 7.2) for 2 hours at 4°C, rinsed, cryoprotected with increasing 
concentrations of sucrose in the buffer, embedded in an albumin-gelatin medium, and frozen. 
Cryostat sections (12 µm) were stored at -20°C until further processing. Air-dried retinal 
sections were blocked with PBS (10 mM, pH = 7.2) containing Triton-X (0.25%), BSA (1%) 
(PBS-T-BSA), and the corresponding normal serum (5%) at room temperature for one hour 
and subsequently incubated with the primary serum (diluted in PBS-T-BSA containing 2% 
normal serum) at 4°C overnight. After thorough rinsing, the sections were incubated with the 
corresponding secondary antibodies diluted in PBS for 90 minutes at room temperature. 
Negative controls were included in which the primary antibody was omitted. Stained sections 
were mounted with an antifading medium, which, in some experiments, contained DAPI for 
visualization of the nuclei (VECTASHIELD®, Vector Laboratories, CA, USA), and were 
examined with a fluorescence microscope (Axiophot, Carl Zeiss Meditec, Inc., Oberkochen, 
Germany). Images were taken with a digital camera and accompanying software (Axiovision 
4.2, Carl Zeiss Meditec) with the same settings for all sections with the same antibody. 
Brightness and contrast of the images were adjusted with Photoshop (Photoshop CS5v., 
Adobe). To facilitate direct comparisons between retinas of different age and/or genotype, 
the images were taken from approximately the same position near the optic nerve head. 
Western blotting 
Mice (PN7, PN14, PN21, and PN60) were killed with carbon dioxide and the eyes quickly 
enucleated. Three to five retinas were pooled and homogenized mechanically in sample 
buffer (2% sodium dodecyl sulphate, 10% glycerol, 0.0625 M Tris-HCl, pH 6.8). The protein 
concentrations were determined with a protein assay kit (DC Protein Assay kit, Bio-Rad, 
Hercules, CA, USA). 10 - 20 µg of protein were separated on 10-15% SDS-polyacrylamide 
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gels and semidry-blotted onto Immobilon polyvinylidene difluoride transfer membranes 
(Millipore, Billerica, MA, USA). After blocking with 5% non-fat dry milk in PBS with 0.1% 
Tween 20 for 2 hours, the membranes were incubated with primary antiserum at 4°C 
overnight and subsequently rinsed. Peroxidase-conjugated secondary antibodies were 
applied for 1 hour at room temperature followed by additional washing steps. The reaction 
was visualized with an enhanced chemiluminescence (ECL) Western Blotting kit and 
Hyperfilm (Amersham Biosciences, Sunnyvale, CA, USA). After a mild stripping in a solution 
containing 0.2 M glycine, 3.5 mM SDS, and 1% Tween 20 with the pH of 2.2, the membranes 
were incubated again to check for the expression of GAPDH as internal loading control. 
 
Antibodies 
Primary serum was applied in the following dilutions for immunohistochemistry (IHC) and 
western blot (WB) analysis, respectively: rabbit anti-aquaporin 4 (AQP4, 1:800 IHC/1:4,000 
WB PN7+14, 1:6,000 WB PN21+60; Sigma-Aldrich, Saint Louis, MO, USA), rabbit anti-Kir2.1 
(1:500 IHC/1:400 WB; Sigma-Aldrich, Saint Louis, MO, USA), rabbit anti-cone arrestin 
(1:1,000 IHC, kindly provided by Cheryl Craft, Univ Southern California, USA), guinea pig 
anti-glutamate-aspartate transporter (GLAST, 1:4,000 IHC/1:40000 WB), rabbit anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1:2,000 WB, Abcam, Cambridge, 
UK), mouse anti-glutamine synthetase (GS, 1:2,000 IHC/1:25,000 WB, BD Biosciences, 
Franklin Lakes, NJ, USA), Kir4.1 (1:1,000 IHC/1:500 WB, Alomone Labs Ltd., Jerusalem, 
Israel), rhodopsin (clone RET-P1, 1:400 IHC, Millipore, Billerica, MA, USA), and Sox-9 
(1:500-600 IHC/1:500 WB; Millipore, Billerica, MA, USA). Fluorescein-labeled Peanut 
agglutinin (PNA, 1:500, Vector Laboratories, Burlingame, CA, USA) was diluted in buffer 
containing 300 mM NaCl, 100 µM CaCl2, and 10 mM HEPES (pH 7.5).  
 The following secondary antibodies were diluted 1:200 in PBS for IHC: goat anti-guinea 
pig (Sigma-Aldrich, Saint Louis, MO, USA), Alexa Fluor®594-conjugated goat anti-rabbit, 
Alexa Fluor®488-conjugated goat anti-mouse and goat anti-rabbit (Invitrogen Ltd., Paisley, 
UK), Texas Red®-conjugated donkey anti-mouse and donkey anti-rabbit (Jackson 
Immunoresearch, Westgrove, PA, USA). DyLightTM549-conjugated donkey anti-mouse and 
DyLightTM488-conjugated donkey anti-rabbit (Jackson Immunoresearch, Westgrove, PA, 
USA) were diluted 1:400. The following secondary antibodies for WB analyses were 
conjugated with horseradish peroxidase and raised in goat: anti-guinea pig (1:60,000), anti-
mouse (1:40,000, Jackson Immunoresearch, Westgrove, PA, USA), anti-rabbit (1:30,000, 
Nordic BioSite, Täby, Sweden).   
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RESULTS 
Electroretinographic Analysis 
The rd1 mouse is a well-characterized model for human retinitis pigmentosa (RP), including 
electrophysiological characterization of the disease progression (Gibson et al., 2013; Strettoi 
et al., 2003). Full-field electroretinography (ERG) is a widely used tool to assess the retinal 
function of humans in clinical diagnostics, but also of mice in vision research (Tanimoto et al., 
2013). Stimulation with light flashes of different wavelengths, frequencies and intensities 
result in changes of the summed electrical potentials of the eye. The resulting ERG-
waveforms generally consist of a cornea-negative deflection, the a-wave, which is produced 
by the hyperpolarizing photoreceptors, followed by the positive b-wave representing the 
activity of postsynaptic neurons. Small wavelets, the oscillatory potentials, are superimposed 
onto the b-wave. Altered latencies (time from stimulus onset to response onset), implicit 
times (time from light flash to response peak) and/or amplitudes are usually a characteristic 
measure of a pathological condition. 
 In the present study, we performed single-flash ERG recordings under dark- (scotopic) 
and light- (photopic) adapted conditions to assess and compare the degree of functional 
decline in retinas from rd1, GFAP+/+Vim+/+ and rd1, GFAP-/-Vim-/- mice. Corresponding with 
the advanced photoreceptor degeneration at PN21, the typical ERG pattern was absent in 
both genotypes. The ERG curves were flat and almost indistinguishable from the baseline, 
lacking an a-wave and showing only a very subtle positively deflecting waveform at higher 
intensities that vaguely resembled the b-wave (Fig. 1). Nevertheless, under both scotopic 
and photopic conditions, the b-wave amplitudes were smaller in rd1, GFAP+/+Vim+/+ than in 
rd1 GFAP-/-Vim-/- mice (Fig. 1A, 1B). Light-adapted rd1, GFAP+/+Vim+/+ seemed to have a 
lower sensitivity than rd1, GFAP-/-Vim-/- mice, shown by the need of higher stimulus 
intensities to induce a response (Fig. 1B). Also, a clearly prolonged implicit time and delayed 
return to the baseline could be observed in rd1, GFAP+/+Vim+/+ compared to rd1, GFAP-/-Vim-/- 
mice, especially when superimposing the scotopic recordings of both genotypes with a 
stretched (200%) Y-axis (Fig. 1A). The averaged b-wave latencies, plotted as a function of 
the logarithm of the stimulus intensity in figure 1B, show that there is a delay in the activation 
phase of rd1, GFAP+/+Vim+/+ in comparison to rd1, GFAP-/-Vim-/- mice. At the age of 5 weeks, 
there were no recordable light responses (Fig. 1C). 
 
Morphology/Photoreceptor distribution 
In order to work out possible explanations for the slight electrophysiological differences, we 
compared the overall structure of PN21 retinas by the means of DAPI staining. The typical 
well organized retina-specific layering in three major nuclear layers (outer nuclear layer, inner 
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nuclear layer and ganglion cell layer) and the synaptical layers separating them – the outer 
plexiform layer and the inner plexiform layer – could be observed for both genotypes. The 
thickness of all layers was also comparable between rd1, GFAP+/+Vim+/+ and rd1, GFAP-/-Vim-
/- mice. One exception was the nerve fiber layer at the vitreous side of the retina, which had 
often sheared off in retinas lacking GFAP and vimentin. As a consequence of the advanced 
cell loss by three weeks of age, the outer nuclear layer consisted of only one to two 
remaining cell rows (Fig. 2, top panel). Despite small variations in outer nuclear layer  
thickness between rd1, GFAP+/+Vim+/+ and rd1 GFAP-/-Vim-/- mice, deviations were observed 
also within the same group, such that no consistent differences could be found between the 
two genotypes. Accordingly, only a few cell bodies in the outer nuclear layer were 
immunostained with the rod photoreceptor-specific marker rhodopsin. No photoreceptor 
segments, where rhodopsin is located in healthy retinas, could be observed in either 
genotype (Fig. 2, second panel). The plant lectin peanut agglutinin (PNA), which binds to 
specific carbohydrates on the surface of cone photoreceptors (Blanks and Johnson, 1984), 
labeled synaptic pedicles in the outer plexiform layer, as well as some rudimental 
photoreceptor segments. The majority of all remaining photoreceptors at this stage of the 
disease are cones, although in the normal mouse retina, these cells are, by far, outnumbered 
by rods (Jeon et al., 1998). Yet again, we could not detect any differences between the two 
genotypes (Fig. 2, third panel) following immunostainings using an antibody against cone 
arrestin (Fig. 2, bottom panel). Taken together, these results indicate that there are no major 
morphological differences neither in the structure of the retina nor in the outer nuclear layer, 
in particular, that could explain the electrophysiological differences observed between the 
two genotypes. 
 
Analysis of retinal glial proteins 
Since the expression of intermediate filaments is strongly up-regulated in the rd1 mouse 
retina from PN11 onwards (Ekström et al., 1988; Wunderlich et al., 2010), one could expect 
that the lack of GFAP and vimentin might have an impact on the levels of other molecules 
normally expressed in reactive Müller cells (and astrocytes) in the degenerating retina. We 
therefore examined the expression of several established glial cell markers and of proteins 
involved in fundamental functions of retinal glia cells, such as uptake and recycling of 
glutamate from the extracellular space and homeostasis of potassium and water.  
 Western blot analysis of retinal lysates from PN7, PN14, PN21, and PN60 mice for the 
SRY-box 9 (SOX9) protein resulted in an equally sized double band in both genotypes at all 
ages (Fig. 3). Immunohistological evaluation of this protein in retinal sections of PN21 rd1, 
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GFAP+/+Vim+/+ and rd1, GFAP-/-Vim-/- mice revealed similar SOX9 expression in the nuclei of 
Müller cells (Fig. 4A, B) and in the retinal pigment epithelium (not shown) in both genotypes. 
 The levels of the glutamate aspartate transporter (GLAST) were low at PN7 and 
increased with age in both genotypes, but were slightly reduced in rd1, GFAP-/-Vim-/- 
compared to rd1, GFAP+/+Vim+/+ mice. There was no glutamine synthetase (GS) expression 
detectable at PN7, but increasing levels were found from PN14 and onwards, with weaker 
bands for rd1, GFAP-/-Vim-/- mice than for rd1, GFAP+/+Vim+/+ at PN14 and PN21 (Fig. 3). 
Immunolabeling showed strong glutamine synthetase (GS) staining in Müller cell bodies in 
the inner nuclear layer as well as their processes in all retinal layers (Fig. 4C, D). A slightly 
decreased staining intensity could be noted in PN21 rd1, GFAP-/-Vim-/- mice, reflecting the 
reduced expression levels.  
 Expression of the inwardly rectifying potassium channel Kir2.1 was found in Müller cell-
bodies and -processes of both genotypes at PN21, but the fluorescence intensity was overall 
stronger in the rd1, GFAP+/+Vim+/+ than in the rd1, GFAP-/-Vim-/- (Fig. 4E, F). Indeed, the 
levels of Kir2.1 in Western blots were found to be lower in rd1, GFAP-/-Vim-/- than in rd1, 
GFAP+/+Vim+/+ mice, which was especially prominent at the ages PN14 and PN21 (Fig. 3). 
Kir4.1 was not detectable at PN7 by western blotting, but double bands with increasing 
protein amounts with increasing age could be observed from PN14 onwards (Fig. 3). There 
was a lower Kir4.1 expression in mice lacking GFAP and vimentin, which could also be 
appreciated in the immunostainings; antiserum against Kir4.1 distinctively labeled Müller cell 
processes, most prominently in the region of the inner and outer limiting membranes, as well 
as in the proximity of blood vessels in both animal groups. However, the staining intensity 
was clearly reduced in the proximal Müller cell processes of rd1, GFAP-/-Vim-/- mice (Fig. 4G, 
H).  
 The water channel aquaporin 4 (AQP4) was not detectable at PN7, but its levels 
increased significantly with age in both genotypes (Fig. 3). Slightly weaker AQP4-expression 
levels were observed in the GFAP-/-Vim-/- mice at PN14 and PN21. Differences in staining 
intensities or distribution could, however, not be appreciated on immunohistological 
stainings. In both genotypes, AQP4-labeling showed a strong expression of the protein along 
the Müller cell processes. The signal was particularly intense at the Müller cell endfeet in the 
vitreal surface of the retina and around vessels (Fig. 4 I, J).  
 
DISCUSSION 
In the rd1 mouse, a mutation in the Pde6b gene causes photoreceptor cell death (Bowes et 
al., 1990), which is, as in many other pathological conditions, affecting the retina, 
accompanied by glial activation. A common feature of this process of reactive gliosis is the 
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up-regulation of GFAP and vimentin (Ekström et al., 1988), and yet little is known about their 
exact function in the process. As mentioned above, the deficiency of GFAP and vimentin has 
been shown to increase neuronal survival following detachment of the mouse retina 
(Nakazawa et al., 2007; Verardo et al., 2008). In the present study, we have investigated 
which effect the inability to produce (and up-regulate) these IF proteins has on the more 
chronic condition of the rd1 mouse model. For this purpose, we have compared 
electrophysiological function, distribution of photoreceptor cells, and the expression patterns 
of important glial proteins.  
 Predictably, ERG responses of the degenerating retinas were just above background 
noise by PN21. At this age, most rod photoreceptor cells are already lost and only one to two 
cell rows of mainly cones remain in the outer nuclear layer (Fig 2). Large scotopic responses 
cannot be expected even at younger ages due to the non-functional Pde6b in the rd1. 
Indeed, in earlier studies, rod responses were found to be completely absent in rd1 mice at 
any age (Strettoi et al., 2003). Gibson et al., (2013), on the other hand, reported small rod-
mediated b-waves until up to the age of PN16 and PN18, but no responses were detected at 
PN21. These differences could possibly be due to different experimental set-ups and/or the 
use of different mouse strains. We were still able to detect responses from dark-adapted 
animals at PN21, but only at higher intensities (above 0 log cd*s/m2), which could also elicit 
cone responses. Slight differences between rd1 mice expressing GFAP and vimentin and 
those lacking the IFs were detected (Fig. 1). Rod- and cone-driven responses to light stimuli 
were larger in amplitudes and faster with regards to response onset, implicit time and return 
to baseline in rd1 GFAP-/-Vim-/- mice compared to rd1 GFAP+/+Vim+/+  mice. Delayed onset 
and return to baseline, as well as prolonged implicit times compared to normal mice, are 
known characteristics of the progression of the disease in the rd1 mouse (Strettoi et al., 
2003). Cones in the rd1, GFAP-/-Vim-/- mouse retina seemed also slightly more sensitive to 
light than cones in rd1, GFAP+/+Vim+/+ retinas.  
 These results could indicate that the lack of GFAP and vimentin has a small but positive 
effect on photoreceptor cell survival. However, considering the generally very low responses 
seen at PN21, these results are to be taken with caution. Gibson et al., (2013) have shown 
that retinal function only reaches maturity at PN30 in wildtype mice. It is thus possible that 
the improved cone responses result from a developmental delay. Nonetheless, ERG 
responses could no longer be measured at five weeks of age, regardless of the genotype 
(Fig. 1C).  
 Our previous studies have revealed higher b-wave amplitudes in mice lacking GFAP and 
vimentin even without photoreceptor degeneration (Wunderlich et al., submitted). In that 
case, the alterations were assumed to involve the rod system, since no differences were 
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observed under photopic conditions. In the present study, we have therefore examined the 
retinal morphology and the subpopulation of photoreceptor cells in more detail. In DAPI-
stained retinal sections, no obvious difference in the thickness of the nuclear layers was 
noted. The retinal organization was comparable between both genotypes with the exception 
that the innermost layers of the retinas often tended to shear off in GFAP/vimentin-deficient 
mice. This instability has been described before for GFAP-/-Vim-/- mice without any retinal 
degeneration and is explained by lower resistance to mechanical stress during the handling 
of the tissue (Kinouchi et al., 2003; Lundkvist et al., 2004; Verardo et al., 2008; Wunderlich et 
al., submitted).  
 At PN21 in the rd1 mouse retina, very few photoreceptors can be found, and most of 
those remaining correspond to cones. We found no indication that photoreceptors were 
protected in GFAP+/+Vim+/+ mice, as the retinas of both genotypes were comparable in terms 
of number and distribution of rods and cones (FIG. 2). Both groups of animals had only one 
to two cell rows remaining in the outer nuclear layer, consisting of a few rods and mostly 
cones. Rhodopsin, which is normally abundant in rod outer segments, was mislocalized to 
the cell body, which is a common feature of degenerating rods, in which the photoreceptor 
segments are affected first or do not develop properly altogether (Nir et al., 1989). PNA 
labeling of cones did not reveal any differences in cone cell number or distribution, neither 
did the immunostaining with an antibody against the cone specific arrestin. In conclusion, we 
found that the number and distribution of remaining photoreceptors are comparable between 
the two genotypes. The lack of GFAP and vimentin does not seem to affect rod and cone cell 
numbers, at least not to an extent that could explain the electrophysiological alterations. 
The a-wave, reflecting the light-induced closure of sodium channels in photoreceptor 
outer segments, was too low to make out possible differences between the rd1, 
GFAP+/+Vim+/+ and the rd1, GFAP-/-Vim-/- mouse. We can only assume that there was no 
difference, since there were no obvious morphological differences in photoreceptor 
distribution between the two genotypes. More in-depth analyses of the biophysical and 
biochemical properties of the photoreceptors would be necessary to conclude this more 
definitely.  
  GFAP and vimentin are cytoskeletal glial proteins, and the up-regulation of these IFs in 
Müller cells is a well-known reaction to many pathological conditions affecting the retina 
including the photoreceptor degeneration in the rd1 mouse (Eberhardt et al., 2011; Ekström 
et al., 1988; Iandiev et al., 2008a; Lewis et al., 2010; Wunderlich et al., 2010). Even though it 
has been shown that Müller glia cells are not responsible for the generation of the b-wave 
(Lei and Perlman, 1999), it is still debated whether and how much they contribute to this 
response. In every case, Müller cells are important for the maintenance of the homeostasis 
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of extracellular ions and water, as well as for transmitter clearance and recycling (reviewed in 
Bringmann et al., 2006; Newman, 2009), and have thus at least a modulatory role. We have 
therefore investigated, whether the lack of GFAP and vimentin alters some of those 
properties.  
 The SRY-box 9 (SOX9) protein is expressed in Müller cell nuclei (Muto et al., 2009), and 
the fact that the expression level as well as the distribution was similar in rd1, GFAP+/+Vim+/+ 
and rd1, GFAP-/-Vim-/- mice leads to the assumption that the lack of GFAP and vimentin did 
not affect the number of Müller cells. We have also examined two proteins that are involved 
in glutamate homeostasis, namely the glutamate aspartate transporter (GLAST) and 
glutamine synthetase (GS). Both proteins showed a slight reduction in protein expression in 
rd1 mice lacking GFAP and vimentin, particularly at PN14 and PN21 and less so at PN60 
(Fig. 1), concomitant with the transient GFAP up-regulation in normal rd1 mice (Chua et al., 
2013; Strettoi et al., 2002). GLAST is important for the clearing of glutamate from the 
extracellular space to prevent glutamate excitotoxicity and to ensure quick termination of 
neuronal signals (reviewed in e.g., Bringmann et al., 2009). Lower glutamate levels in the 
retina have been reported in rd1 mice compared to age-matched wildtype controls, possibly 
simply because of decreased glutamate release and turnover in association with the 
photoreceptor cell loss (Gibson et al., 2013). Reduced GLAST expression could potentially 
result in higher extracellular glutamate levels and/or prolonged glutamate signaling. This 
could partly underlie the larger b-wave amplitudes and the prolonged response times in rd1 
GFAP-/-Vim-/- mice. However, in contrast to what was seen in the present study, we have 
previously found that GLAST levels were comparable, if not even slightly increased, in 
GFAP-/-Vim-/- mice without a retinal degeneration phenotype, when compared to their 
wildtype controls (Wunderlich et al., submitted). It has been suggested earlier that the 
absence of GFAP impairs the accurate expression, trafficking, and anchoring of GLAST 
(Hughes et al., 2004; Sullivan et al., 2007). The knockout or knockdown of GLAST, on the 
other hand, has been shown to result in suppressed b-wave formation, which we could not 
observe here in rd1, GFAP-/-Vim-/- mice, and prolonged latencies in healthy retinas (Barnett 
and Pow, 2000; Harada et al., 1998). 
 The pharmacological inhibition of GS has also been shown to cause a rapid decrease of 
the b-wave (Barnett et al., 2000). GS converts glutamate to glutamine in Müller glial cells. We 
have shown that GS levels are reduced in rd1, GFAP-/-Vim-/- mice compared to rd1, 
GFAP+/+Vim+/+ (Fig. 3). Lower GS levels have also been reported in non-degenerating GFAP-
/-Vim-/- mouse retinas (Verardo et al., 2008; Wunderlich et al., submitted). A decreased 
glutamate uptake into Müller cells, due to lower GLAST levels, could be the reason for the 
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down-regulated expression of GS, as its expression is regulated by the availability of 
glutamate (Shen et al., 2004).  
 Glutamate uptake is also dependent on a potassium gradient between the intra- and the 
extracellular space, since GLAST counter-transports one K+-ion with each glutamate 
molecule (Barbour et al., 1988; Sarantis and Attwell, 1990). Potassium siphoning by Müller 
cells is mainly carried out by inwardly rectifying potassium (Kir) channels (reviewed in e.g., 
Bringmann et al., 2009). We have previously found that the lack of GFAP and vimentin 
changes the electrophysiological responses of the healthy retina to light stimuli, possibly as a 
result of altered levels and distribution of Kir channels along the Müller cells (Wunderlich et 
al., submitted). Here, we show similar alterations in Kir channel expression in rd1 mice 
lacking these IFs. The overall expression of both Kir2.1 and Kir4.1 is reduced in rd1, GFAP-/-
Vim-/- mice compared to rd1, GFAP+/+Vim+/+ (Fig. 3). Kir4.1 is particularly weakly expressed in 
the proximal processes of Müller cells in the rd1, GFAP-/-Vim-/- mice (Fig. 4H). This 
expression pattern has also been observed in GFAP-/-Vim-/- mice without retinal degeneration 
(Wunderlich et al., submitted). Reduced levels and redistribution of Kir4.1 is characteristic for 
both immaturity and reactive gliosis (reviewed in Bringmann et al., 2000; Bringmann et al., 
2006). Knockout of Kir4.1 has been reported to evoke increased b-wave amplitudes (Kofuji et 
al., 2000; Wu et al., 2004). Similarly augmented b-waves could be observed in experiments 
with intraocular barium injections, which almost completely block the potassium conductance 
in Müller cells (Sharma et al., 2005).  
 The water-channel aquaporin 4 (AQP4) is often co-localized with Kir4.1 (Connors and 
Kofuji, 2006; Fort et al., 2008). However, a direct functional coupling does not seem to exist 
(Ruiz-Ederra et al., 2007; Zhang and Verkman, 2008). In a recent study, we did not observe 
any functional coupling of Kir4.1 and AQP4, as the levels of Kir4.1, but not AQP4, were 
reduced in the intact GFAP-/-Vim-/- mouse retinas compared to the wildtype controls 
(Wunderlich et al., submitted). The decreased AQP4 expression could therefore be a more 
direct effect of the inability to up-regulate GFAP and vimentin in response to photoreceptor 
cell death. Altered distribution of AQP4 has been observed following light-damage in the 
retina (Iandiev et al., 2008a; Iandiev et al., 2008b), but not the rd1 mouse model (Roesch et 
al., 2012). AQP4 is supposedly involved in the hypertrophy of glia upon activation (Auguste 
et al., 2007; Saadoun et al., 2005) and the altered AQP4 expression could be associated 
with this, since Müller cells are less hypertrophic when they lack intermediate filaments 
(Wilhelmsson et al., 2004). 
 In conclusion, our findings do not support the idea that the inability to up-regulate GFAP 
and vimentin is beneficial for photoreceptor survival in the rd1 mouse, an inherited model of 
retinal degeneration, or that it slows down the progression of the disease. The higher b-
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waves in the animals lacking glial IFs do not seem to be an effect of better preserved cone 
function and/or improved photoreceptor survival, but rather an effect of the altered glial 
physiology. The exact mechanisms by which the ERG findings are connected to alterations 
in glutamate metabolism and potassium and/or water siphoning by Müller cells will have to 
be further evaluated.   
 
 
Figure legends: 
Figure 1. Electroretinographic (ERG) evaluation of retinal function in rd1, 
GFAP+/+Vim+/+ and rd1, GFAP-/-Vim-/- mice. In (A), selected single-flash ERGs from rd1, 
GFAP+/+Vim+/+ (green, left column, n=5) and rd1, GFAP-/-Vim-/- (blue, middle column, n=5) 
mice of 3 weeks of age are shown with the overlay in the right column. The vertical lines are 
indicating the timing of the light flash. (B) Averaged b-wave amplitudes, measured from the 
minimum peak to the maximum peak following the light stimulation, are plotted against the 
logarithm of the stimulus intensity in the right panel. In the left panel, the averaged b-wave 
latencies are plotted against the stimulus intensity. Top: scotopic conditions, bottom: 
photopic conditions. Boxes indicate the 25% and 75% quantile range, whiskers indicate the 
5% and 95% quantiles, and the asterisks indicate the median of the data. (C) Selected 
single-flash ERGs from 5-week-old rd1, GFAP+/+Vim+/+ (green, left column) and rd1, GFAP-/-
Vim-/- (blue, right column) mice. The vertical lines indicate the timing of the light flash. 
 
Figure 2. Comparable layering and distribution of photoreceptor cells in the retinas of 
three-week-old rd1, GFAP+/+Vim+/+ and rd1, GFAP-/-Vim-/- mice.  DAPI staining of retinal 
cell nuclei showed similarly organized layering into outer nuclear layer (ONL), inner nuclear 
layer (INL), and ganglion cell layer (GCL). The ONL consisted of one to two cell rows in 
rd1,GFAP+/+Vim+/+ and rd1, GFAP-/-Vim-/- mice (top). Rod photoreceptors were stained with 
an antibody against rhodopsin (RHO; second panel). RHO expression was found in a few 
cell bodies in the ONL. Peanut agglutinin (PNA) staining showed comparably labeled 
synaptic pedicles and rudimental cone photoreceptor segments in both genotypes (third 
panel). Cone arrestin (CAR) expression was detected in cone cell bodies (bottom panel). The 
number and distribution of rods and cones were comparable in rd1, GFAP+/+Vim+/+ and rd1, 
GFAP-/-Vim-/- mice. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell 
layer. Scale bar, 20 µm. 
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Figure 3. Expression levels of glial proteins in the retinas of rd1, GFAP+/+Vim+/+ and 
rd1, GFAP-/-Vim-/- mice of different ages. Western blot analyses of retina lysates were 
performed to compare the levels of the glial proteins SRY-box 9 (SOX9; ~65 kDa), glutamate 
aspartate transporter (GLAST; ~67 kDa), glutamine synthetase (GS; ~45 kDa), inwardly 
rectifying potassium channels Kir2.1 (~48 kDa) and Kir4.1 (~45 kDa), and aquaporin 4 
(AQP4; ~32 kDa) in rd1, GFAP+/+Vim+/+ and rd1, GFAP-/-Vim-/- mice of different ages: PN 
(postnatal day) 7, PN14, PN21, and PN60. The housekeeping proteins glyceraldehyde-3-
phosphate dehydrogenase (GAPDH; ~36 kDa) was used as a loading control.  
 
Figure 4. Localization of glial proteins in the retinas of three-week-old rd1, 
GFAP
+/+
Vim
+/+ and rd1, GFAP-/-Vim-/- mice. (A, B) Müller cell nuclei in the inner nuclear 
layer (INL) were stained with an antibody against the SRY-box 9 (SOX9) protein in both 
genotypes, and appeared to be slightly weaker in rd1, GFAP-/-Vim-/- mice. (C, D) Staining of 
Müller cell nuclei and radial processes for glutamine synthetase (GS) was weaker in rd1, 
GFAP-/-Vim-/- mice compared to the control group. (E, F) The inwardly rectifying potassium 
(Kir) channel Kir2.1 was found in Müller cell bodies and processes of both genotypes, but the 
fluorescence intensity was again overall stronger in the rd1, GFAP+/+Vim+/+ than in the rd1, 
GFAP-/-Vim-/-. (G, H) A distinct Kir4.1 labeling of Müller cell processes was observed, which 
was very prominent in the region of the inner and outer limiting membranes, as well as in the 
proximity of blood vessels. A clearly decreased staining in the proximal radial processes was 
detected in rd1, GFAP-/-Vim-/- mice. (I, J) Aquaporin 4 (AQP4) showed a comparable 
distribution pattern along the Müller cell processes in both genotypes. The signal was 
particularly strong at the Müller cell endfeet in the ganglion cell layer (GCL) and around blood 
vessels. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. Scale 
bar, 20 µm. 
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4.3 Altered expression of metallothionein-I and -II and their receptor megalin 
in inherited photoreceptor degeneration 
Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4809-20. 
Summary 
 
It has been shown that in different models of photoreceptor degeneration, activated Müller 
cells up-regulate the synthesis of several neuroprotective molecules (reviewed in Bringmann 
et al., 2006 and Bringmann et al., 2009). Metallothioneins, a superfamily of proteins with four 
major isoforms (metallothionein-I to metallothionein-IV) are presumable neuroprotectants 
(see above; reviewed in Chung et al., 2008 and West et al., 2008), and numerous insults 
have been shown to cause changes in their expression levels (Chen et al., 2004; Suemori et 
al., 2006; Thiersch et al., 2008; Vázquez-Chona et al., 2004). It has been found that 
metallothioneins can also be released by astrocytes and taken up by retinal ganglion cells 
mediated through the receptor megalin, where they promote neurite outgrowth and cell 
survival (Chung et al., 2008; Fitzgerald et al., 2007).  
In chapter 4.3, the retinal expression patterns of metallothionein-I+II and megalin in two 
different mouse models of retinal degeneration (rd1 and rds) and the RCS rat were 
compared with those of congenic controls by the means of microarray analyses (performed 
by Thierry Léveillard in Paris), semi-quantitative RT-PCR, immunohistochemistry, and 
proximity ligation assays. Metallothionein-I and II RNA levels slightly increased with age in 
normal mouse and rat retinas, and were significantly up-regulated in the course of the 
disease in all three models. Immunohistochemical analyses showed metallothionein-I+II 
protein expression in the RPE of all animals. A small number of metallothionein-I+II-positive 
microglia could be observed in the inner retinas of wildtype mice and of mice with 
photoreceptor degeneration mice between postnatal (PN) 7 and PN11, which was confirmed 
by co-labeling with the microglial markers CD11b and isolectin B4. Additional 
metallothionein-I+II-stained microglia were located in the outer nuclear layer of degenerating 
mouse retinas during the peak of cell death.  
Metallothionein-I+II was strongly expressed in Müller cell bodies and processes of 
degenerating retinas, which was verified by co-stainings with the Müller cell specific markers 
CRALBP and GFAP. GFAP is commonly used to detect Müller cell activation, and the first 
time point when metallothionein-I+II-protein expression was observed in the two mouse 
models coincided with the onset of GFAP expression, some days after signs of oxidative 
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damage and cell death could first be detected by avidin staining and TUNEL assay, 
respectively. In RCS rats, however, oxidative damage and cell death were detected by PN12. 
GFAP staining indicated first Müller cell activation already by PN21, but metallothionein-I+II-
positive Müller cells were not observed before PN32. Metallothionein expression in Müller 
cells was still present at later ages (PN150 in rd1, PN270 in rds, PN449 in RCS), when most 
photoreceptors have already been lost, but mainly in the cell bodies of Müller cells (rds) and 
mainly in the far periphery (rd1). Metallothionein-I+IIexpression does not seem thus to be a 
response to cell death per se, but to changes in one or several factors accompanying glial 
cell activation, where the type and degree of change might determine the onset.  
Megalin expression could be detected in the nerve fiber layer and the photoreceptor 
segments of normal mice. By PN13, megalin expression was more prominent over the 
photoreceptor inner segments, whereas in older animals staining was strongest over the 
outer segments. Additional megalin staining was noted in astrocytes and/or Müller cell 
endfeet and their ascending processes. In rd1 mice, strong staining of the inner retina was 
noted at earlier ages than in wildtype mice. Initially, labeling of the photoreceptor segments 
was also detected, but was significantly reduced by PN15 and absent at PN25. In rds mouse 
retinas, megalin expression was still observed at PN14 but no longer visible at later ages, 
whereas sporadic Müller cell processes appeared labeled. In rats, megalin expression was 
found in the nerve fiber layer, the subretinal space, and in younger animals also in the 
plexiform layers. As opposed to the mouse retinas, positively labeled Müller cell processes 
could not be observed even in older animals (PN202). In retinas of RCS rats, megalin 
staining was initially undistinguishable from that in normal rats, but disappeared completely in 
the photoreceptor segments with age. Co-localization of metallothionein-I+II and megalin in 
retinal sections was assessed by in situ PLA, an assay that only results in positive, punctate 
signal when the two proteins are in close proximity to each other (max. 30-40 nm). In normal 
mouse and rat retinas, a distinct and consistent signal was observed over the photoreceptor 
inner and outer segments, in the ganglion cell layer, and in the nerve fiber layer at the 
examined ages (PN13 to PN40). In the three degeneration models, the same distribution was 
observed in younger animals, while at older ages, signal in the outer retina was absent or 
reduced to a narrow band next to the retinal pigment epithelium. The fact that megalin 
expression is lost in the outer retina during the course of the degeneration is likely to limit any 
potential protective effect of endogenous metallothionein-I+II despite its marked up-
regulation. Moreover, it is possible that increased metallothionein-I+II expression supports 
the various events mediated by glial cells, secondary to photoreceptor degeneration and/or 
supports the glial cells themselves. 
Altered Expression of Metallothionein-I and -II
and Their Receptor Megalin in Inherited
Photoreceptor Degeneration
Kirsten A. Wunderlich,1,2,3 Thierry Leveillard,4 Milena Penkowa,5 Eberhart Zrenner,3
and Maria-Thereza Perez1,6
PURPOSE. To examine in rodent models of retinitis pigmentosa
(RP) the expression of the neuroprotectants metallothionein-I
and -II and of megalin, an endocytic receptor that mediates
their transport into neurons.
METHODS. Gene and protein expression were analyzed in reti-
nas of rd1 and rds mice and in those of RCS (Royal College of
Surgeons) rats of various ages. Glial cell markers (cellular reti-
naldehyde binding protein, CRALBP; glial fibrillary acidic pro-
tein, GFAP; CD11b; and isolectin B4) were used to establish the
identity of the cells.
RESULTS. Metallothionein-I and -II gene expression increased
with age in normal and degenerating retinas and was signifi-
cantly greater in the latter. Protein expression, corresponding
to metallothionein-III, was first observed in rd1 mice in
Mu¨ller cells at postnatal day (P)12 and in rds mice at P16,
coinciding with the onset of GFAP expression in these cells. In
RCS rats, the same distribution was observed, but not until P32,
long after the onset of GFAP expression. Metallothionein-III
was observed also in a small number of microglial cells. Mega-
lin was expressed in the nerve fiber layer and in the region of
the inner and outer segments in normal animals, but expres-
sion in the outer retina was lost with age in degenerating
retinas.
CONCLUSIONS. Induction of metallothionein-I and -II occurs in
the RP models studied and correlates with glial activation. The
progressive loss of megalin suggests that transport of metallo-
thionein-III into the degenerating photoreceptors (from e.g.,
Mu¨ller cells), could be impaired, potentially limiting the ac-
tions of these metallothioneins. (Invest Ophthalmol Vis Sci.
2010;51:4809–4820) DOI:10.1167/iovs.09-5073
Development and maintenance of the retina require thatsufficient levels of survival factors be continuously synthe-
sized and secreted. Predictably, even higher levels are neces-
sary after mutations or injury, and a number of studies have
shown that acute and chronic retinal cell damage triggers
distinct endogenous protective mechanisms. In retinitis pig-
mentosa (RP), a progressive and irreversible loss of photore-
ceptor cells occurs as a result of mutations in primarily rod-
specific genes (http://www.sph.uth.tmc.edu/Retnet/ RetNet is
provided in the public domain by the University of Texas
Houston Health Science Center, Houston, TX). Over time, cone
cells also die, leading eventually to total loss of vision.1,2 In the
course of the disease, prosurvival signaling cascades are acti-
vated in the dysfunctional photoreceptor cells themselves and
in support cells. Numerous endogenous protective molecules
are upregulated, such as growth factors, cytokines, and anti-
oxidants, some of which have also been shown to extend, at
least temporarily, the lifespan of photoreceptors when applied
exogenously.3–7
In the present study, we have examined the expression of
metallothionein-I and -II in three rodent models of RP. Metal-
lothioneins constitute a class of low-molecular-mass (6–7 kDa),
cysteine-rich proteins and exist in four major isoforms. Metal-
lothionein-I and -II are ubiquitously expressed in most tissues,
whereas metallothionein-III and -IV are rather restricted to a
few specific tissues. Metallothionein-I and -II are structurally
and functionally analogous and are often referred to as a single
entity (metallothionein-III in the present study). In the rodent
CNS, they are regulated and induced together by various patho-
genic factors, including metals, hormones, proinflammatory
cytokines, and reactive oxygen species (ROS).8–15
Because of the high abundance of thiol groups, metallothio-
neins bind and release both essential (e.g., zinc) and toxic
metals, serving thereby as intracellular regulating factors
of metal ions during physiological and pathologic condi-
tions.9,14–16 The redox properties of metallothionein, in addi-
tion, enable its own oxidation even by mild oxidants, allowing
zinc to be transferred from metallothionein to other proteins to
subserve numerous cellular functions. Via the metal thiolates,
metallothioneins also exchange zinc with ROS that are scav-
enged during cellular oxidative stress.9,14,16–19
Metallothionein-I and -II are expressed in the retina and in
the retinal pigment epithelium (RPE),20–25 and significantly
higher levels have been observed after intraocular application
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of N-methyl-D-aspartate (NMDA),26 phototoxic insult,27 me-
chanical damage,28 and hypoxic preconditioning.29 Cell loss is
increased after NMDA application in metallothionein-III-defi-
cient mice,26 and a correlation has been suggested between
low levels of metallothionein in retinal pigment epithelial cells
and macular degeneration.22,30–32 Accordingly, induction of
metallothionein in the RPE directly, by plasmid transfection,
and indirectly, by reduction of the adaptor protein p66Shc, has
been shown to contribute to protect these cells against oxida-
tive damage.31,32
More recently, a report showed that metallothionein-III
can also function in a paracrine manner, being secreted by
astrocytes and thus regulating survival and regeneration of
retinal ganglion cell axons.33,34 This effect is mediated through
interaction with megalin, a member of the low-density lipopro-
tein receptor (LDLR) receptor family, which binds and takes
up, not only lipoproteins, but also a range of other ligands,
including metallothionein-III.35–37 In this article, we examine
the expression patterns of megalin and of metallothionein-III
in normal and degenerating retinas.
MATERIALS AND METHODS
Animals
All experiments were approved by the local committee for animal
experimentation and ethics. Handling of animals was in accordance
with the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. The animals were kept on a 12-hour light–dark cycle,
with no limitation of food or water.
The examined animals included rd1 mice, rds mice, and wild-type
(wt) mice (own colonies, homozygous, and C3H/HeA background), as
well as pink-eyed, tan-hooded Royal College of Surgeon rats (RCS;
rdy/rdy; own colony), and congenic wt RCS-rdy rats (kindly provided
by Olaf Strauss, Freie Universita¨t, Berlin, Germany). Wild-type Sprague-
Dawley (SD) rats were purchased from B&K Universal (Uppsala, Swe-
den) and Scanbur (Stockholm, Sweden).
In the rd1 mouse, a mutation in the  subunit of the rod cGMP-
phosphodiesterase gene (Pde6b) leads to a fast degeneration of rods
during the first 3 weeks after birth.38 Homozygous retinal degeneration
slow (rds) mice lack rod and cone outer segments because of a null
mutation in the Prph2 gene (Prph2Rd2) encoding peripherin, and
photoreceptors are lost over a period of several months.39 In RCS rats,
a mutation in the Mertk gene expressed in retinal pigment epithelial
cells leads to the accumulation of photoreceptor outer segment debris
in the subretinal space.40 Although the primary defect is not in a
photoreceptor-specific gene, photoreceptors die within the first 3
months after birth.
Microarray: Sample Isolation Procedures
Neural retinas from wt control and rd1 mice (number of replicates:
wt/rd1),41 were dissected at postnatal days (P) 5 (2/2), 6 (2/2), 7 (3/3),
8 (3/3), 9 (3/3), 11 (3/3), 12 (3/3), 13 (3/3), 15 (3/3), 21 (2/2), 28 (2/2),
and 35 (2/2), resulting in 24 experimental conditions (12 time points 
2 strains). Total RNA was purified by sedimentation through cesium
chloride.42 Double-stranded cDNA was synthesized from 5 g total
RNA (Superscript Choice System; Invitrogen, Carlsbad, CA). The cDNA
was then transcribed in vitro with an RNA transcript labeling kit (ENZO
Diagnostics, Farmingdale, NY), to form biotin-labeled cRNA.
GeneChip Hybridization and Scan
The labeled RNA was hybridized to mouse gene microarrays (MG 430
2.0 GeneChips; Affymetrix, Santa Clara, CA) using standard proto-
cols.43 Quality control reports were generated as published else-
where.44,45 The data were uploaded into Retinobase.46
q-RT-PCR
Retinas of three to five animals per age group were isolated through a
cut in the cornea, snap-frozen separately in liquid nitrogen, and stored
at 80°C until further processing. The following ages were examined
(the number of specimen per age appears in parentheses): rd1 mice at
P7 (4), 11 (4), 14 (5), 21 (4), 28 (5), 60 (4), 120 (3) (total n  29); rds
mice at P7 (3), 14 (3), 17 (3), 21 (4), 28 (3), 60 (3), 120 (4), 280 (4)
(total n  27); wt mice at P7 (4), 11 (4), 14 (4), 17 (3), 21 (4), 28 (4),
60 (5), 120 (4), 280 (3) (total n  35); RCS rats at P8 (3), 15 (3), 22 (4)
28 (4), 35 (4), 43 (4), 60 (4) (total n  26); and SD rats at P8 (3), 15 (3),
22 (4), 28 (4), 35 (3), 43 (3), 60 (3) (total n  23).
After homogenization of the retinas, RNA was isolated (RNeasy
MiniKit; Qiagen, Hilden, Germany), including a DNase treatment step
to remove any contamination of genomic DNA, according to the
manufacturer’s instructions (RNase-Free DNase Set; Qiagen). RNA con-
centration was spectrophotometrically measured and its purity con-
firmed with 260-nm/280-nm absorbance ratios. RNA was reverse tran-
scribed with a kit (QuantiTect Reverse Transcription Kit; Qiagen).
Equal amounts of cDNA were applied for PCR amplification in
triplicate in a thermocycler (LightCycler; Roche, Mannheim, Ger-
many), using SYBR green master-mix (SYBR Green JumpStart Taq
ReadyMix for qPCR Capillary Formulation; Sigma-Aldrich, Stockholm,
Sweden) with a total reaction volume of 10 L in each glass capillary
(LightCycler Capillaries; Roche). The primers indicated in Table 1 were
used in a final concentration of 0.25 M. PCR conditions were set to
95°C for 10 minutes’ initialization, followed by 45 cycles of 5 seconds’
denaturation at 95°C, 8 seconds’ annealing at 62°C, and 4 to 12
seconds’ elongation at 72°C. Fluorescence from the SYBR green that
binds to double-stranded DNA was measured at the end of each
extension period. A calibrator sample, produced by mixing samples of
different genotypes and ages from either mouse or rat tissue, provided
a constant calibration point for all samples within and between runs. A
software program (LightCycler Relative Quantification Software, ver.
1.01; Roche) automatically calculated ratios between calibrator-nor-
malized target and reference. To verify the absence of genomic DNA
contamination, control samples were run in which no reverse tran-
scriptase was included. Also, controls without cDNA but only water
were included in some experiments. Specificity of the PCR template
was verified by melting-curve analysis. Subsequent gel electrophoresis
assured amplification of only one PCR product of the expected size. A
spreadsheet (Excel; Microsoft, Redmond, WA) was used for further
data analysis and graphical visualization. Statistical evaluation was per-
formed online (two-sample t-tests, F-test, one-way ANOVA, Tukey’s
HSD procedure for independent samples, http://faculty.vassar.
edu/lowry/VassarStats.html).
TABLE 1. Primers Used to Amplify Mouse and Rat Metallothionein-I and -II, and -Actin
Gene Forward (5–3) Reverse (5–3) Size (bp)
-Actin47 CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG 153
Mouse metallothionein-I47 GAATGGACCCCAACTGCTC GCAGCAGCTCTTCTTGCAG 104
Mouse metallothionein-II47 TGTACTTCCTGCAAGAAAAGCTG ACTTGTCGGAAGCCTCTTTG 94
Rat metallothionein-I48 GCTGTGTCTGCAAAGGTGC ATTTACACCTGAGGGCAGCA 82
Rat metallothionein-II (adapted from Ref.47) GAATGGACCCCAACTGCTC GCATTTGCAGTTCTTGCAG 94
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Tissue Staining
Eyes were quickly enucleated and fixed with Bouin’s solution (Sigma-
Aldrich, St. Louis, MO) at 4°C overnight and thereafter washed several
times with ethanol of increasing concentrations. After a last dehydra-
tion step in xylene, the eyes were embedded in paraffin. Sections (4–5
m) were stained with hematoxylin and eosin.
Some eyes were fixed with 4% paraformaldehyde in Sørensen’s
buffer for 2 hours at 4°C. The tissue was rinsed several times with the
same buffer and thereafter cryoprotected by increasing concentrations
of sucrose in the buffer. The eyes were embedded in an albumin-
gelatin medium and frozen. Twelve-micrometer cryostat sections were
collected on gelatin/chrome alum-coated glass slides and air-dried
before storage at 20°C.
Immunohistochemistry
Cryosections from one to seven animals of the following ages were
used in the immunohistochemical studies: rd1 mice, P2 to P150 (total
n  53); rds mice, P2 to P274 (total n  29); wt mice, P2 to P150 (total
n  37); RCS rats, P2 to P449 (total n  50); RCS-rdy, P13 to P202
(total n  4); and SD rats embryonic day (E)19 to P60 (total n  15).
The sections were preincubated for 60 to 90 minutes at room
temperature in PBS-TBN: phosphate-buffered saline (PBS) containing
0.25% Triton X-100 (T), 1% bovine serum albumin (BSA), and 2% to 5%
goat and/or donkey normal serum (N). Incubation with primary anti-
bodies was performed overnight at 4°C and included an antibody that
recognizes both metallothionein-III (monoclonal mouse anti-metallo-
thionein E9, 1:50; Dako, Glostrup, Denmark); a polyclonal rabbit anti-
glial fibrillary acidic protein (GFAP, 1:1500; Dako); or a polyclonal
rabbit anti-megalin (1:50; Santa Cruz Biotechnology Inc., Santa Cruz,
CA), all diluted in PBS-TBN. For colocalization studies, the metallothio-
nein-III antibody was applied in combination with rabbit anti-cellular
retinaldehyde binding protein (CRALBP, 1:5000 in PBS-TBN; kind gift from
John C. Saari, University of Washington, Seattle, WA), monoclonal rat
anti-mouse CD11b (1:75 in Tris-buffered saline [TBS] containing TBN;
R&D Systems, Abingdon, UK), Alexa Fluor 594-conjugated isolectin B4
(IB4, 1:50; Molecular Probes, Eugene, OR) in buffer containing 300 mM
NaCl, 100 M CaCl2, and 10 mM HEPES (pH 7.5), or tomato lectin
(1:50 in PBS-TBN; Sigma-Aldrich).
The sections were washed three times with PBS or TBS and incu-
bated for 90 minutes with the corresponding secondary antibody at
1:200: biotinylated rabbit anti-rat (Vector Laboratories, Burlingame,
CA) followed by streptavidin Cy3 (Jackson ImmunoResearch Labora-
tories, West Chester, PA); Texas red sulfonyl chloride-conjugated don-
key anti-mouse (Jackson ImmunoResearch Laboratories); Alexa fluores-
cein isothiocyanate- or Alexa Fluor-conjugated goat anti-mouse or anti-
rabbit (Molecular Probes).
The specificity of the labeling was verified by preadsorbing the
metallothionein-III antiserum with purified rabbit metallothionein
protein (1:5 molar ratio for 4 hours; Sigma-Aldrich) before application
to the sections. A secondary antibody control was also performed on
some sections.
TUNEL Assay
Dying cells were detected with a terminal deoxynucleotidyl transferase
dUTP nick end- labeling (TUNEL) assay (TMR red In Situ Cell Death
Detection Kit; Roche). Briefly, the enzyme solution was diluted 1:9 and
the labeling solution 1:4 in PBS. The two components were mixed
1:4.44 immediately before application to the sections for 45 minutes at
37°C. The reaction was stopped by several washes with cold PBS
before mounting.
Oxidative Stress and Damage Assay
Oxidatively damaged DNA was detected by incubating retinal sections
for 1 hour at room temperature with Texas red- or Alexa Fluor 488-
conjugated avidin (10 g/mL in PBS-TB, Molecular Probes Inc.).49,50
In Situ Proximity Ligation Assay
The proximity ligation assay (PLA; Olink AB, Uppsala, Sweden) was ap-
plied to visualize the co-localization of metallothionein-III and megalin.
In this assay, a signal is produced only when the oligonucleotide-labeled
secondary antibodies (PLA probes) that have been applied bind to the
corresponding primary antibodies (in the present case, metallothionein-
III and megalin) in close proximity.51 The PLA was performed according
to the manufacturer’s protocol, with the reagents provided. All incubation
steps were performed in a humidity chamber at 37°C, except for the
incubation with primary antibodies, which was done at 4°C. Briefly, the
sections were blocked for 30 minutes before incubation with both pri-
mary antibodies (each 1:50) overnight. The slides were washed three
times for 5 minutes each time with TBS-T before incubating with the
secondary anti-mouse and anti-rabbit antibodies conjugated to unique
oligonucleotides for 2 hours. A hybridization and a ligation step followed
for 15 minutes each, with brief and careful washes between. The rolling-
circle DNA amplification was applied for 90 minutes, and the product was
labeled with a complementary DNA linker conjugated to a Tex613 fluoro-
phore for 1 hour. The slides were washed with decreasing concentrations
of SSC buffer (2, 1, 0.2, 0.02) and finally with 70% ethanol before
being air-dried and mounted with the provided antifade medium.
Other stained sections were mounted with antifade medium
(Vectashield; Vector Laboratories) and examined with a fluorescence
microscope (Axiophot; Carl Zeiss Meditec, Inc., Oberkochen, Ger-
many). Images were taken with a digital camera and accompanying
software (Axiovision 4.2; Carl Zeiss Meditec).
RESULTS
Gene Expression
A microarray analysis performed on samples from wt mouse
retinas (P5–P35) showed a modest upregulation particularly of
metallothionein-I with age, noted from P11. In rd1 mouse
retinas, increased expression was observed from P12 to P13
and onward, peaking at P21 for both genes (Fig. 1A).
Gene induction was also verified by q-RT-PCR in retinas of
different ages (Figs. 1B–D). This analysis confirmed that in wt
animals, metallothionein-I and -II levels increase slightly with
age. Significantly higher levels of metallothionein-I were noted
in P21 and older mice than in P7 to P11 animals (P  0.01); for
metallothionein-II, a significant difference was seen between
P7 and P11 and in animals P28 and older (P  0.05). Levels of
both metallothionein-I and -II were significantly higher in P43 and
older normal rats than in younger animals (P8–P15; P  0.05).
The analysis showed also that in the two mouse models,
metallothionein-I and -II gene levels increased relatively rapidly,
whereas in RCS rats, an upregulation was not observed until
weeks after the onset of photoreceptor degeneration, suggesting
that cell death per se is not what triggered metallothionein-I and
-II. In rd1 mouse retinas, significantly higher levels were found
between P14 and P60, but not in older animals (Fig. 1B). In rds
mice, altered expression was found from P14 (metallothionein-II)
and P17 (metallothionein-I; Fig. 1C). At P280, the last time point
examined, gene levels were still several times higher in rds retinas
than in their wt counterparts (Fig. 1C). In RCS rats, an upregula-
tion of metallothionein-I and -II was first observed in the fourth
week of age (Fig. 1D).
It should be noted that the method used to isolate the retina
for gene analysis, although ensuring a quick dissection, does
not control for the amount of RPE contamination in the sam-
ple, and therefore, the increases observed may not correspond
only to stimulated expression in the retina. The immunohisto-
chemical analysis did not allow us to conclusively establish
whether metallothionein-III protein levels changed in the
epithelium, but clearly indicated that they increase substan-
tially with age in the degenerating neural retina.
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Avidin, TUNEL, GFAP, and Metallothionein-III
Wild-Type Mice. In wt mouse retinas, no avidin staining
was noted in the outer nuclear layer (ONL) at any of the time
points examined. A small number of TUNEL-positive cells were
seen in the ONL in the younger ages examined (P7 and P13),
but none at P21 or onward. GFAP labeling was found along the
vitreal margin of the retina and weakly in radial Mu¨ller cell
processes in the far periphery (not shown).
Immunolocalization of metallothionein-III resulted in pos-
itive staining in the RPE, in the inner plexiform layer (IPL), in
sporadic cells with a morphology characteristic of microglia, and in
retinal vessels (Fig. 2F). After preadsorption of the antiserum,
labeling persisted in vessels. The latter were stained also after
incubation of sections with secondary antibodies alone, so a
specific staining could not be verified nor excluded.
rd1 Mice. The number of avidin- and TUNEL-stained cells
detected in the ONL was higher in rd1 retinas than in wt
controls at P8 to P10, mainly in the central areas (Table 2). By
P12 and P13, positive cells were found in all eccentricities
(Figs. 2B, 2C) and at P14, the number of photoreceptor cell
rows was reduced to less than half in the midperiphery (Fig.
2E) compared with age-matched wt controls (Fig. 2A). GFAP
staining of radial Mu¨ller cell processes was noted throughout
the retina from P11 onward (Table 2, Fig. 2D).
Metallothionein-III-positive staining was observed also in
the rd1 mouse in the RPE at all ages examined. Additional
metallothionein-III expression was noted in Mu¨ller cell bodies
and processes in the central retina, near the optic nerve head at
P11 to P12 (Table 2, Fig. 2G). Cellular profiles resembling micro-
glia were also found in the inner retina between P7 and P11 and
in the ONL between P11 and P15 (Fig. 2H). Co-labeling with
microglial cell markers, confirmed the identity of some of these
metallothionein-III-positive cells (see Figs. 5G–I).
Between P12 and P17, an increasing number of metallothio-
nein-III-labeled Mu¨ller cells was observed toward the periph-
ery (Fig. 2I). Staining was observed also in the innermost retina
and could therefore correspond to Mu¨ller cell endfeet and/or
astrocytes.
By P21, the strongest signal was observed in Mu¨ller cell
bodies and processes in the far periphery (Fig. 2J) and more
weakly and in fewer numbers in the midperiphery and central
retina. At later ages (P46, P150), only a few labeled Mu¨ller cells
could still be observed, mainly in the far periphery and close to
the optic nerve head (not shown).
rds Mice. Avidin-stained cells were observed in the ONL in
rds mice from P14 to P16 and TUNEL-positive cells from P12 to
P14 (Table 2). The number of stained cells declined between
the peak at P16 to P18 (Figs. 3B, 3C) and at P270, at which
point three to five rows of photoreceptor cells were still found
(Fig. 3A). Uniform GFAP labeling of Mu¨ller cell radial processes
throughout the retina was observed also at P18 and onward
(Fig. 3D).
FIGURE 1. Metallothionein-I and -II
gene expression by microarray
analysis (A) and q-RT-PCR (B–D).
(A) Expression profiles of wt and de-
generating homozygous rd1 retinas
of corresponding ages. Bars repre-
sent mean  SD. (B–D) q-RT-PCR
analysis of metallothionein-I and -II
expression at different ages in nor-
mal animals (wt mice, SD rats), in
rd1 and rds mice, and in RCS rats.
The bars represent the mean  SEM
of ratios created by comparing, at
different ages, the expression of met-
allothionein-I and -II with that of
-actin in control and in degenerat-
ing retinas. Ratios of a calibrator sam-
ple were set to 1. Statistically signif-
icant differences between control
and degenerating retinas for each
age: *P  0.05; **P  0.01; ***P 
0.001. Differences between ages for
each genotype are given in the text.
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Metallothionein-III expression was observed in the RPE in
rds mouse retinas at all ages examined. In addition, labeled
Mu¨ller cells were noted in rds mouse retinas, but not until P16
(Table 2). Yet, by P18, expression could already be observed
throughout the whole retina in Mu¨ller cell bodies and pro-
cesses (Fig. 3E). This distribution was still observed in older
animals (Fig. 3F), although in 9-month-old animals, labeling was
restricted to the cell bodies only (Fig. 3G). A few microglial
cells appeared also labeled in the younger ages (not shown).
Normal Rats and RCS Rats. Retinas obtained from SD and
from congenic RCS-rdy rats processed for the avidin and
TUNEL assays showed no specific labeling of photoreceptor
cells. GFAP staining was limited also in these specimens to the
innermost retina (not shown). Avidin- and TUNEL-stained cells
were observed in the ONL in RCS rats from P12 onward (Table
2, Figs. 3I, 3J). GFAP labeling of Mu¨ller cell radial processes was
observed from P21 onward (Table 2, Fig. 3K).
Metallothionein-III expression was found in control rat reti-
nas in the RPE and in vessels, as seen with normal mouse retinas
(not shown). In RCS rats, labeling of Mu¨ller cells and processes
was also observed, but not until P32 (Table 2). At this age, less
than half of the photoreceptor layer remains (Fig. 3H). Within a
few days, staining was seen throughout the retina with labeled
processes extending beyond the outer limiting membrane, into
FIGURE 2. Localization of various
markers in wt (A, F) and rd1
(B–E, G–J) mouse retinas: All mark-
ers were detected in the rd1 retina at
P12 to P13, when about half of the
photoreceptor cells remain (E). Spe-
cific metallothionein-III immunore-
activity was observed in the RPE (F,
I, J) and in microglia in the IPL (F, H,
arrows). In rd1 retinas, labeling was
also present in Mu¨ller cells as well as
microglia (arrows) located in the
ONL: (G) P12, central retina; (H) P13,
midperiphery; (I) P17, midperiph-
ery; (J) P21, far periphery. Labeling
of vessels (F, ✱). HE, hematoxylin-
eosin; MT, metallothionein. Scale
bars, 20 m.
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the subretinal space (Figs. 3L, 3M). In older animals (P145, P449),
expression of metallothionein-III was still observed but only in
a few sporadic cells, with accumulation of labeling also in the
subretinal space in some places (Fig. 3N).
Megalin Expression
In younger normal mouse retinas (P6–P40), megalin staining
revealed labeling in the subretinal space and in the nerve fiber
layer (NFL). By P13, expression in the outer retina was still
more prominent over the photoreceptor inner segments (IS;
not shown), whereas at P29 and P40, strong staining was noted
also over the outer segments (OS; Fig. 4A). In older animals,
staining was strongest over the OS and was in addition ob-
served in astrocytes and/or Mu¨ller cell endfeet and their as-
cending processes (Fig. 4B).
In rd1 mice, staining of photoreceptor segments was ini-
tially detected, but was significantly reduced by P15 and absent
at P25 (Fig. 4C). Strong staining was noted also in the inner
retina, but at earlier ages than in normal retinas (Fig. 4C), and
at P46 labeling of proximal Mu¨ller cell processes was already
very prominent (Fig. 4D). In rds mouse retinas, labeling of IS
was still detectable at P14, accompanied by distinct labeling in
the innermost retina (Fig. 4E). At later ages, staining in the
outer retina was no longer visible, whereas sporadic Mu¨ller cell
processes appeared labeled (Fig. 4F).
In young normal rat retinas (SD and rdy), megalin expres-
sion was found in the subretinal space, in the NFL, and in the
plexiform layers (not shown), but decreased in the latter with
age (Fig. 4G). As opposed to normal mouse retinas, staining of
Mu¨ller cell processes was not observed in older animals up to
P202. In retinas of RCS rats, megalin labeling was initially
undistinguishable from that in normal rats. With age, staining
over the photoreceptor segments disappeared completely
(Figs. 4H, 4I).
Co-localization
Most cell bodies and processes expressing metallothionein-
III within the retina were also CRALBP positive (Figs. 5A–C).
Co-labeling with the two markers was also observed in the RPE
in all retinas analyzed (Figs. 5D–F).
Processing of mouse retinas with CD11b, isolectin IB4, or
tomato lectin resulted in labeling of vessels (Figs. 5G–I). In
addition, co-staining with these markers showed that metallo-
thionein-III labeled structures in the ONL of rd1 and rds
mouse retinas corresponded to microglial cells (Figs. 5G–I).
Metallothionein-III labeling of cells resembling microglial
cells was also noted in the IPL in normal (Fig. 2F) and degen-
erating (Fig. 2H) mouse retinas.
Co-localization of metallothionein-III and megalin was as-
sessed in retinal samples using the in situ PLA assay. A distinct
and consistent signal was observed in normal mouse and rat
retinas in the subretinal space, over the photoreceptor IS and
OS and in the ganglion cell layer (GCL) and NFL at the ages
examined (P13–40; Fig. 5J). This distribution was observed in
all three models of degeneration in younger ages (Figs. 5K,
5M), but in older animals, signal in the outer retina was absent
or reduced to a narrow band next to the RPE (Figs. 5L, 5N).
DISCUSSION
The present study confirmed previous reports showing that
metallothioneins are expressed in mouse and rat retinas and
pigment epithelium,20,24,26–29,32 and showed in addition: (1)
that adult expression levels of metallothionein-I and -II are not
reached in normal retinas until around P21 or later; (2) that
metallothionein-III are induced in glial cells in the three
models of hereditary photoreceptor degeneration studied; and
(3) that the receptor megalin is expressed not only in the inner
retina, as previously shown,34 but also in the outer retina, and
that this latter expression is lost in degenerating retinas.
A small but significant increase in metallothionein-I and -II
gene expression levels was observed during the first postnatal
weeks both in mice and rats, which could correlate with the
structural and functional maturation of the retina that takes
place during this period. Expression of these metallothioneins
is tightly regulated by levels of, for example, growth factors
and cytokines, many of which are notably active during early
postnatal retinal development. Increases in expression could
also reflect an increased availability of free zinc. Metallothio-
neins are induced not only to protect cells against potentially
toxic high zinc levels, but seem to be expressed also in asso-
ciation with increases in physiological zinc. Chelatable zinc
and zinc transporters are observed in association with gluta-
matergic synapses52 and co-release of vesicular zinc with glu-
tamate has been shown to occur from photoreceptor terminals
at the level of the outer plexiform layer (OPL).53,54 In addition,
high levels of zinc have been noted around the photoreceptor
IS in light-adapted retina.54,55 Full maturation of both these
retinal regions occurs around the second postnatal week in a
center-to-periphery gradient,56 thus correlating with the in-
creasing levels of metallothionein-I and -II detected, and in
agreement with observations made in the brain.57 However, no
differences were noted in the present study in the expression
of metallothionein-III in developing retinas. There is the
possibility that small increases in protein levels escaped detec-
tion with the antibody used. Alternatively, the increase could
correspond to expression in retinal vessels, which also develop
in rodents during the same period,58 as it has been shown that
endothelial and smooth muscle cells also express metallothio-
nein.59 The specificity of metallothionein-III labeling in the
retinal vessels structures could not be verified in the present
study and needs therefore to be examined further.
A marked increase in both gene and protein expression
was seen, however, in the three models of photoreceptor
degeneration. The microarray and q-RT-PCR analyses
showed that levels of metallothionein-I and -II are signifi-
cantly upregulated in rd1 mice at P12, and that protein
expression can also be observed at this stage in the central
retina in these mice. The increase in expression followed
the center-to-periphery pattern of progression normally ob-
TABLE 2. Ages at Which the Various Markers Were First Detected
Avidin TUNEL GFAP Metallothionein-III
rd1 P8–P10 P8–P10 P11–P12 P11–P12
rds P14–P16 P12–P14 P16–P18 P16–P18
RCS P12–P14 P12–P14 P21–P25 P32–P35
Avidin and TUNEL were detected in the ONL and GFAP and metallothionein-III in Mu¨ller cells and
processes. The time periods indicated reflect individual differences and do not necessarily correspond to
the time point when the markers were uniformly distributed throughout the retina.
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served in this model, but increased protein expression was
still seen in retinas of P46 and P150 animals, when only a
few degenerating cones remained.60,61 The upregulation of
metallothionein-III appears to correlate with glial activa-
tion rather than with the onset of photoreceptor cell death
as such, as the latter was detectable by TUNEL staining as
FIGURE 3. Localization of various
markers in rds mouse (A–G) and RCS
rat (H–N) retinas. At P270 in rds
mice, about half of the photorecep-
tor cells remained (A), although all
markers analyzed were already de-
tected throughout the rds retina in
the first postnatal weeks (B–E). Me-
tallothionein-III staining was ob-
served in the RPE and in Mu¨ller cell
bodies and processes (E–F). In older
animals, staining in Mu¨ller cells was
restricted to the cell bodies (G). In
RCS rats, about half of the ONL was
lost by the first month of age (H).
Avidin and TUNEL staining were ob-
served relatively early (I, J), followed
by GFAP (K) and metallothionein-
III (L, M). The latter was initially
observed in sporadic Mu¨ller cell bod-
ies and processes (L) and in a large
number of cells within a few days
(M). Occasionally, staining was ob-
served in the subretinal space (ar-
rows; L, M). Metallothionein-III
staining was observed also in older
animals in a small number of Mu¨ller
cells (N). HE, hematoxylin-eosin; MT,
metallothionein; SRS, subretinal space.
Scale bars, 20 m.
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early as P9. Further, metallothionein-III expression was
induced mainly in Mu¨ller cells and coincided with the onset
of GFAP expression, one of the earlier indicators of activa-
tion of these cells.62 Such a distribution corresponds to what
has been observed after neuronal damage in various models
of CNS injury, where it is seen that metallothionein-III
accumulate mainly in activated astrocytes, the main source
of these metallothioneins in the brain (see recent reviews in
Refs. 19 and 34).
The accumulation of metallothionein-III observed here in
Mu¨ller cells does not, however, fully correspond to observa-
tions made with a model of light-induced damage.27 In the
latter, an upregulation of metallothionein-III was noted in the
RPE and in the plexiform layers immediately after a 7-hour
exposure to bright light, in the ONL and GCL after 8 hours, and
only in the inner retina 28 hours after exposure,27 with no
obvious expression in the Mu¨ller cells. Bright light exposure
causes massive, immediate damage to photoreceptors, which
involves, at some point, elevated intracellular calcium levels
and an accumulation of reactive oxygen species, which con-
tribute to oxidative damage.63 Most photoreceptors die rela-
tively fast in rd1 mice, compared with those in rds mice or RCS
rats. In rd1 retinas, impaired cGMP-phosphodiesterase activity,38
supposedly also leads to deregulated Ca2 homeostasis, as
suggested by observations that activation of calpain is in-
creased in these retinas64,65 and that application of a Ca2
blocker confers protection.66 Others and we in this study have
found evidence that the rd1 mouse photoreceptors also un-
dergo oxidative damage.50,61 Nonetheless, no accumulation of
metallothionein-III was seen in the present study in photo-
receptors in rd1 mice, as reported to occur after light damage.
As mentioned earlier, metallothionein-III are primarily of
glial origin, and accumulation in photoreceptors would there-
fore require that the metallothioneins be transferred to the
latter. Transport of glial-derived metallothionein into retinal
ganglion cells has recently been shown to occur, where it was
found to modulate axonal regeneration.34 It is possible, thus,
that the events initiated in rd1 mouse photoreceptors are still
not sufficient to induce significant metallothionein synthesis
and accumulation in these cells or that they actually die before
detectable amounts of metallothionein can be found.
However, as found in the present study, metallothionein-
III also did not accumulate in photoreceptors of homozygous
rds mice. In these animals, a mutation of the gene encoding
peripherin leads to the absence of rod photoreceptor disc
membranes and the development of abnormal cone outer seg-
ments.39,67 As a result, the normal compartmentalization of
proteins involved in phototransduction does not occur, alter-
ing expression of at least some genes.68 The inner segments
appear to develop normally but are immediately adjacent to the
microvilli of the RPE.39 We found the first TUNEL-stained cells
in rds retinas at P12 and P14, with the largest number seen
at  P16 and P18, which agrees with previous reports.69,70
Despite this early peak of cell death, complete loss of photo-
receptors was seen only at 12 months of age.39 Yet, no
metallothionein-III was detected in photoreceptors in this
slow-progressing model, but was seen to correlate rather with
some stage of glial activation, as indicated by concomitant
accumulation of GFAP in the Mu¨ller cells.
In RCS rat retinas, overexpression of metallothionein-III
was similarly seen in Mu¨ller cells. Yet, it was not detected until
10 days after the onset of GFAP accumulation in these cells.
In RCS rats, phagocytosis of shed outer segments is not per-
formed due to a mutation in the Mertk gene expressed by
retinal epithelial cells.40 As a consequence, membrane debris
accumulate in the subretinal space, eventually leading to sec-
ondary photoreceptor cell death, which was first detectable by
TUNEL staining at P12 in the present study. We found that
upregulation of mRNA levels of metallothionein-I and -II was
also delayed in RCS rat retinas, indicating that the late expres-
sion of metallothionein-III is not due to slow protein synthe-
sis.
The present study thus shows that metallothionein-I and -II
are induced in the three models of degeneration. The upregu-
lation did not coincide with the onset of photoreceptor cell
loss, but rather with the widespread accumulation of GFAP in
FIGURE 4. Localization of megalin
immunoreactivity in normal and de-
generating retinas. In the young nor-
mal mouse retina (A), megalin immu-
noreactivity was most prominent in
the subretinal space and becomes
more concentrated over the photore-
ceptor outer segments with age (B).
In older animals, the most proximal
processes of Mu¨ller cells were also
labeled (B). In rd1 and rds mice,
staining in the outer retina was ini-
tially weaker and, at older ages, was
absent (C–F). In the latter, Mu¨ller cell
processes were also labeled (D, F).
In normal rat retinas (rdy), megalin
expression was also detected over
the photoreceptor inner and outer
segments (G). In RCS rats, labeling in
the outer retina was lost with age (H,
I). OS, outer segments; IS, inner seg-
ments. Scale bars, 20 m.
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Mu¨ller cells, at least in rd1 and rds mice. In RCS rats, it was
considerably delayed in relation to expression of GFAP. Accu-
mulation of the GFAP is normally associated with the process
of Mu¨ller glia activation,62,71 although it may not necessarily
reflect the time when activation is initiated. We showed, for
instance, in previous studies that glial-derived molecules accu-
mulate in RCS rat retinas long before GFAP upregulation can be
detected and even before signs of photoreceptor cell death.72
Further, although GFAP accumulation occurred in Mu¨ller cells
in the three models, previous studies have shown, for instance,
that the downregulation of inwardly rectifying K (Kir) cur-
rents displayed by Mu¨ller cells and which normally accompa-
nies fast neuronal degeneration is not observed in RCS rats or
rds mice.73,74 Upregulation of metallothionein-III, as other
features of Mu¨ller cell activation, may therefore not corre-
late always with the same specific events triggered in these
cells.
Furthermore, like other glial-derived factors, metallothio-
nein-III levels can be stimulated without neuronal cell death.
It is therefore possible that upregulation is not a response to
cell death, but to changes in one or several factors accompa-
nying or even preceding cell death, where the type and degree
of change determine the onset of metallothionein-III expres-
sion. Previous studies have shown that the levels of free glu-
tamate are increased as photoreceptors degenerate and that
uptake and metabolism of glutamate by Mu¨ller cells is im-
paired, at least in some cases.75,76 As mentioned, zinc is co-
released with glutamate in several neuronal structures, includ-
ing photoreceptor terminals.77,78 Detectable levels of zinc
have in fact been found, not only in the terminal region, but
throughout the rod photoreceptor cell.77 It could thus be
speculated that zinc leaking from dysfunctional/dying photo-
receptors is one of the initial triggers of metallothionein-I and
-II expression. Zinc transporters (ZnT) are localized through-
FIGURE 5. Colocalization of various
markers (A–I) and in situ PLA assay
(J–N). (A) Metallothionein-III stain-
ing, rds mouse, P21; (B) CRALBP stain-
ing, rds mouse, P21; (C) merged image
showing metallothionein-III accumu-
lation in Mu¨ller cells and processes;
(D) metallothionein-III staining, rd1
mouse, P15; (E) CRALBP staining, rd1
mouse, P15; (F) merged image show-
ing metallothionein-III accumulation
in the RPE; (G) metallothionein-III
staining, rd1 mouse, P15; (H) IB4
staining, rd1 mouse, P15; (I) merged
image showing metallothionein-III
accumulation in microglial cells in the
ONL (arrows); accumulation of IB4 in
vessels co-localizes with unspecific
metallothionein-III staining (✱);
(J–N) In situ PLA assay including DAPI
nuclear staining (blue). Dots represent
putative sites of megalin/metallothio-
nein-III interaction (red): (J) wt
mouse, P13: signal in the inner retina
and in the subretinal space, over the
photoreceptor inner and outer seg-
ment region; (K) rd1 mouse, P13: sig-
nal in the nerve fiber layer and reduced
signal in the subretinal space; (L) rd1
mouse, P29: reduction of signal both
in the inner and outer retina; (M) rds
mouse, P18: signal in the inner retina
and in a thin band in the subretinal
space; (N) rds mouse, P110: signal in
the inner retina and diffusely distrib-
uted in the subretinal space. MT, me-
tallothionein; CRALBP, cellular retinal-
dehyde binding protein; IB4, isolectin
B4; SRS, subretinal space. Scale bars,
20 m.
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out the retina, including the photoreceptor inner segment
region and the apical processes of Mu¨ller cells.79–81 An up-
regulation of ZnT was not seen by microarray analysis in rd1
mouse retinas in young ages (P11–P15, P21), when some layers
of photoreceptor cells remain (not shown). Yet, at older ages
(P28, P35), no reduction in expression was observed, despite
the almost complete loss of the photoreceptor cell layer, sug-
gesting that there may indeed be a relative increase over time
in the number of zinc transporters expressed by Mu¨ller cells
and/or other cells in the inner portions of the retina. This
would correlate with our observation that increased metallo-
thionein-III expression was still observed in retinas of rd1
mice and RCS rats long after most photoreceptors had been
lost. Moreover, it is possible that accumulation of other metals,
in addition to zinc, may induce increases in metallothionein-
III expression. In RCS rats, the concentrations of iron and
copper are also increased in the outer retina.82,83 Although it is
not clear how these increases are produced, their accumula-
tion in the subretinal space could contribute to the triggering
of metallothionein-III upregulation in Mu¨ller cells.
A critical question is also whether the increases noted in
endogenous metallothionein-III levels actually contribute to
prolonged photoreceptor survival in the course of degenera-
tion and how protection would be mediated. The endocytic
receptor megalin has been recently shown to mediate the
internalization of exogenous and glial-derived metallothionein-
III into neurons, including retinal ganglion cells.34 The
present study confirmed that megalin is expressed in normal
retinas in the NFL and showed that it is also expressed in the
IS and OS region of the retina at all ages analyzed. This distri-
bution correlates well with the sites of metallothionein-III
expression and the concept that the latter mediates its func-
tions, at least in part, through interactions with megalin.33,34
Of note, the pattern of megalin expression changed with age in
the normal retina, and accumulation was eventually observed
also in Mu¨ller cells, at least in mouse retinas. As megalin
mediates the transport of not only metallothioneins but of
several other ligands,35,36 this could explain its localization in
Mu¨ller cells in the normal retina, even in the absence of
metallothionein-III.
The expression of megalin observed in the outer retina in
normal mice and rats was lost very early in degenerating retinas
(confirmed by a lack of signal in this region using the PLA
assay) and was probably due to the loss of the outer and inner
segments as photoreceptors degenerate. In the degenerating
mouse retinas, megalin expression was instead seen in the
processes of Mu¨ller cells at younger ages than in normal ani-
mals. This expression did not correlate with the increases in
metallothionein-III expression in Mu¨ller cells and may in-
stead be a consequence of the loss of megalin expression in the
subretinal space region. Cubulin, another multiligand endo-
cytic receptor is found to be co-expressed with megalin in
epithelial cells where they mediate the reabsorption of retinol-
binding proteins, for example.84 Defects of chloride channels/
transporters have been shown to cause retinal degenera-
tion,85,86 possibly involving alterations in megalin and cubilin
function. Metallothionein-III could thus be transported by
either megalin or cubilin receptors in the outer retina.87 How-
ever, the activity of cubilin has been shown to depend on the
presence and activity of megalin.88 It appears thus that if
metallothionein-III were to exert a protective effect on pho-
toreceptors, it would not involve megalin- or cubilin-mediated
transport of metallothioneins in the outer retina, which could
also explain why we found no metallothionein-III labeling in
the photoreceptors.
Inability to produce endogenous metallothionein-III has
been shown to exacerbate ganglion cell loss after intraocular
injections of N-methyl-D-aspartate,26 but not the loss of photo-
receptors induced by hyperbaric oxygen exposure,89 suggest-
ing that the dependence on metallothionein for survival varies
with the type of insult and/or the type of cell affected. More-
over, it is possible that increases in metallothionein-III levels
occur, not to protect photoreceptors, but to support the vari-
ous events mediated by glial cells, secondary to photoreceptor
degeneration and/or to support the glial cells themselves. The
activity and function of Mu¨ller cells is regulated by several
factors, including cytokines such as IL-6, acting through signal
transducer and activator of transcription 3 (STAT3).90 The
latter targets several genes, including metallothionein-I and
-II,91,92 suggesting that upregulation of these metallothioneins
is both a cause and an effect of glial activation. The same may
apply to RPE and microglial cells, which we found also to
express metallothionein-III and which react to damage and
injury by upregulating various cytokines.93,94
In summary, although the initial triggers of photoreceptor
dysfunction differ in the three models studied, common pro-
cesses are eventually activated, including an upregulation of
metallothionein-III. The onset of their expression did not
coincide with that of cell death (nor of glial activation in RCS
rats), suggesting that stimulation of these metallothioneins is
controlled, at least in part, by different events in the three
diseases. As to the role of metallothionein-III in photorecep-
tor degeneration, one might argue that cell loss progresses in
the three models studied despite upregulation of metallothio-
neins and of several other neuroprotective factors. However,
whether endogenous metallothioneins actually protects pho-
toreceptors would have to be verified in genetic experiments.
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4.4 Sialoadhesin expression in intact degenerating retinas and following 
transplantation 
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5602-10. 
Summary 
 
 
There is increasing evidence that the immune system is implicated in the pathogenesis and 
progression of retinal diseases such as age-related macular degeneration (AMD), glaucoma 
and diabetic retinopathy (Hageman et al., 2005)(Joussen et al., 2004). It is still unknown 
whether or not immune responses contribute to the progression of retinal cell loss in Retinitis 
Pigmentosa, but it is very likely that they have an effect on the outcome of cell-based 
therapies. Sialoadhesin, a macrophage-restricted cell adhesion molecule, has been shown to 
support immunoregulating functions influencing T-cell behavior in a pro-inflammatory manner 
(Wu et al., 2009), and participates in the recognition and discrimination of pathogens versus 
‘self’ (reviewed in Klaas and Crocker, 2012). It is usually expressed in secondary lymphatic 
tissues. Although normally not present in the central nervous system, retinal 
microglia/macrophages were found to express sialoadhesin in the course of the disease in 
the retinal degeneration slow (rds) mouse (Hughes et al., 2003), suggesting a breakdown of 
the blood-retina barrier. In chapter 4.4, the expression of sialoadhesin was examined in the 
rd1 mouse, an established model for human Retinitis Pigmentosa, as well as after subretinal 
transplantation of neonatal retinal tissue. 
During the course of the retinal degeneration in rds and rd1 mice, microglia that were positive 
for the microglia marker protein CD11b invaded the outer nuclear layer. Still, no sialoadhesin 
expression was detected at any time point. However, after transplantation of neonatal retinal 
cells, derived from PN2 GFP mice, to both, normal and degenerating (rd1) eyes, 
sialoadhesin positive cells could be observed within the graft, at the graft-host interphase and 
in the subretinal space. Due to the size and the anatomy of the mouse eye, the graft needed 
to be delivered through the sclera, which could disrupt the cellular and molecular base of the 
immune-privilege normally observed in mouse eyes (Al-Amro et al., 1999; Jiang et al., 1993; 
Lund et al., 2003). It is thus not absolutely certain whether the expression of sialoadhesin is a 
reaction to the transplant or to the combination of the transplant with tissue damage. Since 
most sialoadhesin positive cells were not GFP positive, they most likely derived from the 
host. Even if sialoadhesin-mediated immune responses do not seem to participate in the 
disease progression in rd1 and rds mice, the occurrence of its expression could be of 
significance for the integration and long-term survival of retinal grafts.  
Sialoadhesin Expression in Intact Degenerating Retinas
and Following Transplantation
Javier Sancho-Pelluz,1,2,3 Kirsten A. Wunderlich,1 Uwe Rauch,4 F. Javier Romero,2
Theo van Veen,1,3 G. Astrid Limb,5,6 Paul R. Crocker,7 and Maria-Thereza Perez1,8
PURPOSE. Resident microglial cells normally do not express
sialoadhesin (Sn; a sialic acid–binding receptor), whereas re-
cruited inflammatory macrophages have been shown to do so.
The expression of Sn was examined in the course of photore-
ceptor cell degeneration and after transplantation.
METHODS. Sn expression was analyzed in retinas of rd1 and rds
mice. For transplantation studies, neonatal (P2) retinal cells
derived from GFP mice were injected intraocularly in adult rd1
mice and control mice. Antibodies recognizing different Sn
epitopes, CD11b, and MHC-II were used to identify activated
microglial cells in intact retinas and 21 days after transplanta-
tion.
RESULTS. In rd1 mice, a few CD11b-positive cells were ob-
served in the outer nuclear layer in the central retina at post-
natal day (P)11 and in increasing numbers between P12 to P21.
In rds mice, CD11b-expressing cells were found from P16
onward. No Sn-expressing cells were observed within the rd1
or rds mouse retinas at any of the ages examined (up to P150).
Specific staining was observed only in cells found in the vitre-
ous margin of the retina and in surrounding tissues (sclera,
cornea, ciliary body, choroid). After transplantation to normal
and rd1 mice, a variable number of Sn-positive cells were
detected within the grafts, in the graft–host interface, and in
the subretinal space.
CONCLUSIONS. The significant activation of microglia/macro-
phages observed in the various stages of degeneration in rd1
and rds mouse retinas is not accompanied by Sn expression.
However, Sn-expressing cells are observed after transplanta-
tion. The occurrence of such cells could be of significance for
the integration and long-term survival of retinal grafts, as the
expression of Sn could facilitate other phagocytic receptors.
(Invest Ophthalmol Vis Sci. 2008;49:5602–5610) DOI:10.1167/
iovs.08-2117
Retinitis pigmentosa (RP) is a genetically and phenotypicallyheterogeneous family of inherited blinding diseases, with a
prevalence of 1:3500 to 1:4000.1,2 It develops as a result of
defects in genes responsible for the structural and/or func-
tional integrity of photoreceptor cells (http://www.sph.uth.
tmc.edu/Retnet/ RetNet is provided in the public domain by
the University of Texas Houston Health Science Center, Hous-
ton, TX). The progressive loss of these cells leads to character-
istic alterations, such as a reduced ability to dark adapt (night
blindness), gradual constriction of the visual field (tunnel vi-
sion), accumulation of intraretinal pigment deposits, and even-
tually loss of central vision.3
Earlier studies have established that the primary rod photo-
receptor cell loss, observed in most forms of RP, occurs by
apoptosis,4–6 although it appears, at least in some cases, to
involve activation of effectors other than caspases.7 A funda-
mental question is why cone photoreceptor cells invariably
degenerate when mutations occur in rod-specific genes. A lack
of rods is likely to lead not only to a lack of rod-derived
structural and paracrine support,8–10 but also to alterations in,
for example, retinal oxygen metabolism, as well as to disrup-
tion of glutamate and calcium homeostasis, which also affects
the rest of the retina.7,11–13 Accordingly, numerous reports
have shown that secondary pathologic changes, such as reac-
tive gliosis, neuronal remodeling, retinal pigment epithelium
(RPE) cell proliferation and migration, vascular attenuation,
and neovascularization, occur in retinas of several RP animal
models and in patients.11,14–16 It is therefore important to
consider that responses elicited in the other retinal cells (neu-
ronal and nonneuronal) are very likely to affect the progression
of the disease and ultimately also the outcome of potential
treatments.
There is strong evidence that the immune system may play
a central role in the pathogenesis of another group of photo-
receptor degenerative diseases, age-related macular degenera-
tion (AMD).17 Several studies have implicated inflammation
and immune system activation in the progression of retinal cell
loss in other prevalent ocular diseases, as well, such as diabetic
retinopathy and glaucoma.18–21 Although whether inflamma-
tion and other immune responses contribute to the progres-
sion of photoreceptor cell loss in human retinitis pigmentosa
and animal models is still unresolved, it is likely that they play
a role in the outcome of cell-based therapies designed to treat
photoreceptor degeneration. Several studies have explored the
use of various cell types (e.g., neuroretinal cells, retinal pig-
ment epithelial cells, brain and retinal precursors, and
Schwann cells) in retinal transplantation approaches aimed at
slowing down the progression of the degenerative process or
reconstructing the degenerating retina.22–26 Although intraoc-
ular grafts are seen to thrive for relatively long periods, it is
clear that host immune responses are triggered,27–29 ultimately
limiting the survival and function of the grafts.
Sialoadhesin (Sn), also known as CD169 or Siglec-1, is the
prototypic member of the Siglec (sialic acid binding Ig-like
From the 1Department of Ophthalmology and 4Vessel Wall Biol-
ogy Group, Lund University, Lund, Sweden; the 2Fundacio´n Oftalmo-
lo´gica del Mediterra´neo (FOM) and Universidad Cardenal Herrera-CEU,
Valencia, Spain; 3Experimental Ophthalmology, University Eye Hospi-
tal, Tu¨bingen, Germany; the Divisions of 5Pathology and 6Cell Biology,
UCL Institute of Ophthalmology, London, United Kingdom; the 7Well-
come Trust Biocentre, University of Dundee, Dundee, United King-
dom; and the 8Department of Ophthalmology, University of Copenha-
gen, Glostrup Hospital, Glostrup, Denmark.
Supported by European Union Grant LSHG-CT-2005-512036 and
MEST-CT-2005-020235; The Foundation Fighting Blindness; Swedish
Medical Research Council Grant MTP12209; Crown Princess Margare-
ta’s Committee for the Blind; Stiftelse fo¨r Synskadade i f.d. Malmo¨hus
La¨n; Crafoordska Stiftelsen; and Thorsten och Elsa Segerfalks Stiftelse.
Submitted for publication April 2, 2008; revised June 1, 2008;
accepted October 22, 2008.
Disclosure: J. Sancho-Pelluz, None; K.A. Wunderlich, None; U.
Rauch, None; F.J. Romero, None; T. van Veen, None; G.A. Limb,
None; P.R. Crocker, None; M.-T. Perez, None
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked “advertise-
ment” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Maria-Thereza Perez, Department of Oph-
thalmology, Lund University, BMC B13, S-221 84, Lund, Sweden;
maria_thereza.perez@med.lu.se.
Investigative Ophthalmology & Visual Science, December 2008, Vol. 49, No. 12
5602 Copyright © Association for Research in Vision and Ophthalmology
lectin) family of cellular interaction molecules. Sn is a cell
surface adhesion receptor that binds preferentially to a partic-
ular subpopulation of sialic acids, negatively charged carbohy-
drate residues that are found on the cell surfaces and glyco-
proteins.30–32 It is constitutively expressed at high levels by
subsets of macrophages, for example, in the perifollicular
zones of lymphoid tissues and in the inner marginal zone of the
spleen, but can be expressed also by inflammatory macro-
phages, promoting their adhesion to T cells, to neutrophils, or
to other activated macrophages.33 It has been shown to be
expressed by macrophages in the eye after experimental auto-
immune uveoretinitis and to contribute to the inflammatory
response elicited in this model.34,35 It has also been reported to
be expressed in retinal microglia/macrophages in a model of
photoreceptor degeneration, the retina degeneration slow
(rds) mouse.36
The present studies were conducted with the purpose of
examining the distribution of Sn in the rd1 mouse model of
human RP,37,38 a model extensively used to elucidate the
mechanisms of photoreceptor cell death, and after transplan-
tation of retinal cells in this same model. Sn expression was
examined with several monoclonal antibodies recognizing the
different epitopes of Sn.
MATERIALS AND METHODS
Animals
The experiments were conducted with the approval of the local animal
experimentation and ethics committee. Animals were handled accord-
ing to the guidelines on care and use of experimental animals set forth
by the Government Committee on Animal Experimentation at the
University of Lund and the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research.
Retinal degeneration 1 (rd1), rds, and corresponding control wild-
type (wt) mice were used for studies on the expression of retinal
CD11b, Sn, and MHC. Animals were bred on a homozygous back-
ground (rd1: C3H/HeA or C57BL6/129; rds: C3H/HeA; and wt: C3H/
HeA or C57BL6/129; own colonies), and maintained on a 12-hour
light-dark cycle, with free access to food and water. They were killed
with carbon dioxide at different ages (rd1: postnatal days (P)7–P150,
n  24; rds: P8–P30, n  16; and wt: P11–P150, n  8). Eyes were
thereafter quickly enucleated and immersed in a solution of 4% para-
formaldehyde (PFA) in Sørensen’s buffer (pH 7.4) for 2 hours at 4°C.
The tissue was subsequently rinsed, cryoprotected in the same buffer
containing increasing concentrations of sucrose, embedded in an al-
bumin-gelatin medium, frozen, and stored at 20°C. The sections were
obtained on a cryostat (12 m), collected on gelatin/chrome alum-
coated glass slides, air-dried, and stored at 20°C until further pro-
cessing. Some eyes from all groups were enucleated, quickly frozen
without prior fixation (n  8), and stored at 80°C. Retinas from
wild-type control mice were also dissected from the pigment epithe-
lium under cold Sørensen’s buffer and transferred to a 3-m pore filter
(Millipore AB, Solna, Sweden) with the photoreceptor side down. The
attached flattened retinas were fixed for 5 minutes with 4% PFA and
rinsed thereafter with Sørensen’s buffer.
Transplantation
For the transplantation studies, neonatal (P2) retinal tissue derived
from transgenic mice expressing green fluorescent protein (GFP,
C57BL6) was injected intraocularly in adult (P55 to P70) rd1 mice and
in wild-type control animals (C57BL6/129), as previously de-
scribed.39–40 Briefly, the eyes were enucleated from GFP mouse pups
and the neural retinas carefully dissected (without RPE or the optic
nerve head region). The retinal pieces were kept for up to 20 minutes
in Ames’ medium (Sigma-Aldrich, St. Louis, MO) at 4°C until trans-
planted. The recipients were anesthetized with an intraperitoneal
injection of xylazine (100 mg/kg; Rompun; Bayer AG, Go¨teborg, Swe-
den) and ketamine (100 mg/kg; Ketalar; Parke, Davis & Co., Morris
Plains, NJ) and locally anesthetized with 1% amethocaine hydrochlo-
ride. Donor tissue was drawn into a plastic (polyethylene) pipette tip
(GELoader Tip, Eppendorf, Hamburg, Germany) connected to a preci-
sion microsyringe, and injected (1.0 L total volume) through the
sclera into the superior subretinal or epiretinal space of recipients.
Twenty-one days after transplantation, the recipients were killed with
carbon dioxide and the surgically altered eyes (rd1, n  7; wt, n  8)
were enucleated and processed as just described. A group of animals
received a subretinal injection of 1.0 L of Ames’ medium alone (sham
surgery; rd1, n  3; wt, n  4). No immunosuppression was used.
Immunohistochemistry
Retinal sections were thawed and air dried before preincubation for 60
to 90 minutes at room temperature in Tris-buffered saline (TBS; pH 7.2)
containing 0.25% Triton X-100 (TBS-T), 1% bovine serum albumin
(BSA), 50% fetal bovine serum, and 20% normal serum (goat or rabbit).
Immunohistochemistry was performed overnight at 4°C, with rat anti-
mouse monoclonal antibodies (Abs) that recognize different Sn
epitopes: CD169 (four different batches of clone 3D6.112; 1:75; Sero-
tec, Oxford, UK) and SER-4 (1:20; provided by author PRC).41 MOMA-1
(rat anti-mouse metallophilic macrophage antibody), which has been
recently shown to recognize Sn42 was also used (1:75; BMA Biomedi-
cal, Augst, Switzerland). To identify microglia/macrophages, CD11b
(monoclonal rat anti-mouse; 1:75; R&D Systems, Abingdon, UK) was
used. In addition, a rat anti-mouse I-A/I-E monoclonal antibody (clone
M5/114.15.2; Alexa Fluor 647–conjugated; 1:100; BioLegend, San Di-
ego, CA) was used to detect major histocompatibility complex (MHC)-
II–expressing cells. All primary antibodies were diluted in TBS-T con-
taining 5% goat or donkey normal serum. The tissue was subsequently
rinsed and incubated for 90 minutes with one of the following second-
ary antibodies: Alexa 594 goat anti-rat, Alexa 488 goat anti-rat (1:200;
Invitrogen-Molecular Probes, Leiden, The Netherlands), Texas-red don-
key anti-rat (1:200; Jackson ImmunoResearch Laboratories, West
Grove, PA), or biotinylated rabbit anti-rat IgG (HL, 1:200; Vector
Laboratories, Burlingame, CA), followed by anti-biotin streptoavidin-
cy3 (1:400; Jackson ImmunoResearch Laboratories). The sections were
rinsed and mounted (Vectashield; Vector Laboratories). Flat-mounted
retinas were processed in a similar manner, except that incubation
with the primary antibody was performed for 48 hours at 4°C.
In addition to testing different antibodies recognizing Sn, a series of
further control experiments were performed by including the follow-
ing: (1) sections obtained from the spleen of adult normal mice (C3H
and C56BL6/129; n  2). Pieces of the spleens were either fixed,
cryoprotected, and sectioned as described earlier (n  2) or frozen
without prior fixation (n  2); (2) eyes and spleens from Sn-deficient
mice42 (C56BL6; n  2); (3) sections from fresh-frozen retinas (n  9).
The sections were thawed, air-dried, fixed in cold acetone for 10
minutes, rinsed and further processed for immunohistochemistry. Im-
munodetection was also performed with the avidin-biotin complex
(ABC) method. Retinal sections were incubated with the primary
antibodies as described earlier, followed by a biotinylated rabbit anti-
rat secondary antibody (1:75; Vector Laboratories) for 45 minutes.
Staining was performed using ABC and diaminobenzidine (DAB) sub-
strate kits (Vectastain ABC Elite; Vector Laboratories), according to the
manufacturer’s protocol (n  3). Sections were washed, dehydrated,
and mounted. An additional control was also performed by omitting
the primary antibody and incubating ocular and spleen sections with
secondary antibodies alone. Epifluorescence and confocal microscopes
were used to examine the sections (Carl Zeiss Meditec, Inc.,
Oberkochen, Germany). Images were captured with digital cameras
and software (Axiovision 4.2 and LSM5 Pascal, respectively; Carl Zeiss
Meditec). Image-analysis software (Photoshop; Adobe, San Jose, CA)
was used for contrast and brightness adjustment of images.
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RESULTS
Microglial Cell Activation in Intact Retinas
In wild-type control mice, CD11b-positive cells were found
mostly in the inner retina, over the inner plexiform (IPL) and
ganglion cell (GCL) layers, and at the level of the outer plexi-
form layer (OPL). The labeled cells exhibited a typical ramified
morphology and were observed in both the central and the
peripheral retina (Fig. 1A). The morphology and localization of
these CD11b-expressing cells indicate that they correspond to
microglial cells.
In the rd1 mouse retina, a large number of labeled cells
were also noted in the outer nuclear layer (ONL; Fig. 1B). The
first cells were observed in this layer at postnatal day (P11) in
the central areas of the retina, but were seen in the whole
retina as early as P17 to P18. From P21 onward, when the ONL
consists of only about one cell row, it was no longer possible
to determine the exact localization of the labeled cells in the
outer retina. Most labeled cells were then observed in the OPL
and occasionally also in the subretinal space. The same distri-
bution of CD11b-positive cells was seen in all rd1 mouse
retinas, irrespective of the strain examined (C3H/HeA or
C57Bl6/129). In the rds mouse retina, a few CD11b-positive
cells were also observed over the ONL both in the central and
peripheral retina from P16 onward (Fig. 1C).
Sn in Intact Retinas
In this study, it was essential to verify the specificity of the
Sn-recognizing antibodies, and this was accomplished with
several assays. Staining of spleen sections obtained from nor-
mal animals revealed the presence of immunoreactive macro-
phages in the inner marginal zone with all batches of anti-
CD169 antibodies examined (Fig. 2A), whereas no specific
staining was observed with any of the batches in Sn-deficient
mice (Fig. 2B). The same was observed after staining with
MOMA-1 (Fig. 2C) and SER-4 (Fig. 2D). No labeling was noted
in the ocular tissues of Sn-deficient animals with two of the
batches of anti-CD169 tested (hereafter referred to as CD169-
specific; Fig. 2E), whereas staining with the two other batches
resulted in labeling of some cells in the peripheral retina and
choroid (Fig. 2F) and within the degenerating retina (see be-
low). These batches of anti-CD169 are hereafter referred to as
nonspecific. The observations were consistent whether using
unfixed or fixed spleen and ocular tissues and irrespective of
the detection method used.
With the specific CD-169 antibodies, no labeled cells were
observed in the retina of wild-type control mice at any of the
examined ages (Figs. 3A, 3B). Labeled cells were, however,
observed in the ciliary body (Figs. 3C, 3D), in the sclera (Fig.
3E), and between the lens and the retina. Many of the latter
appeared to adhere to the vitreous–retinal surface (Fig. 3A). In
Sn-deficient mice, no labeled cells were noted in these ocular
tissues when the specific CD169 antibodies were used (Fig.
FIGURE 1. CD11b expression. (A)
Wild-type control mouse retina at
P13: labeled cells were seen in the
inner retina over the IPL and at the
level of the OPL. (B) Rd1 mouse ret-
ina at P14: numerous labeled cells
were also seen in the ONL and in the
subretinal space. (C) Rds mouse ret-
ina at P21: CD11b-positive cells were
seen in the inner retina, in the OPL,
and in small numbers in the ONL.
Scale bars, 50 m.
FIGURE 2. Sn expression in the spleen and retina with different anti-
bodies. (A) Wild-type mouse spleen: characteristic localization of
CD169-labeled macrophages in the marginal zone with all antibodies
tested. (B) No specific signal was observed in the spleen of Sn-deficient
mice. (C, D) The same distribution of labeled macrophages was seen in
the spleen of wild-type mice with MOMA-1 (C) and SER-4 (D). (E) No
labeling was observed in ocular tissues in Sn-deficient mice with
CD-169 specific antibodies. (F) CD-169-positive cells (arrowheads)
were seen in the choroid in Sn-deficient mice with the nonspecific
antibodies. chor, choroid; OS, outer segments. Scale bars, 50 m.
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3F). These antibodies and MOMA-1 and SER-4 antibodies also
produced no signal in rd1 or rds mouse degenerating retinas at
any of the ages examined (Figs. 4B–J) and detected only occa-
sional cells in the other ocular tissues (Figs. 4D, 4G, 4J).
With the nonspecific CD169 antibody batches, however,
several stained cells were noted over the ONL and in the
subretinal space in rd1 mice (Fig. 4A) and in rds mice (not
shown).
Sn after Transplantation
After subretinal transplantation in wild-type control mice, GFP-
positive cells were noted within the ONL, where many of them
assumed the position and morphology of photoreceptor cells
(Figs. 5A, 6B). Little or no migration of graft cells was noted in
transplantation to rd1 mice (Figs. 5C, 5E, 5G, 5I, 5K).
Transplantation resulted in a variable number of Sn express-
ing cells within the grafts and at the graft-host interface, both
in transplantation into wild-type (Fig. 5B) and rd1 mice (Figs.
5D, 5F). In addition, labeled cells were found in the subretinal
space in the vicinity of the grafts, even after intravitreous
grafting (Figs. 5F, 5H). The same observations were made with
the specific CD169 antibodies, MOMA-1, and Ser-4. The extent
of the detachment produced in the host retina by the surgery
and the size of the grafts varied considerably between the
different specimens, precluding a reliable quantitative analysis.
However, there was no indication that the number of Sn-
expressing cells was higher in transplantation into rd1 mice
than in transplantation into wild-type mice.
MHC-II Expression
No MHC-II-labeled cells were detected within the retina of
unoperated, normal or rd1 mice. However, a highly variable
number of MHC-II-expressing cells were observed in both
FIGURE 3. Sn expression in the eye detected by specific CD169 anti-
bodies. (A, B) Wild-type mouse retina at P13 (A) and P150 (B): staining
was not observed within the retina, with occasional labeled cells seen
only along the vitreous margin of the retina (arrow). (C–E) CD169-
positive cells are observed in wild-type animals also in the ciliary body
and retinal margin (arrowheads), in the intravitreous space (arrow),
and in the sclera (✽). No specific labeling was observed in the sclera of
Sn-deficient animals (F). The image in (D) was taken from a flat-
mounted retina. Scale bars, 50 m.
FIGURE 4. Sn expression in the retina of rd1 (A–E) and rds (F–J) mouse retinas. (A) A large number of stained cells (arrowheads) over the ONL
in rd1 mouse retina at P14 detected by a nonspecific CD169 antibody. No staining was observed within the retina with specific antibodies at P14
(B; CD169), P150 (C, CD169), P15 (D, MOMA-1), or P15 (E, Ser-4). The same was observed in rds mouse retinas with specific CD169 antibodies:
P8 (F), P16 (G), P18 (H), P21 (I), and P30 (J). A few cells found next to the vitreous margin of the retina were labeled with all antibodies (A, D,
G, J, arrows). Scale bars, 50 m.
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groups after transplantation. Positive cells were mostly found
within the grafts and in the graft–host interface (Figs. 6A, 6C),
but were occasionally observed also in the subretinal space. In
three cases (of nine), a large number of labeled dendriform
cells were seen near the host ciliary body (Figs. 6D, 6F). These
cells were observed after transplantation in both rd1 (n  2)
and wild-type (n  1) mice. As observed with Sn, most MHC-
II-positive cells did not coexpress GFP (Figs. 6C, 6F), suggest-
ing that some of them should be of host origin. No Sn or
MHC-II expression was noted within the retina or subretinal
space in sham-surgery animals (wild type and rd1 mice; not
shown).
DISCUSSION
The present study confirms previous reports showing micro-
glial cell activation in different models of photoreceptor de-
generation.43–49 CD11b-positive cells were visible in the ONL
in rd1 and rds mouse retinas in the early stages of degenera-
tion, which corresponds to observations made using this and
other markers.36,47–50
Sn and Degenerating Retinas
Sn is expressed by activated microglia and macrophages within
the parenchyma in brain tissue only after exposure to plasma
proteins, which occurs as a consequence of damage to the
blood–brain barrier.51 In experimental autoimmune uveoreti-
nitis (EAU), a marked increase in the number of Sn-expressing
cells has been observed in the retina and in other inflammatory
areas in the eye.34,35 It was found in this model that Sn-
expressing cells constitute a subset of activated macrophages
that do not coexpress CD11b or MHC class II, and it was
suggested that they are not involved in antigen presentation,
but correspond rather to phagocytic macrophages.
A slow, but constant migration of blood-borne monocytes
into the retina has been shown to occur even under physio-
logical conditions.52 In addition, changes associated with the
vasculature, such as vascular attenuation and neovasculariza-
tion, and blood–retina barrier breakdown are observed in the
course of photoreceptor degeneration in several animal models
and in patients.14,15,53–55 Such changes are generally consid-
ered to be relatively late events, although we have also de-
tected an alteration of the matrix composition surrounding the
intraretinal vessels in another model of photoreceptor degen-
eration, the Royal College of Surgeons (RCS) rat, at a very early
stage of degeneration.56 In the rd1 mouse retina, increased
levels of monocyte chemoattractant protein (MCP)-1, MCP-3,
macrophage inflammatory protein (MIP)-1, MIP-1, regulated
on activation normal t-cell expressed and secreted (RANTES),
and TNF- have been detected as photoreceptor cell loss
progresses.48,57,58 The expression of aquaporin-4, essential for
the maturation and maintenance of the blood–brain barrier,59
FIGURE 5. Transplantation to nor-
mal (A, B) and rd1 mice (C–L). Sub-
retinal (A–D) and epiretinal (E, F, I,
J) grafts (G) are shown: (A) GFP-ex-
pressing cells were observed within
the ONL of the host (H) wild-type
mouse retina (✽). (B, D, F, H) Sn-
expressing cells were seen in the
graft–host interface (B, D, arrows)
and within the grafts (B, F, short ar-
rows). Labeled cells (arrowheads)
were also found in the subretinal
space near (F) and away (H) from the
grafts. (J, L). The localization of
CD11b-positive cells within the host
retina and in the subretinal space (ar-
rowheads) near an epiretinal graft (I,
J) and away from a subretinal graft
(K, L). Scale bars, 50 m.
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is also elevated in older rd1 mouse retinas.58 It is therefore
reasonable to assume that activated blood-borne macrophages
may be recruited in the process of photoreceptor cell loss, at
least in some types of degeneration.
Yet, our results showed that no Sn expression could be
observed in the rd1 mouse retina in areas of microglial activa-
tion at any stage of the degeneration (0–7 weeks old) or at 5
months of age, when significant vascular alterations are nor-
mally observed.15 It was also not possible to confirm the
observations made previously in rds mouse retinas.36
The observations made in the present study were obtained
with antibodies recognizing different Sn epitopes: clone
3D6.112 (four batches available through Serotec), SER-4, and
MOMA-1. Two batches of 3D6.112 produced distinct labeling
of microglia/macrophages over the ONL in rd1 mice and of
occasional cells in the subretinal space in rds mouse retinas.
On the other hand, none of the remaining four batches of
monoclonal antibodies was seen to produce a specific signal in
the retina of any of these animals. The rds mice examined in
the previous study36 were on a different genetic background
(CBA). However, the possibility that strain differences or
method of tissue fixation account for the lack of signal in
retinal macrophages in rd1 and rds mouse retinas in the
present study appears unlikely. Specific signal was obtained in
the present study with the four remaining antibody prepara-
tions in spleens of all mice tested irrespective of the strain or
method of fixation and was absent in spleens and eyes of
Sn-deficient mice.
Using the specific antibodies, signal was detected in the
present study in subpopulations of macrophages located in
other ocular tissues, as previously found in different mouse
strains.34,60,61 Sn-positive cells exhibiting an elongated or
spherical shape were also observed near the optic nerve head
and scattered in the vitreous cavity, sometimes next to the
inner surface of the retina. In addition, labeling was seen in
some large cells with irregular shape in the retinal margin, next
to and within the ciliary body. Many, if not all of these cells
found in the vitreous and in association with the ciliary body
are likely to correspond to hyalocytes, which also belong to the
monocyte/macrophage lineage.62,63
Retinal Transplantation
The transplantation model used in the present study is well
established and has been used in studies on graft–host integra-
tion.39,64 Limited graft–host integration was observed, with
only a few cells and fibers bridging the graft–host interface,
also confirming previous observations.39,40 After subretinal
transplantation to normal animals, most of the cells that mi-
grated into the host retina assumed the morphology and posi-
tion of photoreceptor cells. This observation agrees with what
has been recently shown in transplantation of dissociated ret-
inal cells obtained from GFP donor mice of the same age as
used in the present study.24 A certain degree of graft–host
integration was also observed after subretinal transplantation
in rd1 mice and in epiretinal transplantation in both wild-type
and rd1 mice. In rd1 mice, most host photoreceptors had
degenerated at the time of transplantation, reducing the ONL
to a thin layer of sporadic cones. Cells with typical photore-
ceptor morphology were no longer identifiable, and integrated
cells were occasionally seen in the inner host layers (not
shown).
Sn and Retinal Transplantation
A highly variable number of Sn-positive cells were observed
after intraocular grafting of retinal cells in both wild-type and
rd1 mice. Overall, only a relatively small number of labeled
cells were seen after transplantation, and these were most
often seen in the graft–host interface and in the subretinal
space in the vicinity of the grafts, indicating that Sn induction
was a localized response. In transplantation to the rd1 mice,
which was performed on adult animals, one would have ex-
pected elevated levels of at least some immune-related genes to
be present at the time of transplantation, due to the ongoing
degeneration. Induction of Sn was not observed during the
process of photoreceptor degeneration as such (the present
study), which may explain why we could not detect any
obvious differences between transplantation to normal and rd1
mice.
The subretinal and epiretinal spaces have been considered
to be immune privileged sites, although this appears not to be
FIGURE 6. Transplantation in nor-
mal (A–C) and rd1 mice (D–F). Sub-
retinal (A–C) and epiretinal (D–F)
grafts (G) are shown: (A) MHC-II-ex-
pressing cells were seen in the graft–
host interface (arrow) and within
the graft. (C) Merged image, showing
in higher magnification the GFP-ex-
pressing cells seen in (B), within the
graft and within the ONL of the host
retina (H), and a cell expressing
MHC-II (red, arrow). A large number
of MHC-expressing cells were seen in
the host rd1 mouse retina (D), exhib-
iting a dendritic shape. Numerous
MHC-II-positive cells (also GFP-nega-
tive) were observed within the
epiretinal graft (D–F). Scale bars, 20
m.
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absolute.65,66 An intrinsic problem associated with sub- and
epiretinal transplantation in rodents stems from the fact that
grafts need to be delivered through the sclera due to the size
and anatomy of the rodent eye. It has been argued that this
transscleral approach may disrupt the cellular and molecular
bases of immune privilege.66,67 Furthermore, subretinal trans-
plantation induces a localized, permanent detachment of the
host retina, a condition that has been shown to lead to micro-
glial activation and to increased levels of several cytokines and
chemokines.19,68 We observed an increase in the number of
Sn-positive cells after transplantation of tissue, but not after
sham operations. It is not possible to determine in transplan-
tation to the mouse eye, whether Sn expression would have
been triggered without the damage to the choroid and associ-
ated structures. It is clear, however, that the surgical trauma
alone is not sufficient to elicit expression of Sn, as it was
observed only in specimens containing a graft. The latter (per-
haps in conjunction with the trauma) is in some way capable of
triggering or exacerbating a localized immune response.
Allogeneic neuroretinal transplants can survive for several
months without immunosuppression.69,70 However, upregula-
tion of MHC class II expression on donor microglial cells27,28
and induction of potent T-cell responses to donor antigens29
have been observed. We observed MHC-II expression on trans-
plantation, but neither after sham surgery nor within the intact
retinas of wild-type and rd1 mice. It was not possible to
establish the origin of all the MHC-II-expressing cells found
within the grafts (subretinal or epiretinal), but those found in
the subretinal space did not coexpress GFP, indicating that
they are most likely derived from the host. The same was
observed for Sn-expressing cells.
The donor neuroretina, even if derived from neonatal
stages, is considered to be an only partially immune privileged
tissue.27,71 A small population of dendritic cells constitutively
expressing MHC class II has been observed in normal, intact
mice in the retinal margin and in the juxtapapillary region.72
Strain differences were noted, but these cells were clearly
identifiable in C57BL/6 mice. Such cells were not observed
until 2 weeks of age,72 and should thus not have been included
in our donor tissue (obtained from 2-day-old C57BL/6 mice),
unless the cells are present at P2 but only mature enough to
express MHC II at approximately 2 weeks. Microglial cells are
also observed in the normal mouse retina as early as embryonic
day (E)11.5, and although their density is reduced after E18.5,
a significant number of cells are found also in the neonatal
retina.73 Further, although attempts were made in the present
study to dissect the donor neuroretina from the RPE, grafts may
contain a small but variable number of these potential antigen-
presenting cells. We can therefore not exclude the possibility
that a fraction of MHC-II (and perhaps also some Sn)-positive
cells were derived from the donor.
It should be noted also that in some specimens, in which
the grafts were placed near the ciliary body, a very large
number of MHC-II-positive cells of host origin were seen in the
peripheral retina and within the graft itself. The proximity to
the peripheral retina, where subpopulations of dendritic cells
have been shown to express MHC-II even in normal retinas,72
may have facilitated the infiltration of these cells into the host
and the graft. These observations point to the fact that the level
of expression of MHC-II, and possibly also that of Sn, is deter-
mined not only by the presence of a graft, but also by the
position of the graft.
It was not determined in the present study whether and to
what extent Sn and MHC-II were expressed in the same cells
after transplantation. However, there seemed to be no direct
correlation between the number of Sn- and MHC-II-expressing
cells after retinal transplantation. Moreover, in a model of EAU,
it was shown that MHC class II/Cd11b and Sn are in fact
expressed in different subsets of activated macrophages.34
In conclusion, the present study showed that Sn is ex-
pressed by host-activated microglia/macrophages after retinal
transplantation in the mouse. Cotransplantation of neonatal
retinal cells with host-strain–derived immature dendritic cells,
which can induce immune tolerance, was recently shown to
lead to a lower number of activated CD8 T cells and to a
better graft survival rate.74 Thus, although allogeneic grafts are
seen to thrive, expression of Sn (and of MHC-II) by donor- and
host-derived macrophages potentially facilitate other phago-
cytic receptors, making the grafts susceptible to long-term
immune responses. Whether transplantation-induced Sn ex-
pression occurs in other species and what implications it might
have must be verified.
The study also shows that Sn is not expressed in rd1 (or rds)
mouse retinas and that its expression is also not significantly
altered in the other ocular tissues in these models. It appears
that cross-reactivity with an unknown protein may have pro-
duced the positive labeling observed with two of the batches
of 3D6.112 tested in this study, which may also explain the
results previously obtained in the rds mouse retina.36 It has
been shown in genetic studies that lack of functional B and T
cells or of complement factor C1q has no impact on the
progression of photoreceptor cell loss in rd1 mice, suggesting
that the classic complement system of innate immunity and
acquired immune responses may not be implicated.75 Yet,
these observations and the fact that Sn is not expressed in
retinal macrophages in the two models studied should not be
taken as definitive indication that immune-related events do
not contribute to photoreceptor cell loss.
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5. General discussion and future perspectives 
When I look at a staining of glial cells, I do not (in the first instance) think about, how 
important they are, or even only how interesting all their functions may be, but I find them 
amazingly beautiful. A beauty that many people will never be able to appreciate (again). 
Blinding diseases can be devastating, as vision is probably the most important sense for 
people, and it is very difficult to lead an autonomous life without it.  
Despite all the knowledge about the genetic backgrounds and disease mechanisms, there is 
until today no adequate treatment of retinal degenerations available. The large heterogeneity 
challenges the otherwise promising approaches of gene therapy immensely. And since 
different complementary pathways of cell death have been found (for example, once 
caspase-driven apoptosis is blocked, necroptosis pathways are initiated; Sato et al., 2013), it 
has become clear that anti-apoptotic and neuroprotective treatments will not reach the goal 
either, unless probably in multiple combinations.  
The major focus of research lies on the dying neurons. This might be understandable, but it 
is important to be aware of secondary reactive changes in neighboring cells and to find out 
more about their effects on normal physiology, disease progression and treatment outcome. 
In chapter 4.1, it was shown that even in the non-reactive state, the intermediate filament 
proteins GFAP and vimentin play an important role in normal physiology. Some of the 
features disclosed in GFAP-/-Vim-/- mice, such as mislocalized potassium channels along 
Müller cells or down-regulated proteins involved in glutamate homeostasis, are known from 
immature as well as gliotic Müller cells (reviewed in Bringmann 2006, 2009), so the outcome 
of these two stages is probably rather similar: impaired neuronal functionality. The up-
regulation of GFAP and vimentin during retinal pathology has generally been regarded as 
negative, not at least by inhibiting neuronal regeneration through glial scars. Neuronal 
survival and regeneration was shown to be much higher in GFAP-/-Vim-/- than in wildtype 
mice, e.g., after retinal detachment (Nakazawa et al., 2007). In chapter 4.2, we could not find 
any beneficial (nor negative) effect of GFAP and vimentin deficiency on the inherited retinal 
degeneration in the rd1 mouse. The actions of GFAP and vimentin might differ between 
different models, possibly reacting differently to chronic insults than to acute damage. 
Müller cells are also known to exhibit neuroprotective functions. Once activated, they secrete 
numerous growth factors, neurotrophic factors and cytokines (reviewed in Bringmann et al., 
2009). One potential neuroprotective protein that is upregulated during glial reactivity is 
metallothionein. Leung et al. (2009) observed that metallothionein that was exogenously 
applied induced GFAP up-regulation as well as other typical gliotic changes in cultured 
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astrocytes. Yet, the metallothionein-induced gliosis was permissive to neurite outgrowth and 
pro-regenerative. These positive actions were regulated via JAK/STAT and Rho signaling 
pathways rather than via the classical, growth-inhibiting MAPK signaling pathway. 
It seems thus, that reactive gliosis has two faces one needs to be aware of. In future 
therapeutic attempts, blocking or initiating certain glial reactions, such as up-regulation of 
intermediate filament proteins, is probably not desirable but instead modulating molecules 
like metallothioneins.  
Sometimes, secondary reactive changes might not even be part of the disease process, but 
be triggered by treatment approaches themselves. Sialoadhesin expression in retinal 
microglia following transplantation could be such a case. In chapter 4.4, no sialoadhesin 
expression was observed at any time during retinal degeneration. But after transplantation of 
neonatal cells, the macrophage-restricted cell-adhesion molecule was expressed by 
microglia/macrophages in the retina. The occurrence of such cells could be of significance 
for the integration and long-term survival of retinal grafts in the otherwise immune-privileged 
retina, as sialoadhesin is known to participate in the recognition and discrimination of 
pathogens versus 'self' (reviewed in Klaas and Crocker, 2012), and to influence T-cell 
behavior in a pro-inflammatory manner (Wu et al., 2009).  
The studies of the present thesis revealed differential functions and secondary effects of glial 
cells in retinal degeneration itself and after treatment approaches. Therefore, the better 
understanding of glial physiology might not only be valuable for putative treatments, but also 
for improvement of diagnostics and their interpretations (e.g. of ERG). Most importantly, it will 
lead to a broader knowledge of the interconnections between different cells that make up one 
functional tissue. 
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6. Summary 
 
The retina is highly specialized and, due to its unique physiology, at the same time a very 
vulnerable neural tissue. Numerous mutations are known today that lead to photoreceptor 
degeneration, and the exact mechanisms causing cell death are still not completely 
understood. However, photoreceptor cell death is not a stand-alone event, but triggers 
secondary reactive changes in other neurons as well as non-neuronal cells. The key goal of 
this thesis was to elucidate some of the dynamics of reactive changes and how these affect 
the progression of photoreceptor cell loss in several models of human retinal degeneration.  
 
Up-regulation of the intermediate filament proteins, glial fibrilary acidic protein (GFAP) and 
vimentin, in astrocytes and Müller cells is a feature of gliotic stress responses in the retina. 
The inability to produce these filament proteins has been shown to alter the reactivity of glial 
cells to numerous insults. For the present study, mice deficient for GFAP and vimentin 
(GFAP-/-Vim-/- mice) were characterized with regards to their retinal function. The 
electroretinography measurements (ERG, experiments performed by N. Tanimoto) revealed 
alterations of the scotopic responses of post-photoreceptor neurons. While 
immunohistochemical and western blot analysis could show that the number of neurons and 
glia was comparable, the expression of glutamine synthetase (GS) and inwardly rectifying 
potassium (Kir) channels was markedly reduced in GFAP-/-Vim-/- and Vim-/-, but not GFAP-/- 
mice. The Kir4.1 channel was also observed to mislocalize along the Müller cells, which 
could possibly underlie the electrophysiological phenotype. 
 
Similar results were obtained from GFAP-/-Vim-/- mice on the rd1 (retinal degeneration 1) 
background. Levels of GS, Kir2.1, Kir4.1, and the water channel aquaporin 4 were lower in 
rd1 mice lacking GFAP and vimentin than in rd1 mice expressing these proteins. According 
to immunohistochemical results, no alteration of the cell death progression could be detected 
although the ERG analysis revealed a small improvement of retinal function. 
 
Müller cells up-regulate also neuroprotective substances upon activation. In chapter 4.3, the 
spatio-temporal expression changes of the putative neuroprotective metal-binding proteins 
metallothioneins were evaluated at RNA and protein levels in the rd1 and the rds (retinal 
degeneration slow) mouse models as well as in the RCS rat. During the course of the 
disease, the expression of metallothioneins was up-regulated in Müller cells and microglia. 
With the proximity ligation assay, a putative interaction with the endocytic receptor megalin 
that mediates the transport of metallothioneins into neurons could be visualized in situ in the 
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inner and outer photoreceptor segments but was lost at later stages of the retinal 
degeneration. 
 
The rd1 and rds mouse models were also employed to evaluate the microglial reactivity 
during retinal degeneration. In association with photoreceptor cell death, microglia migrated 
into the outer nuclear layer and the subretinal space. The macrophage-restricted cell 
adhesion molecule sialoadhesin, which has been shown to support immunoregulating 
functions influencing T-cell behavior in a pro-inflammatory manner, had been reported to be 
present in activated microglia in the rds mouse retina. This fact could not be reproduced with 
the present study, nor were any sialoadhesin-positive cells found in the rd1 model. However, 
after intraocular transplantation of neonatal cells to wildtype and rd1 mice, sialoadhesin-
positive cells were observed in association with the graft and in the subretinal space. 
 
These results add to the evidence that retinal glial cells are important both under 
physiological and pathological conditions. 
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